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Abstract 
Selenium is a micronutrient essential for human health. Low Se intake versus Se 
supplementation have been reported to elevate and lower mortality from colorectal 
cancer. Se is present in selenoproteins including glutathione peroxidases (GPx) 1-4. 
GPxs are antioxidant enzymes that protect cells from excessive oxidative stress and 
they may have a role in maintaining innate immunity homeostasis against 
inflammatory stimulation from exposure to luminal bacteria. This thesis describes 
studies of the regulatory effects of Se depletion and selenoprotein knockdown in the 
gastrointestinal cell line Caco-2 in relation to inflammatory responses. A luciferase 
reporter model was developed in which Caco-2 cells were stably transfected with 
gene constructs in which luciferase expression was under the control of regulatory 
elements that bind the Nuclear Factor-kappa B (NF B), a transcription factor central 
to inflammatory signaling pathways (Chapter 3). As a control reporter luciferase 
coding sequences were linked to a TATA box. When Caco-2 cells expressing these 
constructs were grown in Se-deficient conditions, a 30% increase of reporter activity 
and a 50% increase in endogenous interleukin 8 mRNA levels were observed after 
stimulation with TNF✁. In comparison, no changes in reporter activity were found in 
Se-deficient  cells after stimulation with flagellin (Chapter 4).  Small interfering RNA 
was used to knockdown expression of individual selenoproteins including GPx1, 
GPx4, SelW and SelH (Chapter 5). Knockdown of GPx1 expression by ~55% led to a 
25% decrease of reporter activity and a 17% decrease of IL8 mRNA level after 
stimulation with TNF✁. Knockdown of SelW or SelH expression had no observable 
effect on reporter activity. In addition, Se depletion elevated cellular ROS production 
as assessed by Carboxy-2’7’-dichlorodihydrofluorescein diacetate staining whereas 
GPx1 knockdown had no significant effect (Chapter 5). Knockdown of GPx4 by 85%, 
 - v - 
as assessed by RT-PCR and Western blotting, had little effect on TNF✁-driven 
luciferase activity. However, GPx4 knockdown lowered flagellin-induced reporter 
activity by 20% and interleukin 8 mRNA levels by 40% (Chapter 6). It is concluded 
that 1] low Se supply affects NF B inflammatory response in Caco-2 cells, 2] the 
exact role of different selenoproteins in this effect remains to be elucidated, and 3] the 
endogenous and exogenous inflammatory responses in Caco-2 cells are differentially 
regulated by Se supply and by antioxidant selenoproteins.  
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1.Introduction: 
1.1 Selenium, selenoproteins and human health 
   1.1a Micronutrient Selenium and its implications for human health 
from epidemiological studies and clinical trials 
Selenium (Se) is contained in all foods with levels usually depending on available soil 
selenium in production area. The biological importance of Se was firstly highlighted 
when its low intake correlated with occurrence of several Se-responsive animal 
disorders in cattle and sheep, for example, white muscle disease (Brown and Arthur, 
2001) and impaired immune defence to microbial challenges (Arthur and Boyne, 1985, 
Boyne and Arthur, 1979). Its relevance to human physiology was firstly highlighted 
when the severe cardiovascular defect Keshan Disease was found in the Keshan 
region of Heilongjiang province, China, where the soil is selenium-deficient (Combs, 
2000). Although the aetiology of Keshan Disease is not completely understood, 
susceptibility to virus infection in human heart muscle together with insufficient Se 
intake has been widely suggested to be involved (Beck, 1999, Combs, 2000). This is 
supported by the fact that Se supplementation has almost completely prevented the 
high incidence of Keshan Disease in the region (Beck, 1999). However, since 1979, 
health implications of Se intake have been studied intensively and associated with 
additional aspects including protection against virus infection, bacterial infection and 
carcinogenesis, and is summarized below. 
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Se deficiency has been correlated with vulnerability to infections including Coxsackie 
virus (Beck, 1997, Beck et al., 1995), influenza virus (Beck et al., 2001, Jaspers et al., 
2007) and human immunodeficiency virus (HIV) (Baum et al., 1997, Fawzi et al., 
2005). Coxsackie B4 was among those viruses isolated from the cardiac muscle 
samples of Keshan disease (Beck, 1997). More recent studies, using a mouse model, 
found that under conditions of low Se intake, Coxsackie virus behaved more 
virulently that a benign strain Coxsackie B3 switched into a virulent type (Beck et al., 
1995, Beck, 1999). In HIV infection, relatively low levels of plasma Se were 
associated with 10 fold, and 6 fold, higher risk of mortality from multiple infections in 
adults and children, respectively (Baum et al., 1997, Campa et al., 1999). Se 
supplementation (100-200µg/day) has been recommended in clinical trials for its 
beneficial effect in enhancing immunity (Fawzi et al., 2005). A recent finding has 
demonstrated that increased activity of selenoprotein Thioredoxin reductase 1 has 
inhibitory effects on HIV transactivation protein, which might partially explain Se’s 
effects on HIV infection (Kalantari et al., 2008).  
 
Se has been suggested to enhance resistance to bacterial infection and insufficient Se 
intake is associated with the progression of inflammatory bowel disease (IBD) (Karp 
and Koch, 2006, Halliwell et al., 2000). Inflammatory bowel disease is presumed to 
result from combined etiological events including genetic variations (Stoll et al., 2004, 
Hugot et al., 2001), microbial infections (Hisamatsu et al., 2008, Marteau et al., 2004) 
and possibly insufficient intake of nutrients including Se (Karp and Koch, 2006, 
3 
 
Geerling et al., 2000). As a result, the colon is often characterized by inflammation in 
response to stimulation by the activities and/or the presence of pathogenic or 
commensal micorbes (Wen and Fiocchi, 2004). Se supplementation was suggested to 
be helpful in the control of IBD symptoms (Halliwell et al., 2000, Tirosh et al., 2007), 
and to decrease the need for therapeutic steroids in clinical immunosuppression 
treatment (Karp and Koch, 2006). These observations suggest that there is a close 
association between Se intake and some bacterial infections. 
 
Higher Se status has also been associated with lowered cancer risk. A low serum Se 
level was associated with increased mortality from multiple cancers, with 
gastrointestinal and prostate cancer showing the strongest association (Whanger, 2004, 
Willett et al., 1983, Russo et al., 1997). Se supplementation (200µg/d) in clinical trials 
was linked with lowered cancer risk in prostate, lung and gastrointestinal tract 
compared with placebo (Clark et al., 1996, Duffield-Lillico et al., 2002). In addition, 
Se’s protective effects were suggested to be specific to some, but not all, types of 
cancers and no significant reduction was found, for example, in the risk of skin cancer 
following Se supplementation (Clark et al., 1996). Interestingly, the particular organs 
associated with lowered cancer risk followed Se supplementation are those frequently 
associated with inflammatory challenge, such as the gastrointestinal tract and lung.  
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To summarize, increased Se status has been suggested to improve the outcome of 
virus infection, bacterial infection and carcinogenesis. From these observations, it is 
reasonable to presume that Se has a more general biological role allowing it to 
participate in the maintenance of the host-defence system, such as in the 
gastrointestinal epithelium, where Se particularly exerts its protective effects. 
However, to date Se has been mainly studied as an antioxidant nutrient for its primary 
effect, mainly for the reason that Se is incorporated into the selenoproteins many of 
which are enzymes with antioxidant functions. As a result, a correlation between Se’s 
antioxidant function and its role in the immune-defence system is central to the 
understanding of how Se exerts its biological functions. 
  
 
1.1b  The incorporation mechanism of Se into selenoproteins 
Se is largely, although not exclusively, incorporated into proteins known as 
selenoproteins in the form of the amino acid Seleno-cysteine (SeCys) (Kryukov et al., 
2003). The incorporation of SeCys into the selenoprotein sequence requires the 
interaction between two mRNA elements: the UGA triplet in the coding region and 
the Selenocysteine Insertion Sequence (SECIS) in the 3’ untranslated region (UTR), 
which are present in all selenoprotein mRNAs (Kryukov et al., 2003, Brigelius-Flohe, 
2008).  
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The triplicate nucleotide coding, UGA, is one of the stop signals (UAG, UAA, and 
UGA) and functions to stop polypeptide synthesis during translation. However, in the 
coding of selenoproteins, the biosynthesis of protein sequence is not terminated, but 
the UGA condon is translated into the specific amino acid SeCys (Meplan et al., 2006, 
Bellinger et al., 2009).  
 
The SECIS is a stem-loop structure present in the 3’UTR of selenoprotein mRNAs 
that enables recognition of UGA as the codon of the SeCys, but not a stop signal 
(Kryukov et al., 2003). In all the selenoproteins, SECIS sequences show a low 
similarity in their sequence alignment, but all share a conserved stem-loop secondary 
structure (Berry, 2005). An example of SECIS secondary structure of human GPx4 
(Villette et al., 2002) is given in Figure 1.  
 
The interaction between UGA codon and SECIS recruits additional protein factors, 
including the SeCys-synthesizing tRNASec (Bosl et al., 1997), a specific elongation 
factor EFsec (Meplan et al., 2006) and binding proteins such as the SECIS-binding 
protein 2 (SBP2) (Copeland et al., 2000). The SeCys incorporation machinery is 
shown in Figure 1. 
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Figure 1: Stem-loop structure of SECIS and incorporation of SeCys in 
selenoprotein synthesis 
Incorporation of Se into selenoproteins requires the interaction between UGA codon 
and SECIS, which is in a stem-loop structure conserved in the 3’UTR of all 
selenoprotein mRNAs (example, SECIS of human GPx4 mRNA, shown in (A)). 
Further, recognition of the UGA codon encoding SeCys by SECIS recruits additional 
factors of EFsec, SBP2 and tRNASec and allows insertion of the SeCys into the 
selenoprotein sequence (shown in (B)). (Taken from (Villette et al., 2002) (Meplan et 
al., 2006) ). 
 
The incorporation machinery is essential for the expression of selenoproteins and 
complete loss of Se incorporation causes severe effects. Such effects are shown by the 
tRNASec knock-out mouse model which exhibits a lethal phenotype of prenatal death 
(Bosl et al., 1997). In contrast, genetic polymorphisms in the 3’UTR of selenoprotein 
mRNAs result in functional selenoproteins but with altered biological activities (Berry, 
7 
 
2005, Pagmantidis et al., 2005). To date, polymorphisms with functional implications 
corresponding to the 3’UTR have been reported in selenoprotein genes: GPX4: 
718T>C close to SECIS; SELP: r25191G>A; SEP 15: 811 C>T and 1125 G>A 
(Villette et al., 2002, Meplan et al., 2007, Jablonska et al., 2008, Kumaraswamy et al., 
2000). The 718T>C polymorphism in GPx4 3’UTR has been associated with 
alterations in the 5-Lipoxygenase metabolism pathway (an inflammatory pathway 
described in Section 1.3a) (Villette et al., 2002), and the 1125 G>A polymorphism in 
Sep 15 3’UTR has been associated with an increased risk of lung cancer (Jablonska et 
al., 2008), presumably due to their effects on selenoprotein biosynthesis. In addition, 
mutations in SEPN1 gene, which encodes selenoprotein N that regulates calcium 
homeostasis in muscle (Arbogast and Ferreiro, 2010), have been identified as 
responsible for early-onset myopathy (Maiti et al., 2009).  
 
Despite the shared basic stem-loop structure, SECIS elements in individual 
selenoprotein mRNAs are variable in sequence and this influences their ability to 
incorporate Se (Berry, 2005, Kryukov et al., 2003). Partially as a result of such 
differences, selenoproteins respond differently to changes of Se supply and a 
hierarchy exists in the synthesis of selenoproteins, with some being synthesized in 
higher priority and others in relatively lower priority, especially when Se supply is 
limiting. For example, a known hierarchy in the GPx family is as follows 
(Brigelius-Flohe, 1999, Bermano et al., 1996a): 
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GPx2• •GPx4• •GPx1=GPx3 
Owing to this effect, depletion in Se supply is known to lower dramatically the 
synthesis of a number of, but not all, selenoproteins, e.g. GPx1, SelW and SelH 
(Sunde et al., 2009, Pagmantidis et al., 2005). 
 
1.1c  selenoproteins and their antioxidant function 
So far twenty-six selenoprotein genes have been identified in the human genome 
(Kryukov et al., 2003). Two groups of these selenoproteins, the Glutathione 
Peroxidase (GPx) family (GPx1-4 and GPx6) and the Thioredoxin Reductase (TrxR) 
family (TrxR1-3), are well-characterized antioxidants involved in metabolism of 
reactive oxygen species (ROS) (Lu and Holmgren, 2009, Arthur, 2000). Another 
group of selenoproteins, the deiodinase (DIO) family (DIO1-3), is specifically 
involved in the metabolism of Iodine (I) in thyroid hormones through 
oxidant-reductive activity (Kohrle, 2000, Brown and Arthur, 2001). Of the remaining 
selenoproteins, whereas some may have antioxidant ability, such as selenoprotein W 
(SelW) and selenoprotein H (SelH) (Dikiy et al., 2007), others are proposed to 
function in Se absorption and transportation (such as selenoprotein P, Sel P) (Kato et 
al., 1992), SeCys tRNA synthesis (such as selenophosphate synthetase 2, SPS2) (Xu 
et al., 2007), or their functions remain undefined. Seven selenoproteins, including Sep 
15, DIO2, SelK, SelM, SelN, SelS and SelT, are localized in the endoplasmic 
reticulum (ER), and these selenoproteins may modulate protein folding in response to 
ER stress (Shchedrina et al., 2010, Labunskyy et al., 2009). The 26 selenoproteins 
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together with their respective tissue distributions, subcellular localizations and 
proposed functions are listed in Table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
selenoprotein Tissue distribution Subcellular 
Localization 
Function 
GPx1(c-GPx) All tissues Cytoplasm Antioxidant 
GPx2(GiGPx) Gastrointestinal 
epithelium, liver 
Cytoplasm Antioxidant 
GPx3(p-GPx) Circulation plasma Extracellular Antioxidant 
GPx4(phGPx) All tissues Cytoplasm 
Mitochondria 
Antioxidant 
GPx6 Unknown Unknown Antioxidant 
TrxR1 All tissues Cytoplasm; 
Mitochondria 
Antioxidant 
TrxR2 Liver, kidney, heart Mitochondria Antioxidant 
TrxR3 Testis Cytoplasm Antioxidant 
IOD1 Thyroid, liver, 
kidney 
Plasma membrane T3 T4 metabolism 
IOD2 Thyroid ER membrane T3 T4 metabolism 
IOD3 Brain, muscle, 
placenta 
Plasma membrane T3 T4 metabolism 
SPS2 Wide Cytoplasm SeCys tRNA synthesis 
SelS Unknown ER Protein folding 
SelP Liver; and others? Extracellular Se transporation 
Sep 15 Wide ER Protein folding 
SelW Muscle Cytoplasm Antioxidant? 
SelN Wide ER membrane Calcium homeostasis 
SelR Liver, kidney, 
pancreas 
Cytoplasm? Unknown 
SelT Prostate Unknown Protein folding? 
SelH Unknown Cytoplasm? Antioxidant? 
SelI Unknown Cytoplasm? Unknown 
SelK Unknown Plasma membrane Protein folding? 
SelM Unknown Perinuclear? Protein folding? 
SelO Unknown Cytoplasm? Unknown 
SelV Unknown Cytoplasm Unknown 
Table 1:  Identified selenoproteins, their tissue distributions, subcellular localizations 
and possible functions.  
Taken from (Moghadaszadeh and Beggs, 2006) and modified according to (Dikiy et al., 2007, 
Brigelius-Flohe, 1999, Curran et al., 2005, Voudouri et al., 2003, Jablonska et al., 2008, 
Shchedrina et al., 2010, Labunskyy et al., 2009). (?=not confirmed) 
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More than half of the 26 selenoproteins have been found capable of reducing 
oxidative species, owing to the presence of SeCys in their core catalytic sequences 
(Table1). Se belongs to the same chemical family of Oxygen (O) and Sulphur (S), but 
is more active in its electron transferring ability. In SeCys where the S cofactor of 
cysteine is replaced by a Se cofactor, the catalytic ability to donate two electrons to 
unsaturated oxygen radicals results in a disulphide of glutathione and conversion of 
unsaturated oxygen radicals to saturated radicals, in the cases of selenoprotein 
glutathione peroxidases (GPxs) (Moghadaszadeh and Beggs, 2006, Brigelius-Flohe 
and Kipp, 2009). An example of the clearance of the free radical H2O2 by GPxs is 
presented in Figure 2 and it results in the following overall reaction: 
2 GSH+H2O2 GSSG+ 2H2O 
Afterwards, the glutathione disulphide (GSSG) is recycled to glutathione by 
Glutathione reductase at the expense of NADPH. 
 
In addition to hydrogen peroxide, other free radicals can also be reduced by 
antioxidant selenoproteins. Removal of superoxides or lipid peroxides (ROOH) can 
be conducted by GPx4 (Imai and Nakagawa, 2003), and reduction of thioredoxin is 
through thioredoxin reductases (TrxRs) using NADPH as substrate (Ganther, 1999). 
However, it is worthwhile to emphasize that the reactive oxygen species (ROS) is 
continuously produced in the cells, and its clearance relies on the co-operation of 
many antioxidants, in which Se and antioxidant selenoproteins play an important part. 
The pathways of ROS production and clearance are given in Figure 2 (Droge, 2002).  
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Figure 2: Pathways of ROS production and clearance in the cell environment & 
Reduction of hydrogen peroxide by GPx 
ROS are produced and reduced constantly in the cell environment and a co-operative 
antioxidant system is required for the clearance of ROS (shown in (A), taken from 
(Droge, 2002)), in which antioxidant selenoproteins play an important part. SeCys 
uses Se as a substitute for S in cysteine and allows antioxidant selenoproteins such as 
GPxs to reduce free radicals. An example is given to show the reduction of H2O2 by 
GPx (shown in (B)), in which Se cross-links two GSH molecules and thereafter 
releases two hydrogen atoms to neutralize the unsaturated H2O2 into water.  
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1.1d  Glutathione Peroxidases, SelW and SelH 
The GPx family contains six members (GPx1 to GPx6), which exhibit considerable 
conservation of their catalytic sequences. Except for GPx5, which uses cysteine, 
GPx1-4 and GPx6 incorporate SeCys during translation and their syntheses are 
dependent on Se supply (Brigelius-Flohe, 1999). As shown in Figure 2, GPxs are 
characterized by their ability to metabolise ROS at the expense of glutathione (GSH). 
As a result, oxidative species are reduced and the reduction-oxidation reaction (redox) 
recovers the balance between ROS production and clearance. However, individual 
GPxs are variable in their tissue distribution, subcellular localization, ability to 
incorporate Se, i.e. Se incorporation hierarchy, and preference for different oxidative 
targets they metabolise (Brigelius-Flohe, 1999). The relatively well-studied 
peroxidases GPx1 to GPx4 are discussed below: 
 
GPx1: GPx1, also known as cellular GPx, is expressed thoroughout in all tissues 
including the gastrointestinal tract (Moghadaszadeh and Beggs, 2006). GPx1 is 
located in the cell cytoplasm and is low in the Se incorporation hierarchy. Its mRNA 
expression decreased by >60% in cells grown in Se-deficient medium (Pagmantidis et 
al., 2005), or in rats and mice fed on Se-deficient diet (Sunde et al., 2009, Bermano et 
al., 1995). GPx1 catalyzes mainly the removal of water soluble hydroperoxides but is 
also able to reduce some fatty acid hydroperoxides after these oxidative species 
become disassociated from membranes by phospholipases (Grossmann and Wendel, 
1983). The GPX1 gene encodes 2 transcript variants, but no publications have 
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suggested that the two GPx1 isoforms are functionally different (Mullenbach et al., 
1988).  
 
GPx2: GPx2, also known as gastrointestinal GPx, is expressed only in the cytoplasm 
of gastrointestinal epithelium and liver (Chu et al., 1993). GPx2 is highest in the Se 
incorporation hierarchy in tissues where it is expressed, and therefore the synthesis of 
GPx2 is barely affected by Se depletion, as observed in mice fed on Se deficient diet 
(Sunde et al., 2009, Kipp et al., 2009). Consistent with this, GPx2 mRNA expression 
is slightly elevated in cells grown in Se deficient medium (Pagmantidis et al., 2005). 
GPx2 has similar substrate specificity to GPx1 (Brigelius-Flohe, 1999). The GPX2 
gene encodes one transcript. 
 
GPx3: GPx3, also known as plasma GPx, is secreted from the kidney tubular cells and 
is present in the blood circulation (Avissar et al., 1994). Similar to GPx1, GPx3 is low 
in the incorporation hierarchy. GPx3 targets mainly the soluble hydroperoxides in the 
extracellular environment (Bjornstedt et al., 1994). The GPX3 gene encodes one 
transcript.  
 
GPx4: GPx4, also known as phospholipid hydroperoxide GPx, is expressed in almost 
all tissues including the gastrointestinal tract (Imai et al., 1995). GPx4 is located in 
cytoplasm and mitochondria, is particularly associated with cell membranes, and may 
be also transported into the nucleus in certain cell types (Imai and Nakagawa, 2003). 
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GPx4 is relatively high in the Se incorporation hierarchy and its expression has been 
found to be unaffected or mildly reduced (by ~20%) by Se depletion (Kipp et al., 
2009, Pagmantidis et al., 2005, Bermano et al., 1996b). Compared with the other 
GPxs, GPx4 has a wider selection of oxidative substrates, which include phospholipid 
hydroperoxides (Ursini et al., 1985), lipid hydroperoxides (from cholesterol and 
cholesteryl esters) (Thomas et al., 1990), and thymine hydroperoxide (Bao et al., 
1997). In addition, GPx4 is able to use reductants other than glutathione (GSH) in 
catalysis (Aumann et al., 1997).  
 
Notably, the GPX4 gene encodes 3 transcript variants, cytosolic GPx4 (cGPx4), 
mitochondrial GPx4 (mGPx4) and nuclear GPx4 (nGPx4). Whereas cGPx4 contains 
only the catalytic sequence and locates non-preferentially in the cytoplasm (Maiorino 
et al., 1991), mGPx4 and nGPx4 contain additional leader sequences for 
mitochondrial and nuclear translocation, respectively, and can be transported into 
mitochondria and the nucleus, respectively (Arai et al., 1996, Pfeifer et al., 2001). 
However, nGPx4 is highly specific and has been found to be present only in testis and 
associated with sperm maturation. Owing to the above features, GPx4 has been 
suggested to have evolved to repress oxidative radicals in lipid environments and are 
important in the protection of the mitochondria (Arai et al., 1996, Liang et al., 2007, 
Nomura et al., 1999). 
 
16 
 
The importance of GPxs has been supported by studies using several mouse 
knock-out models. In GPx1 knock-out (GPx1 -/-) mice, despite no apparent 
abnormalities being observed during embryonic development (Ho et al., 1997), 
increased susceptibility to coxsackievirus B3 infection has been identified (Beck et al., 
1998). This mirrors the aetiology of Keshan disease where low Se intake results in an 
increased vulnerability to coxsackievirus infection. In addition, GPx1 -/- mice are 
more sensitive to secondary necrosis or neutrophil-induced cell injury in liver (Bajt et 
al., 2002), to ischemia-reperfusion injury in brain (Crack et al., 2006), to 
Doxorubicin-induced cyto-toxicity in heart (Gao et al., 2008) and to insulin and 
insulin-induced glucose uptake in muscle (Loh et al., 2009). In line with these 
observations, loss of GPx1 antioxidant protection has been associated with decreased 
cell tolerance to oxidative challenge and increased apoptosis. Moreover, in the studies 
of ischemia-reperfusion injury and insulin response, GPx1 deficiency has also been 
correlated with elevated responses of two signalling pathways, namely the NF B 
inflammatory pathway (Crack et al., 2006) and the Akt signalling pathway (Loh et al., 
2009). 
 
Owing to its specific expression and function in gut, the importance of GPx2 has been 
limitedly revealed by the GPx2 knock-out model itself, owing to the lack of 
systematical phenotype. However, GPx2 -/- mice has been found to be sensitive to 
UV-irradation in skin and vulernable to develop keratinocytes-origined carcinomas, in 
which GPx2 has been suggested to control apoptosis as an stress-responsive gene 
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(Walshe et al., 2007). A recent study of the intestinal tissues of GPx2 -/- mice also 
found that GPx2 might be essential for intestinal mucosal homeostasis in a way that 
GPx2 is the main apoptosis regulator in gut (Florian et al., 2010). In the double 
knock-out model of both GPx1 and GPx2, GPx1 -/- and GPx2-/- mice exhibited 
increased sensitivity to microflora challenge and showed increased colonic 
inflammation (Esworthy et al., 2003). Moreover, the GPx1 and GPx2 double 
knock-out mice have also been found to have a higher risk of developing 
gastrointestinal cancer compared with the normal littermates, probably due to the 
effects of repeated occurrence of colitis (Lee et al., 2006). According to two recent 
findings, the increased carcinogenesis in the colon of GPx1 and GPx2 double 
knock-out mice has been associated with aberrant DNA methylation (Hahn et al., 
2008) and COX-mediated malignant cell migration (Banning et al., 2008b). Therefore, 
a protective role of GPx2 has been suggested in the gut epithelium and combined, 
GPx1 and GPx2, deficiencies result in an elevated inflammatory response to intestinal 
stimuli.  
 
Knock-out mice lacking GPx4 exhibit a severe phenotype and die at a prenatal stage 
with arrested embryonic development (Imai et al., 2003a). The inability to restructure 
the cavities during embryogenesis indicates an essential role of GPx4 in programmed 
cell death, i.e. apoptosis. Additional investigations have been performed on GPx4 
haploid insufficient mice (GPx4 +/-), in which GPx4 mRNA, protein and activity 
were reduced to ~50% (Yant et al., 2003). The GPx4 +/- mice were more sensitive to 
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oxidative challenge by  -irradiation and exhibited a lower survival rate than the 
normal littermates (Yant et al., 2003). In addition, the cultured embryonic fibroblasts 
from GPx4 +/- mice were more sensitive to oxidative attacks by t-butyl 
hydroperoxide, hydrogen peroxide or paraquat, and they displayed more abundant 
caspase-3-dependent apoptosis and lipid membrane peroxidation (Ran et al., 2003). In 
contrast, the livers of mice overexpressing GPx4 were resistant to oxidative challenge 
by diquat, and their fibroblast cells were resistant to challenges by t-butyl 
hydroperoxide and diquat (Ran et al., 2004). Taking these results together, GPx4 has a 
critical role in repressing oxidative stress in cells.  
 
To summarize, GPxs are essential antioxidant selenoproteins and their primary 
function is to regulate ROS levels and neutralise the apoptotic lipid peroxidation 
effects of ROS. However, additional biological roles have also been correlated with 
the GPxs. For example, an association between GPx antioxidant protection and 
inflammatory response/inflammatory signalling has been found through the GPx1 
knockout mouse model (Crack et al., 2006, de Haan et al., 2004) and the double GPx1 
and GPx2 knockout model (Esworthy et al., 2003).  
 
Considering the proposed importance of Se to the human immune response (described 
in section 1.1a), knowledge in this area remains limited and investigations to 
understand the mechanisms, through which Se and/or GPxs regulate inflammatory 
signalling, are necessary. A growing number of in vitro studies have been conducted 
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to investigate potential links between the control of redox-signalling and the 
activation of the NF B inflammatory signalling pathway (Gloire et al., 2006). The 
NF B signalling pathways and their regulation by reactive oxygen species (ROS) will 
be reviewed in Section 1.2, and the current knowledge on Se and/or GPxs’ antioxidant 
function, and their possible interaction with NF B responses will be reviewed in 
Section 1.3.   
 
SelW and SelH: In addition to GPx1, SelW and SelH are two other selenoproteins that 
are highly sensitive to changes of Se supply (Sunde et al., 2009). However, their 
biochemical functions are far less well characterized than those of the GPxs. In 
humans, SelW has been detected in various tissues, with high expression in tissues 
including skeletal muscle, heart, brain, prostate, small intestine, and colon 
(Bellingham et al., 2003, Whanger, 2009). SelW has been associated with antioxidant 
protection against H2O2 and H2O2-induced apoptosis in neurons, myoblasts (by 
overexpression studies) and lung cancer cells (by ectopic expression of SelW) (Chung 
et al., 2009, Loflin et al., 2006, Jeong et al., 2002b). In addition, the catalytic ability of 
SelW has been suggested to be dependent on GSH (Kim et al., 2005, Jeong et al., 
2002b). SelW expression in a gut epithelial cell line is highly sensitive to Se supply 
(Pagmantidis et al., 2005). 
 
SelH has also been found in multiple tissues of humans and mice (Kryukov et al., 
2003). Whereas studies overexpressing SelH in a murine neuron Ht22 cell line found 
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decreased cell death after UV irradiation together with decreased superoxide 
production (Ben Jilani et al., 2007, Mendelev et al., 2009), structural analysis suggests 
that SelH belongs to a family containing a conserved CxxC or CxxU motif (C: 
cysteine; x: unspecified amino acid; U: selenocysteine) and exerting a 
thioredoxin-like redox function (Dikiy et al., 2007). Subcellular localization of SelH 
has been suggested to be nuclear (Novoselov et al., 2007), and some authors 
additionally suggest that it binds DNA through its DNA-binding ability and regulates 
genes involved in glutathione synthesis and phase II detoxification (Panee et al., 
2007). However, details in SelH’s antioxidant function remain largely unknown. The 
other members of the CxxU family based on structural similarity include SelW and 
SelT (Dikiy et al., 2007).   
 
The other essential selenoproteins: Clearly, all the selenoproteins are expected to have 
roles in the cell environment. However, so far not all of their functions have been 
clearly defined (Table 1). Of the remaining selenoproteins, the TrxR family members 
(TrxR1-3) are also essential antioxidants and their function has been associated with 
the control of inflammatory response (see below). TrxR1 is expressed ubiquitously in 
all tissues including the human gastrointestinal tract and is located mainly in the 
cytoplasm (Crosley et al., 2007, Lu and Holmgren, 2009). TrxR2 has been detected in 
various tissues including liver, kidney and heart and is located in the mitochondria 
(Crosley et al., 2007). TrxR3 is expressed at high levels in testis and is found in the 
cytoplasm (Lu and Holmgren, 2009).  
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At the expense of NADPH, TrxRs reduce thioredoxin (Turanov et al., 2010) and 
constitute another redox system co-operating with the GSH-reduction system (Figure 
2(A)) (Lu et al., 2009, Mandal et al., 2010). Thioredoxin has been shown to repress 
the DNA-binding activity (and possibly the phosphorylation) of NF B transcription 
factors by modifying the thiol groups (-SH) of cysteine residues of NF B subunits 
(Hayashi et al., 1993, Glineur et al., 2000). Therefore, TrxR1 and TrxR2 may 
positively regulate the NF B inflammatory response. Overexpression of thioredoxin 
has been shown to inhibit NF B activation in Hela cells (Schenk et al., 1994, Hayashi 
et al., 1993) and overexpression of TrxR1 has been found to enhance the 
DNA-binding activity of NF B and the expression of NF B target genes in vascular 
endothelial cells (Sakurai et al., 2004). Furthermore, both of the knock-out mouse 
models of TrxR1 and TrxR2 resulted in embryonic death. This suggested that TrxR1 
was important for cell proliferation and TrxR2 for mitochondria-related apoptosis 
regulation (Conrad, 2009).   
 
TrxR1 and TrxR2 also respond to changes in Se supply. In a Caco-2 cell culture 
model, Se depletion resulted in 27% decrease of TrxR2 mRNA level compared with 
Se-supplemented cells (Pagmantidis et al., 2005). In the endothelial cell line EAhy926, 
neither TrxR2 protein expression nor activity was affected by 3 days of Se depletion 
but both decreased by ~33% after prolonged Se depletion (7 days) (Crane et al., 2009). 
In an in vivo mouse model, marginally low Se diet decreased TrxR1 mRNA 
expression by ~35% in the colon as assessed by microarray and real-time PCR (Kipp 
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et al., 2009). It appears that TrxR1 lies in the middle of Se incorporation hierarchy, 
whereas TrxR2 might be on a higher level of Se incorporation hierarchy.          
 
Selenoprotein S (SelS) is located in the membrane of endoplasmic reticulum and is 
believed to regulate ER stress (Shchedrina et al., 2010). Notably, a polymorphism in 
the promoter of SelS (-105 G>A) has been associated with altered plasma levels of 
Tumor necrosis factor alpha (TNF- ) and Interleukin 1 beta (IL-1
✁
), both as 
inflammatory biomarkers in human population (Curran et al., 2005). SelS has been 
found to interact with ER membrane proteins and participate in the transport of 
misfolded proteins into the cytosol (Ye et al., 2004, Bellinger et al., 2009). The SelS 
polymorphism has been associated with decreased SelS expression, increased ER 
stress and possibly elevated NF B activation (Bellinger et al., 2009).     
 
Selenoprotein P (SelP) functions extracellularly and is responsible for Se 
transporation from liver to blood circulation (Kato et al., 1992). SelP is sensitive to Se 
status and two functional polymorphisms, rs24731 and rs25191, have been suggested 
to affect sensitivity to Se supply (Meplan et al., 2007). SelP contains ten 
selenocysteines (SeCys), one in the N-terminal domain with redox activity and the 
other nine in the C-terminal domain, functioning in Se-storage and distribution (Burk 
and Hill, 2009). SelP is expressed in most tissues (Dreher et al., 1997). Targeted 
inactivation of SelP in mice (SelP -/-) has been found to decrease the expression of 
multiple selenoproteins, including GPx1 and TrxR1 (Hill et al., 2003), and cause 
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neurological dysfunction (serzures and ataxia), male infertility and premature death 
(Hill et al., 2003, Schomburg et al., 2003). Targeted expression of SelP in hepatic 
tissues rescued the Se transportation, infertility and neurological defects in SelP -/- 
mice (Renko et al., 2008). In addition, SelP -/- mice exhibited increased morbidity 
and mortality from Trypanosoma congolense infection (Bosschaerts et al., 2008). 
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1.2 NF B inflammatory signalling pathway and its regulation by ROS 
   1.2a  NF B transcription factors, their inducers and target genes 
NF B is a group of transcription factors comprising five subunit members, including 
RelA (p65), RelB, c-Rel, NF B1 (precursor p105 and p50) and NF B2 (precursor 
p100 and p52). Importantly the N-terminus of all members contain a conserved Rel 
homology domain (RHD) with DNA binding affinity to regulate the expression of 
NF B target genes (Hayden and Ghosh, 2008, Vallabhapurapu and Karin, 2009). In 
addition, the RHD domains have affinity with each other to form homo- or hetero- 
dimers and as a result NF B is dimeric in structure. NF B subunits and their 
structures are illustrated diagrammatically in Figure 3. 
 
In RelA, RelB and c-Rel (Class II NF B), the C-terminus contains a transactivation 
domain (TAD), whereas in NF B1 and NF B2 (Class I NF B), the C-terminus lacks 
the TAD (Figure 3) (Hayden and Ghosh, 2008). The TAD has been suggested to be 
necessary for full activation of NF B transcription activity and a homo-dimer, such as 
p50/p50, lacking this domain is unable to directly activate gene expression but 
requires disassociation and interaction with other subunits, most commonly p65 
(Kang et al., 1992, Zhong et al., 2002). In addition, the molecules NF B1 and NF B2, 
i.e. p105 and p100, respectively, contain an ankyrin repeat region, which has an 
inhibitory effect against RHD transcriptional activity (Figure 3) (Liou et al., 1992, 
Dobrzanski et al., 1995). As a result, p105 and p100 precursors are not functionally 
active until being cleaved to form p50 and p52, respectively.  
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The NF B transcription factor is normally in an inactive state in which the NF B 
dimer is bound with, and silenced by, the inhibitory  B proteins (I Bs) (Karin and 
Ben-Neriah, 2000). The I B family comprises mainly I B , I B
✁
, I B , I B  and 
Bcl3, and all I B members are characterised by an ankyrin repeat region which 
inactivates the RHD of NF B (Figure 3). However, upon stimulation, the activation of 
the signalling cascade results in the disassociation of the I B-NF B complex and the 
release of NF B, which translocates into the cell nucleus to promote gene expression 
(Vallabhapurapu and Karin, 2009, Hayden and Ghosh, 2008) (see Figures 4 and 5). 
The process of signal transduction from receptor activation to the activation of NF B 
transcriptional activity is described as the NF B inflammatory signalling pathway.  
 
The downstream target genes controlled by NF B comprise over 200 genes (Gilmore, 
2008). Based on their biological roles, the NF B target genes can be categorized as: 
cytokines/chemokines and their modulators, such as IL6 and IL8; immunoreceptors, 
such as CD40 (TNF-receptor family member) and TLR2 (Toll-like receptor member); 
proteins involved in antigen presentation, such as Tapasin (MHC class I presentation 
and assembly); stress response genes, such as 12-Lipoxygenase (an arachidonic acid 
metabolic enzyme) and Cu/Zn superoxide dismutase; regulators of apoptosis, such as 
Bcl-2 (pro-survival factor) and Fas-Ligand (apoptosis inducer) (Gilmore, 2008). The 
majority of these NF B target genes are able to participate directly, or indirectly, in 
the development of inflammatory events in cells. As a consequence, NF B has been 
widely studied as a key controlling factor in the expression of inflammatory cytokines, 
which influence the progression of inflammation and carcinogenesis in human tissues 
(Neurath et al., 1998, Karin and Greten, 2005, Kawai and Akira, 2006). 
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A combination of two out of five NF B subunits generates various types of homo- or 
hetero- NF B dimers, which can be used in different cells and induced by the 
activating signal (Karin and Ben-Neriah, 2000, Hoffmann et al., 2002a). One common 
type abundant in most cells is the NF B1/RelA, i.e. P50/p65 hetero-dimer (shown in 
Figure 3) (Vallabhapurapu and Karin, 2009). The inducers of NF B signalling 
pathways are broad in type and include the following: bacterial or fungal products, 
such as Lipopolysaccharide (LPS) and flagellin; inflammatory cytokines, such as 
Tumor necrosis factor   (TNF ) and interleukin 1
✁
 (IL1
✁
); oxidative stress, such as 
H2O2, tert-Butyl hydroperoxide (tBOOH), reoxygenation; mitogens, growth factors 
and hormones, such as insulin and transforming growth factor (TGF) (Gilmore, 2008). 
As well as exogenous inducers of the NF B signalling pathway, i.e. from bacteria, 
viruses, and fungi, many NF B inducers are endogenously produced. These different 
NF B activation mechanisms are essential for the efficient defence of the host during 
the innate and adaptive immunity.      
 
However, a common feature of both the endogenously and exogenously originated 
NF B signalling pathways is that, frequently, NF B activation is subject to regulation 
by reactive oxygen species (ROS), and therefore, potentially, under the influence of 
antioxidant enzymes (Gloire et al., 2006, Li et al., 2009, Kim et al., 2008, Haddad, 
2002). This is believed to be through ROS, acting as a secondary messenger during 
the signal transduction cascades that response to various inducers. The NF B 
signalling pathways activated by TNF  (endogenous pathway) and by flagellin 
(exogenous pathway) are described in detail in the following two sub-sections. 
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1.2b  TNF -NF B signalling pathway and its regulation by ROS 
TNF  is an essential inflammatory cytokine that extracellularly binds to the TNF 
receptor 1 (TNFR1, also known as CD120a) and mediates two inflammatory 
signalling pathways including the NF B pathway and the Mitogen-activated protein 
kinase (MAPK) pathway, as well as the apoptosis signalling pathway (Chen and 
Goeddel, 2002, Li and Lin, 2008). The other TNF receptor is TNF receptor 2 (TNFR2) 
the expression of which is mainly in cells of the immune system (Li and Lin, 2008). 
Signal transduction through TNF -TNFR1 is generally described as the TNFR1 
pathway and is present ubiquitously in tissues.  
 
Once TNFR1 binds TNF , a conformational change of its intracellular domain occurs 
and this leads to disassociation of the TNFR1 death domain (DD) from silencer of 
death domain (SODD), which normally binds to and inhibits TNFR1 activity (Jiang et 
al., 1999) (Figure 4, Step 1). Subsequently, the exposed DD recruits the adapter 
protein TNFR1-associated death domain protein (TRADD), which further recruits 
Receptor-interacting protein (RIP) and TNFR-associated factor 2 (TRAF2) for 
activation of the NF B and MAPK signalling (Hsu et al., 1996, Ting et al., 1996) 
(Figure 4, Step 2). RIP and TRAF2, as targets of Ubiquitins, then undergo Lysine (K) 
63-linked ubiquitiylnation and conformational change, which are required for the 
recruitment of the I B kinases (IKKs) to the receptor complex (Ea et al., 2006, Devin 
et al., 2000, Wu et al., 2006) (Figure 4, Step 3).  
 
After recruitment of the IKKs to the RIP-TRAF2 adaptor protein complex, the MAP 
kinase kinase kinases (MAP3Ks) are activated and initiate a phosphorylation cascade 
(Li and Lin, 2008). The MAP3Ks responsible for TNF -NF B signalling transduction 
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are variable according to the cell type and include TGF-beta activated kinase 1 
(TAK1), NF B-inducing kinase (NIK), MAP kinase kinase kinase 3 (MAP3K3) and 
MAP kinase kinase kinase 1 (MAP3K1) (Ling et al., 1998, Lee et al., 2008, Yang et 
al., 2001, Blonska et al., 2005). The mechanisms responsible for their activations 
remain not totally understood, but TAK1 and MAP3K3 have been associated with 
phosphorylation and activation by the RIP-TRAF2 complex (Blonska et al., 2005, 
Blonska et al., 2004).  
 
To continue the phosphorylation cascade, TAK1/NIK/MAP3K3 phosphorylate IKKs 
(Shim et al., 2005, Li and Engelhardt, 2006, Ling et al., 1998, Blonska et al., 2004), 
and IKKs then phosphorylate the NF B-binding protein I Bs (Li and Lin, 2008) 
(Figure 4, Step 4). The phosphorylated I B undergoes degradation by proteasome 
lysis and eventually releases the NF B transcription factors for nuclear translocation 
(Figure 4, Steps 5 and 6).   
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Figure 4: Signalling transduction in the TNF -TNFR1 pathway leading to NF B 
activation 
Signalling transduction in the TNF -TNFR1 pathway leads to activation of the NF B 
transcription factors. Step1: TNF  binds to TNFR1 and the activated receptor 
disassociates from the inhibitory protein SODD. Step 2: The receptor complex binds 
to TRADD and further recruits RIP and TRAF2. Step 3: K63 ubiquitination of RIP 
and TRAF2 results in recruitment of the IKKs. Step 4: Phosphorylation cascade 
(RIP/TRAF2 TAK1/NIK/MAP3K1 IKK I B) results in NF B inhibitory protein 
I B being phosphorylated. Step 5: The phosphorylated I B undergoes degradation by 
proteasome lysis and releases NF B transcription factors. Step 6: The released NF B 
tranlocates to cell nucleus and promotes the expression of NF B target genes. 
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The participation of ROS during TNF  signalling is believed to regulate the activities 
of kinases which affect the phosphorylation cascade (Figure 4, Step 4). ROS have 
been suggested to activate the MAP3Ks, including NIK (Li and Engelhardt, 2006, 
Kim et al., 2008) and MAP3K1 (Lee and Koh, 2003, Lee et al., 2008). ROS have also 
been suggested to interact with TAK1 (Morioka et al., 2009, Omori et al., 2008, 
Sanchez-Duffhues et al., 2009), although the direct exposure of TAK1 to hydrogen 
peroxide failed to result in pathway activation (Cheung et al., 2003). In addition, ROS 
have also been suggested to be inactivators of MAPK phosphatases (Kamata et al., 
2005, Chan et al., 2008, Hou et al., 2008), which degrade MAP3Ks and interfere with 
downstream MAPK or NF B signalling (Figure 5) (Shen et al., 2001, King et al., 
2009, Furst et al., 2007).  
 
The origin of ROS production in the TNFR1 pathway is not fully understood. One 
possible source is from mitochondria during apoptosis. In addition to the NF B 
signalling cascade, the TNFR1 death domain can alternatively activate MAPK 
signalling using the adaptor protein TRADD, and activate caspase-8 apoptotic 
signalling using another adaptor protein called Fas-Associated protein with Death 
Domain (FADD) (Figure 5) (Li and Lin, 2008). Both MAPK (mainly the 
stress-related c-Jun N-terminal kinases, a subgroup of MAPK, in terms of TNFR1 
signalling) (Kamata et al., 2005) and caspase-8 cascades have apoptotic effects that 
might result in release of ROS from mitochondria (see Figure 2 (A)). However, it has 
been argued that the ROS production by apoptotic mitochondria is not rapid enough 
to influence NF B signalling.  
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The other possible source of ROS is from the nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidases (Noxs). Noxs are membrane-associated enzymatic 
complexes that generate superoxide and show fast responses to stimuli on the cell 
membrane. In macrophages and neutrophils, Nox2 is known to be activated by TNF  
and results in superoxide production to destroy the phagotrophic microbes 
(Grandvaux et al., 2007). In non-phagocytic cells, Noxs are also expressed 
(Grandvaux et al., 2007) and their function has been associated with the signalling 
transduction in response to TNF  (Kim et al., 2007, Li et al., 2009). Nox2-derived 
H2O2 production was detected in fibroblast cells after TNF
  stimulation, and has been 
suggested to play an important role in the recruitment of the TRAF2 adaptor to the 
TNFR1 complex and to activate the NF B signalling cascade (Figure 5) (Li et al., 
2009). In addition, the linkage between TNFR1 and Nox was identified to be the 
flavokinase, which binds both the TNFR1 death domain and a Nox subunit p22 (phox) 
(Yazdanpanah et al., 2009). The flavokinase phosphorylates Nox, then facilitates the 
assembly of Nox subunits and activates its oxidative activity (Figure 5). 
Comparatively, a similar role of flavokinase was not detected in the ROS generation 
by the Toll-like receptors (TLRs) (Yazdanpanah et al., 2009) (see Section 1.2c). 
Therefore, Nox could also be a critical candidate in the production of ROS for NF B 
activation in the TNFR1 signalling pathway. 
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Figure 5: Scheme showing ROS production in the TNFR1 pathway and its 
possible role in mediation of NF B activation 
Signalling transduction in the TNFR1 pathways may result in the activation of NF B 
transcription factors, MAPK kinases and caspase-8 apoptosis. Whereas NF B 
activation relies on the phosphorylation cascade to activate the I B kinases (IKKs), 
the MAPK and caspase-8 pathways have apoptotic effects and may result in release of 
ROS from mitochondria. In addition, ROS may also be produced from the NADPH 
oxidase 2 which is coupled by flavokinase with TNFR1 death domain. The mediation 
by ROS on the NF B activation is to influence the phosphorylation cascade. ROS has 
been suggested to either activate the TAK1/NIK/MAP3K1 kinases, or inactivate the 
MAPK phosphatases which are negative regulators of the phosphorylation cascade. 
Moreover, the Nox2-derived H2O2 production has also been suggested to facilitate the 
binding between TNFR1 and TRAF2.    
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1.2c  Flagellin-TLR5-NF B signalling pathway and its regulation by 
ROS 
Bacterial components such as flagellin are exogenous to cells and activate 
downstream signalling through their binding to Toll-like receptors (TLRs). There are 
13 TLRs that differentiate various pathogen-associated molecular patterns (Arancibia 
et al., 2007). TLRs are widely expressed in the immune cells such as macrophages 
and dendritic cells (Carmody and Chen, 2007), whereas in non-immune gut epithelial 
cells, TLR5 is selectively expressed (Kawahara et al., 2004, Zeng et al., 2006). 
Importantly, TLR5 is reported to regulate inflammatory responses and apoptosis 
signalling in a model of colon cancer (Rhee et al., 2008). TLR5 recognizes and binds 
with flagellin using its extracellular domain (Andersen-Nissen et al., 2007).  
 
The intracellular parts of all TLRs contain a conserved Toll/IL-1 receptor (TIR) 
domain with homology to the IL-1 receptor. After the formation of flagellin-TLR5 
complex, the TIR domain recruits the essential adaptor protein Myeloid 
differentiation primary response gene 88 (MyD88) (Figure 6, Step 1) (Arancibia et al., 
2007). The TLR5 signalling pathway has been suggested to be uniquely MyD88 
dependent, since knockdown of other candidate adaptor proteins, e.g. 
TIR-domain-containing adapter-inducing interferon-
✁
 (TRIF), Toll-Interleukin 1 
Receptor Domain-Containing Adapter Protein (TIRAP) and TRIF-related adaptor 
molecule (TRAM), appeared to have no effect on the TLR5 response (Yamamoto et 
al., 2003, Horng et al., 2002).  
 
The C-terminus of MyD88 associates with TIR, and the N-terminus contains a death 
domain (DD) (Boldin et al., 1995) that interacts with the death domains of IL-1 
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receptor associated kinases (IRAKs) family member, IRAK4 and IRAK1 (Arancibia 
et al., 2007) (Figure 6, Step 2).  
 
Initiation of the subsequent phosphorylation cascade has been suggested to be through 
IRAK4 auto-phosphorylation (Cheng et al., 2007), and the activated IRAK4 then 
phosphorylates IRAK1 (Suzuki et al., 2002, Kollewe et al., 2004). Meanwhile, the 
IRAK4-IRAK1 complex recruits TNFR-associated factor 6 (TRAF6) (Carmody and 
Chen, 2007, Li et al., 2002) (Figure 6, Step 3).   
 
The phosphorylated IRAK4-IRAK1-TRAF6 complex disassociates from MyD88 
(Kollewe et al., 2004), and TRAF6 undergoes K63-linked ubiquitylination and 
conformational change (Lamothe et al., 2007, Deng et al., 2000) (Figure 6, Step 4).  
 
The release of TRAF6 allows it to recruit the TAK1 binding (TABs) proteins 
(Adhikari et al., 2007, Takaesu et al., 2001), to form a TRAF6-TAB-TAK1 complex 
that results in phosphorylation and activation of TAK1 (Carmody and Chen, 2007). In 
the remaining phosphorylation cascade, TAK1 phosphorylates IKK and IKK 
phosphorylates I B (Sato et al., 2005, Adhikari et al., 2007) (Figure 6, Step 5). The 
phosphorylated I B is degraded by the proteasome and the NF B transcription factors 
are released for nuclear translocation (Figure 6, Step 6).     
36 
 
 
Figure 6: Signalling transduction in the flagellin-TLR5 pathway leading to NF B 
activation 
Signalling transduction in the flagellin-TLR5 pathway leads to activation of the NF B 
transcription factors. Step1: Flagellin binds to TLR5 and the intracellular TLR5-TIR 
domain associates with adaptor protein MyD88. Step 2: The death domain of MyD88 
N-terminus interacts with IRAK4 and IRAK1. Step 3: IRAK4 undergoes 
auto-phosphorylation and then IRAK4 phosphorylates IRAK1. The phosphorylated 
IRAKs recruit TRAF6. Step 4: The IRAK-TRAF6 complex disassociates with 
MyD88 and formation modification of TRAF6 by K63-linked ubiquitination results in 
recruitment of TAK1-TAB kinase complex. Step 5: The phosphorylation cascade 
(TAK1 IKK I B) results in the NF B inhibitory protein I B being phosphorylated. 
Step 6: I B undergoes degradation by proteasome and the NF B transcription factors 
tranlocate to cell nucleus and promote the expression of NF B target genes. 
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The role of ROS during TLR5 signalling has been suggested to be a modulation of the 
kinase activities (such as TAK1) in the phosphorylation cascade (Kim et al., 2008). In 
addition, ROS appears to function downstream of the IRAK4-IRAK1 phosphorylation 
complex, since in the LPS-TLR4 signalling pathway, Nox1 has been identified as a 
phosphorylation target of IRAK4 and to be subject to IRAK4 regulation (Pacquelet et 
al., 2007). In IRAK4 overexpression, Nox activity increases in response to LPS 
(Pacquelet et al., 2007). Comparably, in the flagellin-TLR5 signalling pathway, 
Nox1-derived ROS production has been found and suggested to be responsible for the 
downstream TAK1 activation and IL8 expression (Kawahara et al., 2004). 
Considering the similarity between the TLR4 and TLR5 pathways in the 
MyD88-dependent signal transduction, ROS could also be regulated by IRAK4 in the 
flagellin-TLR5 cascade. Therefore, it is possible that ROS production by Nox1 
functions between IRAK4 phosphorylation and TAK1 activation, and regulates the 
TLR5-NF B signalling pathway by mediating the phosphorylation cascade (Figure 
7). 
 
In addition to IKK-NF B signalling, TAK1 is also known to activate the MAPK 
pathway and the latter might serve as another source of ROS production through its 
apoptotic effect. Indeed, both the MAPK (p38 MAPK subgroup in the case of 
flagellin-TLR5 pathway) and NF B signalling pathways respond to flagellin 
induction in human intestinal epithelial T84, HT29cl19A and Caco-2BBE cells and 
alveolar type II epithelial A549 cells (Im et al., 2009, Yu et al., 2003). However, the 
apoptotic effect of MAPK is frequently not apparent owing to the anti-apoptotic effect 
of NF B (Kreuz et al., 2001, Catz and Johnson, 2001); when NF B was inhibited, 
enhanced p38 activation resulted in increased cellular apoptosis (Zeng et al., 2006). 
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Therefore, ROS production from MAPK-derived apoptotic signalling might also 
occur and, in turn, regulate the NF B signalling in response to flagellin (Figure 7).     
 
 
Figure 7: Scheme showing ROS production in the TLR5 pathway and its 
possible role in mediation of NF B activation 
Signalling transduction in the flagellin-TLR5 MyD88 dependent pathway may result 
in the activation of NF B transcription factors and MAPK kinases. ROS production 
by flagellin could be generated through the apoptotic effect of MAPK on the 
mitochondria. In addition, a close association between IRAK4 and Nox1 has been 
identified, in which IRAK4 phosphorylates and activates Nox1 to produce ROS for 
downstream NF B and MAPK signalling activation. The role of ROS in NF B 
activation seems to regulate the TAK1 activity and therefore to influence the 
phosphorylation cascade.  
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1.2d  Summary: the mediation of NF B signalling activation by ROS  
The described NF B signalling pathways activated by TNF  and flagellin show how 
signals are transferred from receptor to the cytoplasmic NF B-I B complex. In 
summary, this involves multiple co-operative steps of ubiquitinylation (such as 
TRAF2 and TRAF6 K63 ubiquitnylation), phosphorylation (such as IKK 
phosphorylation by TAK1 and I B phosphorylation by IKK) and proteolysis (such as 
I B proteasome lysis). Importantly the regulatory effect of ROS is to enhance the 
phosphorylation cascade by either activation of the MAP3Ks or inactivation of the 
counteracting MAPK phosphatases (MKPs).  
 
In addition, ROS also have regulatory effects on the I B proteolysis. The oxidized 
I B protein has been observed to be more sensitive to proteasome lysis, and 
undergoes more rapid degradation after exposure to micromolar concentration of 
H2O2 (Kretz-Remy et al., 1998, Schoonbroodt et al., 2000). This corresponds to the 
general observations of proteolysis, in which treatment with 20-400µM H2O2 
increases proteolysis but treatment with high amount (>1mM) H2O2 causes 
accumulation of oxidized protein (Grune et al., 1997). In general, the physiological 
level of H2O2 production in cells is less than 100µM and therefore would be expected 
to mainly affect the process of I B proteolysis (Droge, 2002, Gautam et al., 2006). 
Finally, ROS may further mediate the NF B transcription activity in the nucleus by 
affecting chromatin remodeling, recruitment of co-activators, and DNA binding 
(Gloire and Piette, 2009).  
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1.3 Effects of Se and selenoproteins on NF B signalling 
 
1.3a  Effects of Se/GPxs on eicosanoid synthesis 
The repression of leukotriene (LT) and prostaglandin (PG) biosynthesis by GPx1 and 
GPx4 is thought to be through their mediation of lipoxygenase (LOX) and 
cyclooxygenase (COX)-catalyzed arachidonic acid metabolism pathways, which are 
also sensitive to redox-signalling, reviewed in (Brigelius-Flohe, 1999, Imai and 
Nakagawa, 2003). Leukotrienes are metabolites of 5-LOX (a subgroup of LOXs) and 
in this pathway, arachidonic acid is first oxidized by 5-LOX into 
5-hydroperoxyeicosatetraenoic acids (5-HPETE) and then the 5-HPETE undergo 
further dehydration to form LTs (Hyde and Missailidis, 2009) (Figure 8). The 
intermediate product 5-HPETE can activate 5-LOX in an autonomous feedback cycle 
(Rouzer and Samuelsson, 1986). In the presence of GPx1 and GPx4, the antioxidant 
selenoproteins are thought to degrade 5-HPETE into 5-HETE and therefore impede 
the feedback activation of 5-LOX pathway (Imai et al., 1998, Straif et al., 2000) 
(Figure 8).  
 
 
Figure 8: Inhibition of 5-LOX activation and LT production by GPx 
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The biosynthesis of leukotrienes is through the metabolism of arachidonic acid into 
5-HPETE and catalyzed by 5-LOX. 5-LOX oxidizes arachidonic acid into 5-HPETE, 
which, in turn, activates 5-LOX in a positive feedback cycle. GPx1 and GPx4 are able 
to reduce 5-HPETE into 5-HETE and therefore break the 5-LOX feedback cycle and 
inhibit the LT production.    
 
Similarly, GPx4 has also been observed to regulate the 12-LOX, 15-LOX (the other 
two subtypes of LOXs), and COX pathways by repressing their oxidized intermediary 
products and positive feedback (Sakamoto et al., 2000, Heirman et al., 2006, Chen et 
al., 2003), respectively. A number of investigations have identified these links and are 
listed in Table 2. 
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Leukotriene and prostaglandin eicosanoids mediate inflammatory events such as 
leukocyte adhesion (LTB4), smooth muscle contraction (PGE2), pain sensing (PGE2) 
and vasodilation (PGI2) (Henderson, 1994), as well as carcinogenic events, such as 
cell differentiation and apoptosis (Shureiqi et al., 2005, Sordillo et al., 2008, Eisinger 
et al., 2007). In addition, LTB4, 12(S)-HETrE and platelet-type 12-LOX have been 
identified as NF B inducers in human monocytes, endothelial cells and prostate 
cancer cells, respectively (Huang et al., 2004, Laniado-Schwartzman et al., 1994, 
Kandouz et al., 2003). Meanwhile, COX-2, 5-LOX and 12-LOX have been identified 
as NF B target genes in human neuronal cells, guinea pig cells and human 
erythroleukemia cells, respectively (Kaltschmidt et al., 2002, Chopra et al., 1992, 
Arakawa et al., 1995). Overall, these studies suggest that the LOX and COX 
eicosanoid biosynthesis pathways are closely associated with inflammatory cytokine 
synthesis and partially associated with the inflammatory response driven by NF B.  
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1.3b  NF B regulation by Se  
The inflammatory cytokine TNF  induces the classical NF B signalling pathway, 
described in Section 1.2b, and over the past decade, a few publications have reported 
the association between Se supplementation and TNF -induced NF B activation. In 
transformed prostate cells, supplementation of the growth medium with sodium 
selenite or organic Se-compound methylseleninic acid was found to inhibit the 
DNA-binding ability of NF B in response to TNF , together with reduced IKK 
kinase activity, I B phosphorylation and I B proteolysis (Gasparian et al., 2002). 
Similarly, in human airway epithelial cells, sodium selenite supplementation 
increased GPx1 expression and decreased H2O2 production and NF
 B activation by 
TNF  (Jeong et al., 2002a). However, in human umbilical vein endothelial cells, the 
nuclear translocation of NF B subunit p65 following TNF  induction was unaffected 
by Se supplementation (Zhang et al., 2002). Taken together these results suggested 
that Se regulates TNF -activated NF B signalling in a cell-type dependent manner.  
 
Similar to flagellin, the bacterial component Lipopolysaccharide (LPS) is also capable 
of inducing the classical NF B signalling pathway through a MyD88 dependent 
mechanism (described in Section 1.2c). In a prostate cell study, Se supplementation 
also inhibited NF B activation by LPS (Gasparian et al., 2002). Conversely, in 
macrophage cells stimulated with LPS, Se depletion decreased GPx1 expression, 
increased cellular ROS production, and increased NF B nuclear translocation and the 
expression of NF B target gene COX-2 (Zamamiri-Davis et al., 2002). Interestingly, 
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the repressive effect of Se against LPS-induced NF B activation in macrophage cells 
was associated with the generation of a prostaglandin product, 
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2), which is produced through the 
COX-1 pathway (Vunta et al., 2007). Se supplementation was suggested to elevate the 
expression of 15d-PGJ2, which inhibits IKK
✁
 (Vunta et al., 2007), a subunit of IKK 
that functions in the phosphorylation cascade of NF B signalling transduction 
(Section 1.2b and c). As a result, Se may enhance IKK
✁
 inhibition by 15d-PGJ2 and 
repress NF B activation induced by LPS.  
 
In addition to ROS production, in macrophage cells the LPS-induced NF B signalling 
pathway has been associated with inducible nitric oxide (NO) production, and it has 
been suggested that Se supplementation inhibits the response of nitric oxide synthase 
(iNOS) together with NF B activation by LPS (Prabhu et al., 2002, Kim et al., 2004). 
Moreover, this inhibitory effect of Se against NO production was specific to the 
MyD88-dependent NF B signalling pathway, but not the other pathways upon LPS 
induction (Yun et al., 2007) and resulted in decreased I B degradation and p65 
nuclear translocation (Yun et al., 2007, Shin et al., 2009). Therefore, at least in certain 
cell-types such as macrophage cells, Se regulates NO production in addition to ROS, 
both of which might direct the NF B response.  
 
Finally, in unstimulated prostate cancer cells, a high concentration (7.6mM) of Se 
directly affected the DNA-binding ability of NF B, but not affect the phosphorylation 
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cascade, I B degradation and NF B nuclear translocation, suggesting that Se might 
directly associate with NF B subunits (Christensen et al., 2007). Interestingly, two 
organic Se-compounds, benzyl selenocyanate (BSC) and 1,4-phenylenebis (methylene) 
selenocyanate (p-XSC), were identified to catalyze Cys62 of NF
 B subunit p50, a site 
within p50’s DNA-binding domain (Chen et al., 2007). The Cys62 was suggested to be 
chemically modified and inhibited by Se-compounds (SeCys corss-linking) (also see 
Figure 2). Therefore, Se might also regulate the NF B transcription activity in a 
non-specific manner.  
 
In summary findings suggest that Se exerts a wide range of effects on the NF B 
response in multiple cell types. However, its regulatory effect also depends on the 
cell-type and the specific transductional signalling used to activate NF B transcription 
factors.  
 
1.3c  NF B regulation by selenoprotein GPx1  
The decreased tolerance of transgenic GPX1 -/- mice (described in Section 1.1d) to 
oxidative stress appears not only to be due to the elevated apoptosis response, but has 
also been associated with elevated NF B inflammatory response in various mouse 
tissues. For example, in a study of ischemia-reperfusion injury, a condition causing 
oxidative damage focussed in neuronal cells, GPX1 -/- mice exhibited increased 
DNA-binding of p50/p65 NF B dimer and p65 phosphorylation compared with 
normal littermates (Crack et al., 2006). Comparably, the fibroblast cells derived from 
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GPX1 -/- mice also displayed more abundant NF B activation in response to H2O2 
than control cells (de Haan et al., 2004). In contrast, transgenic mice overexpressing 
GPx1 were more resistant to ischemia-reperfusion in renal cells, and exhibited 
reduced NF B activation and the reduced attraction of neutrophil cells (Ishibashi et al., 
1999). Together these findings, from in vivo mouse model study, have identified 
GPx1 to be a potential NF B modulator in response to oxidative stress.  
 
The regulatory effects of GPx1 on NF B activation have also been studied in vitro. In 
T47D breast cancer cells challenged with H2O2, GPx1 overexpression lowers cellular 
ROS production, inhibit I B  degradation and decrease NF B (p50) nuclear 
translocation (Kretz-Remy et al., 1996, Kretz-Remy and Arrigo, 2001). These effects 
were shown to be reversed by Se depletion, which limits GPx1 synthesis (Kretz-Remy 
et al., 1996). GPx1 overexpression also exerts a protective effect against the NF B 
responses induced by TNF , UV irradiation, IL1
✁
 and hypoxia/reoxygenation (H/R) 
in breast cancer and Hela cells (Kretz-Remy et al., 1996, Li et al., 2001, Fan et al., 
2003, Li and Engelhardt, 2006). In fact, in T47D breast cancer cells, TNF -induced 
NF B activation was repressed by GPx1 overexpression, as shown by decreased ROS 
production and inhibition of I B  phosphorylation (Kretz-Remy et al., 1996). In 
another breast cancer cell line, MCF7, GPx1-overexpressing cells showed reduced 
NF B activation in response to TNF  (lowered by 25~30%), UV irradiation (by 
25~30%) and H2O2 (by >50%), respectively, as assessed by the NF
 B DNA-binding 
ability and reporter gene expression (Li et al., 2001).  
49 
 
The mechanism by which GPx1 regulates NF B signalling is not fully known. The 
reduction in NF B activation linked to GPx1 overexpression has been suggested to 
occur through inhibition of the IKK  Serine phosphorylation of I B, which has been 
observed in the NF B response to TNF  (Kretz-Remy et al., 1996, Li et al., 2001), to 
IL1
✁
 (Li and Engelhardt, 2006) and to H2O2 (Li et al., 2001). However, GPx1 
overexpression in HeLa cells also inhibits NF B activation through an I B Tyrosine 
phosphorylation mechanism, where the NF B signalling activated by H/R is 
IKK-independent (Fan et al., 2003). Together these findings, from in vitro 
experiments, suggest that GPx1 regulates NF B activation by inhibiting I B Serine or 
Tyrosine phosphorylation depending on the inducer. However, the current knowledge 
is from the breast cancer cells and the regulatory effects of GPx1 in alternative cell 
types remain to be explored.   
 
In addition, in MCF7 cells stimulated with IL1 
✁
, NF B activation has been 
associated with Nox-driven H2O2 production, which was suggested to be necessary 
for the recruitment of NF B-inducing kinase (NIK) to the adaptor protein TRAF6 (Li 
and Engelhardt, 2006). As a result, both GPx1 overexpression and siRNA knockdown 
of Nox subunit were found to inhibit this process and lead to a reduced NF B 
response. Therefore GPx1 may regulate NF B response by repressing the H2O2 
production related to Nox acitivity. Moreover, GPx1 overexpression also inhibited the 
kinase activity of NIK, whereas the MAPK phosphatase- (described in Section 1.2d) 
inhibitor, okadaic acid, enhanced the kinase activity of NIK, suggesting that the role 
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of H2O2 is potentially to inhibit the MAPK phosphatase and then enhance NF
 B 
activation (Li and Engelhardt, 2006). These results highlight the interaction between 
Nox-mediated redox signalling and antioxidant repression of NF B response, 
indicating that different types of Nox also mediate NF B induction by TNF , flagellin 
(described in Section 1.2b and 1.2c, respectively) and LPS (Gloire et al., 2006). 
 
1.3d  NF B regulation by selenoprotein GPx4  
GPx4 is able to use a wider range of substrates than GPx1 and its essential function is 
to prevent lipid peroxidation in membrane (described in Section 1.1d). Nevertheless, 
to date little is known about its regulatory effect(s) on the NF B signalling pathway. 
The limited number of relevant studies are described below. 
 
In human ECV304 cells, GPx4 overexpression combined with selenophosphate 
synthetase overexpression, the latter to optimise selenoprotein incorporation, was 
adapted to enhance the GPx4 biosynthesis (Brigelius-Flohe et al., 1997). Under the 
conditions of Se depletion, GPx1 expression was reduced whereas GPx4 expression 
was selectively elevated. Using this model, it was found that IL1-induced NF B 
activation, assessed by p65/p50 DNA-binding ability, was inhibited by GPx4 
overexpression (Brigelius-Flohe et al., 1997). In rabbit abdominal smooth muscle 
cells, linoleic acid hydroperoxide was used to induce NF B signalling, and GPx4 
overexpressing cells exhibited a reduction in lipid peroxidation together with an 
inhibited NF B response and apoptosis (Brigelius-Flohe et al., 2000). In addition, in 
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epidermal fibroblasts, NF B activation following UV-irradiation was inhibited by 
GPx4 overexpression. GPx4 overexpression resulted in the decreased production of 
phosphatidylcholine hydroperoxides, p65 phosphorylation and nuclear translocation 
(Wenk et al., 2004). Finally, an NF B target gene, vascular cell adhesion molecule-1 
(VCAM), was also inhibited by GPx4 overexpression in rabbit smooth muscle cells 
stimulated by IL1 (Banning et al., 2004) but whether the regulatory effect is mediated 
through an NF B-dependent mechanism remains to be elucidated (Banning et al., 
2004, Zhang et al., 2002). 
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1.3e  Summary  
Whereas Se and selenoprotein GPxs exert important regulatory effects on apoptosis 
(Section 1.1d) and eicosanoid biosynthesis (Section 1.3a), investigations into their 
roles in the NF B inflammatory responses suggest that Se and GPxs are potential 
mediators of NF B signalling pathways in response to various endogenous and 
exogenous inducers. However, to-date the findings are limited, both in relation to the 
inducers and the tissues investigated, and NF B signalling does appear to vary 
according to the cell-type and the inducer-type. The regulation of NF B signalling 
pathways in many tissues, including the gastrointestinal tract, by Se and/or GPxs, is 
not understood. Therefore, the studies described in this thesis were undertaken to 
investigate whether, and how, Se and /or GPxs modulate NF B signalling in a human 
gastrointestinal epithelial cell line. 
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1.4 Aim of the project 
 
• To develop a luciferase reporter model driven by NF B transcription 
activity in the colonic epithelial cell line Caco-2 as a means to monitor the 
NF B inflammatory response 
• To study the regulatory effect of Se depletion on the NF B response in 
Caco-2 cells to stimuli such as TNF  or bacteral flagellin  
• To study the effects of knocking-down expression of selenoproteins GPx1, 
SelW and SelH on the NF B response in Caco-2 cells 
• To study the regulatory effect of selenoprotein GPx4 on the NF B 
response in Caco-2 cells   
 
Previous research has used various methods to assess NF B activation (briefly 
reviewed in Chapter 3 Section 3.1 introduction) and of them, one, a luciferase reporter 
system, has been developed by fusing a luciferase coding sequence with a promoter 
containing three NF B binding sites (3X  B) (Carlsen et al., 2002, Kirillov et al., 
1996) so as to monitor NF B transcription activity. The first part of the work 
described in this thesis describes the generation of appropriate gene constructs to 
develop this luciferase reporter system (NF B and control luciferase reporters) in 
stably transfected Caco-2 cells. These cells were then used to investigate the effects of 
Se depletion on the TNF -induced and flagellin-induced NF B response and such 
experiments are described in the second part of this thesis. 
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GPx1, SelW and SelH are selenoproteins sensitive to Se supply and their expression is 
reduced in Se depletion. GPx1 is a well-characterized antioxidant, and furthermore 
SelW and SelH may also have antioxidant effect (Dikiy et al., 2007). In addition, two 
existing publications have studied the effects of GPx1 overexpression on TNF -NF B 
response in breast cancer cells (Kretz-Remy et al., 1996, Li et al., 2001). The third 
part of the work described in this thesis was to knockdown the expression of GPx1 or 
SelW or SelH in Caco-2 cells using the siRNA technique and to assess the effects on 
the TNF -NF B response.  
 
GPx4 catalyzes a wide selection of oxidative substrates and protects specifically 
against lipid peroxidation in membrane. Little previous work has explored its 
regulatory effect on NF B responses, and only in fibroblasts (Wenk et al., 2004) or 
ECV304 cells (Brigelius-Flohe et al., 1997). The last part of the work described in 
this thesis was to knockdown GPx4 expression using siRNA and to assess its effect 
on the flagellin-NF B response. 
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2.   Materials and methods 
 
All glassware and microcentrifuge tubes were sterilized by autoclaving at 121ºC for 
20 minutes. All buffers and solutions were sterilized by autoclaving at 121ºC for 20 
minutes or by filtration using a 0.2µm syringe filter (Whatman). All tissue culture and 
bacterial work was carried out in a sterile environment and with good microbial/cell 
culture practice. DEPC-treated water was prepared by adding 250µl Diethyl 
pyrocarbonate (DEPC) to 500ml distilled water, mixing thoroughly for 3 hours and 
autoclaving at 121ºC for 20 minutes. DEPC-treated water was used to dilute DNA 
(plasmids, primers, cDNAs and PCR products) and RNA and prepare buffers and 
solutions.   
 
2.1  Routine techniques 
2.1.1 Restriction enzyme digestion 
Restriction enzyme digestion was carried out using Apa I, BamH I, EcoR V, Hind III, 
Kpn I and Sal I restriction enzymes (Promega) in reactions listed in Tables 4 and 5, 
according to instructions provided by the manufacturer. In each reaction of 20µl total 
volume, 1µg of substrate DNA (plasmid) was digested with 0.5µl of each restriction 
enzyme (concentration 10u/µl) together with 2µl of 10X buffer, 0.2µl of 10µg/µl 
acetylated bovine serum albumin (BSA) and DEPC water (added to fill the 20µl total 
volume). The respective buffers and enzymatic activities employed in different 
restriction digestions are as illustrated in Tables 4 and 5. In each case, the mixture was 
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mixed thoroughly by pipetting, briefly centrifuged and incubated at 37ºC for 4 hours 
for complete restriction digestion. Controls were carried out by adding no substrate 
DNA, no restriction enzymes (uncut) or adding single restriction enzyme (single cut) 
when the reaction required restriction digestion by double or triple enzymes. After 
digestion, products were checked by DNA electrophoresis. 
 
2.1.2 Separation of DNA molecules by agarose gel electrophoresis 
DNA molecules are normally negatively charged and migrate towards the positive 
electrode in agarose gel electrophoresis. DNA molecules large in size are more 
difficult to traverse the agarose gel than the small DNA molecules and therefore 
migrate in a slower speed. As a result, DNA molecules can be separated by agarose 
gel electrophoresis. The technique is frequently employed to separate the DNA 
fragments harvested from restriction digestion or polymerase chain reaction (PCR). 
Together with the DNA fragments to be tested, DNA molecules of known sizes (DNA 
markers) are generally co-electrophoresized and comparison between the two allows 
estimation of the actual sizes of the DNA products. 
 
To separate the DNA fragments of restriction digestion products, 1% agarose gels 
were prepared by adding 1% agarose into 1X TAE buffer (Promega), heating gently 
in a microwave oven until thoroughly mixed, cooling down slowly until 50-60ºC, and 
adding, and mixing gently, with ethidium bromide (EB) (Promega) for DNA 
visualization. The mixture was then poured into a gel casting tray and left in room 
temperature until solid. A comb was also placed in the gel casting tray to generate 
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spaces for loading DNA samples. DNA samples were prepared by mixing with 5X 
loading buffers (Bioline) in a ratio of 4:1 (e.g. 8µl DNA sample and 2µl 5X loading 
buffer) and loaded into agarose gel. In addition, one or two extra lanes were used to 
load the DNA markers (Hyperladder I, Bioline) in parallel with the DNA samples. 
The agarose gel electrophoresis was carried out at <5 volts per cm gel until the dye 
front reached the bottom of the gel. Bands of DNA molecules were visualized on 
agarose gel after exposure under an UV light and the sizes of DNA molecules were 
estimated according to the lengths of Hyperladder I DNA markers. Examples of 1% 
agarose gel electrophoresis are shown in Figure 12 and 13. 
 
To separate PCR products, 2% agarose gels were prepared following the same 
protocol as described above. DNA samples were prepared and co-electrophoresized 
with alternative DNA markers (Hyperladder IV or Hyperladder V, Bioline). Examples 
of 2% agarose gel electrophoresis are shown in Figures 18 and 19.  
 
2.1.3 Extraction of DNA fragments from agarose gel 
Following agarose gel electrophoresis, DNA fragments were extracted from the gel 
using the QIAquick Gel Extraction Kit™ (Qiagen) according to the protocol provided 
by the manufacturer. This was to harvest the DNA products from previous 
experiments (restriction digest and agarose gel electrophoresis) and the DNA 
fragments were subsequently purified to be used in further applications such as DNA 
ligation reactions.  
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Under an UV light, DNA fragments were visualized as bright bands on the agarose 
gel. The DNA fragments of correct estimated molecule sizes were excised from the 
agarose gel using a clean scalpel. Each sample was weighted and removed into a 
sterile microcentrifuge tube. Three volumes of Buffer QG, the gel solubilization and 
DNA-binding buffer (with pH indicator) (provided with kit), were added to one 
volume of excised gel slice (e.g. 300µl of Buffer QG and 100mg of gel). Buffer QG 
and gel were incubated at 50ºC for approximately 10 minutes until the gel slice was 
completely dissolved, at which point the mixture was transparent and a yellow colour 
(PH appropriate for the absorption of DNA molecules to the QIAquick spin column). 
Then the mixture was added to one volume of isopropanol (e.g. 100µl of isopropanol 
and 100mg of gel) and mixed thoroughly by vortexing. Each sample (mixture of 
dissolved gel slice, Buffer QG and isopropanol) was transferred into a QIAquick spin 
column and centrifuged at 13,000rpm for 1 minute. Any DNA molecules were 
absorbed on the column membrane and the flow-through was discarded. To remove 
the remaining trace agarose gel, 500µl Buffer QG was added to the spin column and 
centrifuged at 13,000rpm for 1 minute and the flow-through was discarded. To 
remove any remaining salt, 750µl Buffer PE was then added to each spin column, left 
at room temperature for 3 minutes and the column centrifuged at 13,000rpm for 1 
minute, and the flow-through was discarded. To remove the remaining Buffer PE, 
each spin column was further centrifuged at 13,000rpm for 1 minute. Thereafter, each 
QIAquick spin column was placed into a sterile 1.5ml microcentrifuge tube and 50µl 
DEPC-treated water was applied gently to the centre of column membrane on which 
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the DNA molecules were absorbed. The spin column was centrifuged at 13,000rpm 
for 1 minute and the DNA sample, dissolved in approximately 50µl water, was 
collected in the microcentrifuge tube.   
 
2.1.4 Spectrophotometric quantification of nucleic acids 
The spectrophotometric quantification of nucleic acids (DNA and RNA) provides 
information of the concentration and purity (OD 260nm/280nm) of DNA/RNA 
solutions. The 260nm wavelength is the peak absorption wavelength of both DNA 
and RNA and a 260nm OD value of ‘1’ equals to a concentration of 50µg/ml for 
DNA or 33µg/ml for RNA. Therefore, the concentrations of DNA/RNA samples can 
be derived from the measured 260nm OD values. Frequently when the DNA/RNA 
samples were highly concentrated (ranging from hundreds µg/ml to several thousand 
µg/ml), a dilution of 1/100, 1/70 or 1/50 with double distilled water (ddH2O) was 
used. 
 
The parameter of 260nm/280nm OD ratio is an indicator for the purity of DNA/RNA 
samples. For DNA samples a ratio of 1.6~1.8 or for RNA samples a ratio of 1.8~2.0 
indicates that the sample is of good purity and can be used reliably in the further 
experiments such as PCR, ligation and reverse transcription (RT).  
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2.1.5 DNA ligation 
Ligation of two DNA molecule ends takes advantage of DNA ligase which links the 
ends of two DNA molecules and generates the phosphate backbone at the ligation site. 
Commonly the two ligation ends are complementary with each other and each end 
comprises of one overhanging strand, which are called “sticky ends”. Sometimes the 
two ligation ends do not contain any overhanging strands, which are called “blunt 
ends”. Ligation of two DNA molecules either containing paired sticky ends or blunt 
ends can be achieved using DNA ligase. An example of ligation of two DNA 
molecules containing sticky ends resulting from Hind III restriction digestion is given 
below: 
 
5'-A     +        A G C T T-3'                       5'-A A G C T T-3' 
3'-T T C G A-5’            A-5'                        3'-T T C G A A-5' 
 
 
In the works described in this thesis, DNA ligation was used to ligate the DNA 
fragments of plasmid vectors and inserts obtained from previous experiments 
(restriction digestion, agarose gel electrophoresis and gel extraction of DNA 
fragments) and the ligation products were plasmid constructs to be stably transfected 
into human colonic epithelial Caco-2 cells. Details of the plasmid vectors and inserts 
are described in Chapter 3.  
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DNA ligation was carried out using the T4 DNA ligase kit (Promega). DNA 
fragments of plasmid insert and vector were added in a molar ratio of 5:1, 3:1, 1:1, 1:3 
or 1:5. In each reaction of 10µl total volume, 100ng of vector DNA was used and the 
amount of insert DNA was calculated according to the formula:  
 
ng of insert = (100ng vector × kb size of insert/ kb size of vector) × molar ratio (of 
insert/vector) 
 
According to their respective concentrations measured using spectrophotometric 
quantification, vector DNA and insert DNA were added into a sterile microcentrifuge 
tube. One microlitre of 10X DNA ligase buffer and 1µl of T4 DNA ligase were also 
added and nuclease free water (provided with the kit) was added to fill the 10µl total 
volume. The mixture (vector DNA, insert DNA, buffer, T4 DNA ligase and water) 
was mixed gently and ligation of insert and vector DNA molecules was achieved by 
incubating the mixture at room temperature for 3 hours, or alternatively at 4ºC 
overnight. After incubation was complete, the ligation product was transformed into 
chemically competent bacterial cells for amplification in further experiments.  
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2.1.6 Transformation of chemically competent bacterial cells 
Transformation of chemically competent bacterial cells takes advantage of competent 
bacteria, which are capable of taking up and expressing (known as ‘transform with’) 
genetic material such as plasmid constructs. Selective growth of these transformed 
bacteria allows amplification of the plasmid constructs together with bacterial growth 
cycles. In the molecular cloning work described in this thesis, commercial competent 
bacteria, One Shot® TOP10 Chemically Competent E. Coli cells (Invitrogen), were 
used and the protocol followed the instructions provided by the manufacturer. 
 
In each transformation, ~100ng of plasmid or 10µl of ligation product (containing 
putative plasmid construct produced from 100ng of vector DNA and various ng of 
insert DNA, see above) was mixed gently with one vial (50µl) TOP10 bacterial cells 
by flicking the bottom of the microcentrifuge tube. The mixture was incubated on ice 
for 1-2h, then heat-shocked at 42ºC for 30 seconds and then placed back on ice for 2 
minutes. These steps enabled the uptake of DNA into TOP10 cells. Afterwards 250µl 
of pre-warmed (37ºC) S.O.C medium (Super Optimal broth with Catabolite repression 
medium, provided with the TOP10 kit) was added and incubated at 37°C and shaken 
at 225 rpm for 1 hour in a shaking incubator. Under these conditions, the TOP10 
bacteria (containing the transformed bacteria) started to grow and after incubation, 10 
to 100µl of transformation mix were spread on LB agar plates.  
 
 
63 
 
LB agar plates were prepared as follows. A dissolved agar gel solution containing 
500ml water, 5g (1%) Tryptone (Sigma), 5g (1%) Sodium chloride (Sigma), 2.5g 
(0.5%) Yeast extract (Sigma) and 4g (0.8%) Agar (Sigma), was heated in a 
microwave oven until complete melting was achieved and then autoclaved at 121ºC 
for 20 minutes, cooled down until 50ºC and Ampicillin (100ug/ml) added. 25ml of 
agar gel solution was poured into a 100mm   Petri-dish near the flame of a Bunsen 
burner, left at room temperature until the gel was solid, stored at 4ºC and pre-warmed 
at 37ºC before use. After being spread with the transformation mix, the LB agar plates 
were incubated at 37ºC overnight, which allowed the bacteria to grow under the 
selection of the antibiotic ampicillin. Any transformed bacteria that had acquired the 
plasmid that contains the ampicillin resistance gene are insensitive to ampicillin, 
whereas the non-transformed bacteria do not have the ampicillin resistance gene and 
are sensitive. As a result, those strains expressing the plasmid were selected to grow 
and after 16 hours, bacterial clones derived from each single transformed bacterium 
appeared on the surface of LB agar.  
 
Single colonies were picked and incubated in 5ml LB medium at 37ºC overnight. The 
LB medium is a solution following the same recipe of LB agar (1% Tryptone, 1% 
sodium chloride and 0.5% Yeast extract) without agar being present. The LB medium 
was made following the same procedure of LB agar (heating, autoclaving and cooling) 
and contained 100ug/ml Ampicillin. When the incubation was finished, bacterial 
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suspension of each tube containing large number of cells split from the same 
transformed bacterial strain was used to harvest the plasmids.  
 
2.1.7 Small scale plasmid preparation 
Small scale plasmid preparation can be used to harvest and purify plasmid DNA from 
small scales (millilitres) of bacterial cultural suspension and yields approximately 
10µg plasmid DNA per 1.5ml of bacterial suspension. In this study, the QIAprep® 
Miniprep kit (Qiagen) was used and the protocol followed the instructions provided 
by the manufacturer. The harvested plasmid DNA was ready to be used in various 
applications including PCR, sequencing, restriction digestion and transfection into 
mammalian cells in culture.    
 
Each microcentrifuge tube containing 1.5ml of LB medium bacterial suspension was 
centrifuged at 13,000rpm for 3 minutes at room temperature, the supernatant 
discarded and the pelleted bacterial cells were resuspended in 250µl Buffer P1. The 
mixture was then transferred into a sterile microcentrifuge tube and 250µl Buffer P2 
was added. The tube was gently inverted 4-6 times for thorough mixing, the mixture 
incubated at room temperature for 5 minutes and 350µl Buffer N3 added. The tube 
was gently inverted 4-6 times again, incubated at room temperature for 5 minutes and 
centrifuged at 13,000rpm for 10 minutes at room temperature. After centrifugation, 
the plasmid DNA was retained in the supernatant fluid whereas the waste was pelleted 
and discarded.  
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The supernatant fluid was removed to a QIAprep spin column and the column was 
centrifuged at 13,000rpm for 1 minute. The plasmid DNA was absorbed on the 
column membrane and flow-through was discarded. 500µl of Buffer PB was then 
added to the column and centrifuged at 13,000rpm for 1 minute. This step is to wash 
off the trace residual nuclease on the membrane. 750µl of Buffer PE was then added 
to the column and centrifuged at 13,000rpm for 1 minute. This step is to wash off the 
residual salts combining with the plasmid DNA. Additional centrifugation at 
13,000rpm for 1 minute was then performed to remove the residual Buffer PE, which 
contains ethanol that might inhibit enzymatic activity in some experiments, such as 
PCR or restriction digestion. Finally, the column was moved to a new microcentrifuge 
tube and 50µl DEPC-treated water was gently added to the center of column 
membrane. The column was left for 1 minute and centrifuged at 13,000rpm for 1 
minute, and the plasmid DNA, dissolved in approximately 50µl water, was collected 
in the tube.   
 
2.1.8 DNA sequencing 
The sequences of the NF B-luciferase and TATA-luciferase reporter constructs 
(details in Chapter 3) were determined by DNA sequencing. Briefly, for each sample, 
>1µg of purified plasmid DNA was dried using a vacuum pump and then send for 
commercial sequencing (Eurofins). The primers used in sequencing were prepared in 
a 20µl solution at a concentration of 2pmol/µl. These primers were T7 primer 
(provided by Eurofins) for forward sequencing, short-reverse primer (binding to 
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luciferase coding sequence proximal to the NF B sites) and long-reverse primer 
(binding to luciferase coding sequence distal to the NF B sites) (for details, see 
Chapter 3, primer sequences in Table 3) for reverse sequencing.  
 
2.1.9 Mammalian cell culture 
The work described in this thesis used human colon adenocarcinoma Caco-2 cell line 
which is a model of differentiating colonic epithelial cells. Stocks of Caco-2 cells 
were routinely grown in DMEM + GlutaMAX-1 medium (4.5g/L D-Glucose and 
pyruvate, Gibco) supplemented with 10% (v/v) foetal calf serum (FCS) (Sigma) and 
1% (v/v) penicillin-streptomycin (P/S)) and at 37°C in a 5% CO• • atmosphere. Cells 
were passaged when being 100% confluent. Cells were gently washed 2-3 times with 
1X PBS, trypsinized at 37ºC for 10 minutes until being detached, resuspended in 
growth medium, pelleted by centrifugation at 1,500rpm for 5 minutes, resuspended in 
growth medium and sub-cultured at a concentration of 10-30% in a new flask. 
Alternative selections of cell growth medium were used in the experiments of stable 
transfection, siRNA transfection and Se depletion and supplementation, which are 
described in the following sections.   
 
2.1.10 Stable transfection of human colonic epithelial Caco-2 cells with 
plasmid DNA 
Transfection refers to selective delivery of genetic material such as plasmid DNA into 
eukaryotic cells and stable transfection, as opposed to transient transfection (such as 
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siRNA transfection, see Section 2.1.11), results in persistent expression of the target 
gene in the plasmid DNA. The uptake of the plasmid DNA into mammalian cells 
frequently takes advantage of an artificial cationic lipid agent which forms liposomes 
coating the plasmid, fuses with cell membrane so as to deliver the DNA into cells. In 
the work described in this study, the stable transfection experiments were carried out 
using Lipofectamine 2000™ (Invitrogen) following the procedure recommended by 
the manufacturer. The plasmids used were NF B-luciferase and TATA-luciferase 
reporter constructs contained in PBLUE-TOPO (details in Chapter 3) and these two 
plasmids contain the Neomycin resistant gene. Therefore, persistent selection of 
successfully transfected cells was carried out using Neomycin (G418) (Invitrogen), 
and any untransfected cells were killed and screened out. This selection step generally 
takes several weeks. Four to six weeks were needed in this study.     
 
To stably transfect the human colonic epithelial Caco-2 cells with the plasmid DNA, 
cells were seeded in a 6-well plate 24 hours before transfection, each well containing 
2ml normal cell growth medium (DMEM + GlutaMAX-1 (4.5g/L D-Glucose and 
pyruvate, Gibco), supplemented with 10% (v/v) feotal calf serum and 1% (v/v) 
penicillin-streptomycin); cells were ~95% confluent. In each well, cell growth 
medium was changed to 2ml Optimem (Gibco). Five microlitres Lipofectamine 
2000™ was mixed gently with 250µl Optimem in a universal tube by gently shaking 
and the mixture was incubated at room temperature for 5 minutes. At the same time, 
2.0, 4.0 or 6.0µg DNA of each plasmid (the two plasmid constructs described above) 
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was mixed gently with 250µl Optimem in a second universal tube by gently shaking 
and the mixture was also incubated at room temperature for 5 minutes. Then the 
Lipofectamine mix and the DNA mix were added together, mixed gently and 
incubated at room temperature for 20 minutes. These steps allowed the coating of 
plasmid DNA with Lipofectamine. The 500µl transfection mix was dripped gently to 
wells each containing 2ml Optimem. The treated cells were grown in an ordinary cell 
culture environment at 37ºC with 5% CO• • for 24 hours in an incubator.    
 
Twenty-four hours later, the uptake of plasmid DNA was complete (according to 
manufacturer’s protocol) and the medium in each well was then replaced with 2ml 
normal cell growth medium. Cells were grown for another 24 hours and treated with 
0.5ml trypsin to be detached from 6-well plate. Cells from each well were then moved 
into a 100mm petri-dish and grown in 10ml normal medium supplemented with 
750µg/ml G418 to select the transfected cells. The culture medium was changed every 
3-4 days. Cells were washed twice with 1X Phosphate buffered saline (PBS) to 
remove dead cells and fresh medium containing 750µg/ml G418 added. Cells were 
continuously cultured in such condition for 4-6 weeks until all the untransfected cells 
had been killed. The remaining cells transfected with each type of plasmid DNA were 
harvested in a mixed population.  
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2.1.11 Transient transfection of human colonic epithelial Caco-2 cells with 
small interfering RNA (siRNA) 
Transient transfection delivers genetic material (such as plasmid DNA and siRNA) 
into eukaryotic cells so that the genetic material is expressed transiently in the cells 
for a few days. Selection using an antibiotic marker is not required. Transient 
transfection also uses cationic lipid transfection agent and the experiments described 
in this study used Lipofectamine 2000™ (Invitrogen).  
 
Small interfering RNA (siRNA) is a small dimeric double-stranded RNA. Generally 
each strand contains 21nt, comprising 19nt complementary sequence together with 
2nt AA overhang. siRNA are experimentally designed to be homologous with a 21nt 
sequence of a target mammalian transcript (mRNA target). After being delivered into 
cells, the siRNA double-strandeds dissociate from each other and recognize the 
mRNA target. The binding formation between an mRNA sequence and a siRNA 
strand results in the recruitment of an enzymatic complex, RNA-induced silencing 
complex (RISC), and degradation of mRNA by RISC (the process known as RNA 
interference). Therefore, transient transfection of mammalian cells with siRNA 
selectively degrades the target transcripts in the cells and is used to knockdown gene 
expression for a short period of approximately 2 days. siRNA has been suggested to 
decrease gene expression most efficiently on mRNA level 2 days after delivery and 
on protein level 3 days after delivery. In the present experiments, siRNAs were 
designed to knockdown the expressions of human GPX1, SELW, SELH and GPX4 
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genes, and commercially synthesized (20nmol siRNA annealed and with standard 
purity, AM16104, Ambion). In addition, a scrambledd control siRNA that is not 
homologous with any human mRNA transcripts was also designed and synthesized. 
Details of the siRNA and mRNA target sequences are given in Chapter 5 Section 
5.2.1 and Chapter 6 Section 6.2.1.    
 
To transiently transfect the human colonic epithelial Caco-2 cells with siRNA, 5X105 
cells were seeded in a 6-well plate and grown for 24 hours before transfection. Each 
well contained 2ml normal cell growth medium (DMEM + GlutaMAX-1 (4.5g/L 
D-Glucose and pyruvate, Gibco), supplemented with 10% (v/v) foetal calf serum 
(FCS) and 1% (v/v) penicillin-streptomycin (P/S)) and cells were 40-50% confluent. 
For transfection, each well was changed with 2ml of modified growth medium 
containing DMEM + GlutaMAX-1 (Gibco) supplemented with 5% (v/v) FCS and no 
P/S, as recommended in the manuals provided by the manufacturer (Ambion). Five 
microlitres Lipofectamine 2000™ was mixed gently with 250µl Optimem in a 
universal tube by gently shaking and the mixture was incubated at room temperature 
for 5 minutes. At the same time, 40, 80, or 120pmol siRNA or scrambledd control 
siRNA was mixed gently with 250µl Optimem in a second universal tube by gently 
shaking and the mixture was also incubated at room temperature for 5 minutes. Then 
the Lipofectamine mix and the siRNA mix were added together, mixed gently by 
gently shaking and incubated at room temperature for 20 minutes. The 500µl 
transfection mix was then dripped gently into one well containing 2ml reduced-serum 
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medium. After being added into the well and diluted in the total 2.5ml medium, the 40, 
80 and 120pmol siRNA resulted in working concentrations of approximately 15, 30 
and 45nM, respectively; the range of working concentration recommended by 
Ambion is 10-100nM.   
 
Cells treated with the transfection mix were grown for 24 hours and then the medium 
was replaced with 2ml reduced-serum medium for a further 1-2 days until harvest. In 
general, to assess the effect of siRNA transfection on mRNA expression, cells were 
further grown for 24 hours and total RNA was harvested 2 days after transfection, 
whereas to assess the effect of siRNA transfection on protein expression, cells were 
further grown for 48 hours and total protein lysis was harvested 3 days after 
transfection. 
 
2.1.12 Mammalian cell culture in Se-depleted and Se-supplemented 
medium  
To assess the effect of Se depletion on selenoprotein expression and inflammatory 
response, a previously established protocol of mammalian cell culture in Se-depleted 
and Se-supplemented growth medium (Pagmantidis et al., 2005) was used. Briefly, 
106 Caco-2 cells were seeded in each well of a 6-well plate and grown for 24 hours in 
normal cell growth medium (as described in Section 2.1.9) at 37°C in a 5% CO• • 
atmosphere. Cells were then grown in either Se-depleted or Se-supplemented culture 
medium for 3 days. Se-depleted medium was prepared from serum-free DMEM + 
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GlutaMAX-1 medium (4.5g/L D-Glucose and pyruvate, Gibco) supplemented with 
0.1% (v/v) penicillin-streptomycin (P/S), 1% (v/v) non-essential amino acids (NEAA, 
Gibco), insulin (5 g/ml) and transferrin (5 g/ml). Se-supplemented medium was 
prepared from serum-free DMEM + GlutaMAX-1 medium (4.5g/L D-Glucose and 
pyruvate, Gibco) supplemented with 0.1% (v/v) penicillin-streptomycin (P/S), 1% 
(v/v) non-essential amino acids (NEAA, Gibco), insulin (5 g/ml), transferrin (5 g/ml) 
and selenium in the form of sodium selenite (7ng/ml).  
 
Usually, Caco-2 cells seeded at 106 cells/well were 80~90% confluent after growing 
for 3 days in Se-depleted or Se-supplemented medium. Similarly, following siRNA 
transfection, Caco-2 cells seeded at 5X105 cells/well were also 80~90% confluent 
after growing for 3 days in reduced-serum (5% (v/v) FCS) medium. Se depletion has 
been found (Pagmantidis et al., 2005) to lower the expressions of selenoproteins most 
efficiently at day 3 after changing into low Se medium (Chapter 4) and siRNA 
decreased the protein expression of a target gene (Chapter 6) at day 3 after 
transfection. Therefore, the comparable cell confluencies between the Se depletion 
and siRNA transfection experiments at day 3 were important for the comparison of 
their biological effects between experiments.  
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2.1.13 Extraction of total RNA from mammalian cells 
Total RNA extraction from Caco-2 cells was carried out based on the method of 
(Chomczynski and Sacchi, 1987). For each sample, cells were washed twice with 1X 
PBS and then incubated with 0.5ml (in each well of a 6-well plate) or 1ml (in a 75mm 
flask) of TRIzol® (Invitrogen) at room temperature for 5 minutes. Cells were 
detached from 6-well plate or flask using a cell scraper. Each sample of cell 
suspension in TRIzol was transferred into a sterile 1.5ml microcentrifuge tube and 
then 200µl of chloroform (Sigma) added. The mixture was vertexed vigorously for 15 
seconds and incubated at room temperature for 3 minutes. TRIzol is a mixture of 
guanidinium isothiocyanate and phenol. Whereas guanidinium isothiocyanate is used 
to lyse the cells and disassociate the nucleoprotein complexes, phenol and 
supplemented chloroform are used to dissolve protein, genomic DNA and RNA and 
separate these components in different phases after centrifugation. The sample was 
centrifuged at 12,000g for 15 minutes at 4ºC and total RNA was retained in the upper 
clear aqueous phase. The white-colour intermediate phase contained a mixture of cell 
debris and undissolved DNA and protein, and the pink lower organic phase contained 
the majority of DNA and protein. The upper aqueous phase was carefully transferred 
into another sterile 1.5ml microcentrifuge tube.   
 
To participate the RNA, 500µl isopropanol (Sigma) was added into the upper aqueous 
phase solution (approximately 200-400µl), and the mixture was mixed by inverting 
the tube for 6-8 times and incubated at room temperature for 10 minutes. The sample 
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was centrifuged at 12,000g for 15 minutes at 4ºC and total RNA was participated in a 
pellet at the bottom of the tube. The supernatant was discarded and the RNA pellet 
was washed once with 1ml 75% ethanol by vortexing the tube for a few seconds. The 
sample was then centrifuged again at 7500g for 5 minutes at 4ºC, and the pelleted 
total RNA was briefly air dried and dissolved in 50µl of DEPC-treated water.  
 
2.1.14 Reverse transcription to generate cDNA from RNA template 
Reverse transcriptase, also known as RNA-dependent DNA polymerase, reversely 
transcribes single-stranded RNA into double-stranded DNA (cDNA) which can be 
used as a template for PCR amplification. Reverse transcription was carried out using 
Transcriptor Reverse Transcriptase® kit (Roche) following manufacturer’s 
instructions.  
 
Briefly, in each reaction of 20µl total volume, 1µg of total RNA was used as template 
and mixed with 4 l of 5X Transcription buffer (provided in kit), 2 l of ddNTP mix 
(Bioline) at a concentration of 10mM, 1 l of Oligo(dt)15 primer (100µM) (Roche), 
0.5 l of RNAse inhibitor (40U/µl) (Roche). DEPC-treated water was added to make 
the total volume to 19.5µl and then 0.5 l of Transcriptor Reverse Transcriptase® 
(20U/µl) was added and mixed gently by pipetting. A programme for reverse 
transcription was set up on a PCR machine so as to incubate the sample at 55°C for 30 
minutes and then cool down to 4°C. The cDNA produced was stored at -20°C before 
use.  
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2.1.15 Polymerase chain reaction (PCR) and semi-quantitative RT-PCR  
Polymerase chain reaction takes advantage of the ability of a DNA polymerase, 
generally the thermostable Taq polymerase, to amplify a section of DNA sequence 
from very small number of copies to up to millions of copies. Combined with reverse 
transcription (RT-PCR), it is frequently used to detect gene expression. RT-PCR uses 
PCR amplification with the cDNA product from reverse transcription (Section 2.1.14). 
To disassociate the double-stranded DNA into single-stranded DNA, the initial step of 
PCR (Step 1: initial denaturation) is to denature DNA by heating at 94ºC for 5 
minutes.  
 
PCR amplification uses a pair of short (generally 20-30nt) single-stranded DNA 
oligonucleotides (known as the PCR primers, comprising a forward primer and a 
reverse primer), which are designed to be complementary to the template DNA, as 
initiation substrates to replicate the novel DNA strands from the template DNA. 
Following the initial denaturation, the template DNA and primer DNA are heated 
briefly at 94ºC for 30 seconds (Step 2a: denaturation) and then temperature lowered to 
50-70ºC for 30 seconds. This allows the denatured single-stranded primer DNA to 
anneal to the template DNA (Step 2b: annealing). The annealing temperature is 
variable from one primer pair to another and is mainly dependent on the GC content 
of the primer oligonucleotides. The primer and template DNA are then heated to 72ºC 
for 1 minute and Taq polymerase synthesizes a novel DNA strand by elongating 
3’end of the primer oligonucleotide in the presence of ddNTP mix (ddATP, ddTTP, 
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ddCTP and ddGTP) (Step 2c. elongation). Together, the three steps occurring in a 
series (denaturation, annealing and elongation) constitute a single cycle of PCR 
amplification. Theoretically, each PCR amplification cycle results in double number 
of copies of the amplified region (between the two primer binding sites) on the 
template DNA. To continuously increase the copy numbers, one PCR cycle is simply 
followed by another and generally 20-40 cycles are used in PCR amplification.   
 
When the PCR amplification is finished, the final step is to heat the PCR sample at 
72ºC for a few minutes (7 minutes in this study). This is to ensure that all 
single-stranded DNA finish the elongation (Step 3: final elongation). Together, the 
programme for PCR amplification is described as following:   
 
Step 1 (initial denaturation):                   94ºC        X      5 minutes 
Step 2a (denaturation):                       94ºC        X     30 seconds 
Step 2b (annealing):                         50-70ºC   X     30 seconds 
Step 2c (elongation):                         72ºC        X      1 minute 
• Step 2 (PCR amplification) = (Step 2a + Step 2b +Step 2c) X cycle numbers 
Step 3 (final elongation):                     72ºC        X      7 minutes 
 
PCR amplification in experiments described in this thesis used BIOTAQ polymerase 
(Bioline) following the protocol provided by manufacturer. In each reaction of 25µl 
total volume, 0.5µl of cDNA sample (RT product) was used as template DNA and 
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mixed with 2.5µl of 10X PCR buffer (provided in kit), 2.5 l of ddNTP mix (Bioline) 
at a concentration of 10mM, 2.5 l of forward primer and 2.5 l of reverse primer 
(each in solution at a concentration of 20pmol/µl) (custom synthesized, Eurofin) and 
1µl of magnesium chloride (50mM). DEPC-treated water was added to make up the 
total volume to 20µl and then 0.15µl of BIOTAQ (Bioline) (5U/µl) was added to the 
sample.  
 
The semi-quantitative RT-PCR is a variant technique of ordinary PCR amplification. 
When RT employs equal amount (1µg) of total RNA and PCR employs equal amount 
(0.5µl) of RT product for all the samples, the resulting copy numbers of the amplified 
DNA fragment following RT-PCR rely on the abundance of the template transcripts 
existing in the total RNA in different samples. Although a copy number cannot be 
quantified, the comparison of the intensities of PCR bands from different samples can 
be quantified and calculated as a percentage expression relative to one chosen as 
control (standardized as ‘1’). As a result, the abundance of template transcripts can be 
compared between one and another sample using a semi-quantitative method to 
calculate the relative percentages of the PCR band intensities. The method was 
adapted in this study to calculate the mRNA expression levels of GPX1, SELW, SELH, 
GPX4, GPX2 and IL8 genes (described in Chapter 4-6).  
 
The semi-quantitative RT-PCR requires the PCR amplification to be at the linear 
stage before saturation. This is to ensure that the PCR amplification for all the 
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samples is effective for the reliability of the semi-quantification. For example, in the 
semi-quantitative RT-PCR experiments comparing GPx4 expression in normal 
Caco-2 cells and in cells treated with GPx4 siRNA, PCR amplification of GPx4 was 
performed at 25, 27, 29 and 31 cycles and results suggested that the 29 cycle PCR 
amplification for both samples was at the linear stage. Therefore, comparison of GPx4 
expression between the normal and siRNA-treated samples was performed using 
29-cycle PCR amplification and the GPx4 expression in the siRNA-treated cells was 
expressed in a percentage relative to the GPx4 level in the normal cells.  
     
A list of PCR primers used in work described in this thesis is given in Table 3. 
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Primers Sequences Tm 
GPX4 for 5’-CGA TAC GCT GAG TGT GGT TTG C-3’ 
GPX4 rev 5’-CAT TTC CCA GGA TGC CCT TG-3’ 
66ºC 
GPX4 m-for 5’-CAT TGG TCG GCT GGA CGA G-3’ 65 ºC 
GAPDH for 5’-TGA AGG TCG GAG TCA ACG GAT TTG-3’ 
GAPDH rev 5’-CAT GTA AAC CAT GTA GTT GAG GTC-3’ 
55 ºC 
 
GPX1 for 5’-CAG TCG GTG TAT GCC TTC TCG-3’ 
GPX1 rev 5’-TGT CAG GCT CGA TGT CAA TG-3’ 
56 ºC 
 
GPX2 for 5’-GGC TTT CAT TGC CAA GTC CTT C-3’ 
GPX2 rev 5’-CTA TAT GGC AAC TTT AAG GAG GCG C-3’ 
60ºC 
 
SELW for 5’-GTT TAT TGT GGC GCT TGA GGC-3’ 
SELW rev 5’-GAA CAT CAG GGA AAG ACC ACC-3’ 
60 ºC 
 
SELH for 5’-GCT TCC AGT AAA GGT GAA CCC G-3’ 
SELH rev 5’-ACC CAA ATC TCC CTA CGA CAG G-3’ 
62 ºC 
 
IL8 for 5’-ATG ACT TCC AAG CTG GCC GTG GCT-3’ 
IL8 rev 5’-TCT CAG CCC TCT TCA AAA ACT TCT C-3’ 
60 ºC 
 
NF B for 5’-CAG GGG ACT TTC CGA AGG CTC-3’ 60 ºC 
TATA for 5’-CCG ATC TGG GGC AGA GCA TAT AAG-3’ 60 ºC 
Short rev 5’-CGT ACG TGA TGT TCA CCT CGA TAT GTG-3’ 61 ºC 
Long rev 5’-CGA CTT CTT TCG AAA GAG GTG CG-3’ 60 ºC 
Table 3: Primers for generating products from mRNA transcripts by PCR 
amplification and semi-quantitative RT-PCR 
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2.1.16 Preparation of cell lysate from mammalian cells using a sonication 
method 
Cell lysates were prepared from Caco-2 cells by disruption using sonication and GPx4 
protein levels then measured by Western blot. Briefly, cultured Caco-2 cells in a 
6-well plate were washed twice with 1X PBS, 0.5-1ml ice-cold 1X PBS added per 
well and incubated on ice for 10 minutes. This resulted in detachment of cells from 
the surface of 6-well plate without affecting cell integrity. The cell suspension was 
then transferred into a sterile 1.5ml microcentrifuge tube, centrifuged at 1,500rpm for 
5 minutes at room temperature and the pelleted cells were re-suspended in 200µl 1X 
PBS containing 0.1% (v/v) Triton. The cell suspension was sonicated twice for 10 
seconds with a 30-50% pulse using a LAB SONIC U sonicator. This caused cell 
disruption. The cell debris was pelleted by centrifugation at 3,500rpm for 10 minutes 
at 4ºC. The supernatant fluid (cell lysate) was aliquoted into 30µl quantities, 
snap-frozen in liquid nitrogen and stored at -80ºC before use.   
 
2.1.17 Separation of protein molecules by SDS-PAGE   
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is an 
electrophoretic technique used to separate protein molecules on the basis of molecular 
weight. SDS binds to the polypeptide sequences, disrupts the non-covalent bonds to 
open their folding conformation and results in evenly distributed negative charges on 
the SDS-polypeptide, the amount of which are proportional to the polypeptide length. 
Polyacrylamide gels provide the matrix on which protein molecules migrate with 
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different electrophoretic mobility. Low concentration gels (e.g. 8%) can be used to 
separate large protein molecules whereas high concentration gels (e.g. 12.5%) are 
used to separate smaller protein molecules. In addition, a mix of protein molecules of 
known size (protein marker) is generally co-electrophoresized and used to estimate 
protein molecular weight.  
 
Work described in this thesis used 12.5% SDS-polyacrylamide gels to separate 
protein molecules including the 19kDa GPx4 protein prior to western blot. The 12.5% 
SDS-polyacrylamide gel (resolving gel) solution was prepared with 3.125ml of 30% 
Acrylamide/Bis-acrylamide solution (ratio 29:1) (Sigma), 3.75ml of  1M Tris-Cl 
solution (pH=8.8) (Promega), 2.925ml of ddH2O, 100µl of 10% SDS solution 
(obtained from 20% SDS stock solution, Sigma), 100µl of 10% Ammonium 
persulphate (APS) solution (Sigma, solution stored at -20ºC before use) and 10µl of N, 
N, N', N'-tetramethylethylenediamine (Sigma) in 10ml total volume. The stacking gel 
was prepared with 3.75ml of 1M Tris-Cl solution (pH=6.8) and 
Acrylamide/Bis-acrylamide solution, ddH2O, 10% SDS solution and 10% APS 
solution in equal amounts as the resolving gel. 
 
The SDS-PAGE running buffer (1X) was diluted from a 5X stock, which was 
prepared by dissolving 60.6g Tris-Cl, 144.1g Glycine and 5g SDS (all chemicals from 
Promega) in 800ml of water, adjusting pH to 8.8 and adding water to a 1000ml total 
volume. The 5X sample loading buffer was prepared by mixing and dissolving 2.25ml 
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of 1M Tris-Cl solution (pH=6.8), 5ml of Glycerol (Sigma), 0.5g SDS (Promega), 5mg 
Bromophenol Blue (Sigma) and 2.5ml of 1M DTT solution for each 10ml stock, 
aliquoted and stored at -20ºC before use. 
 
For each sample, 20µg cell lysate protein was mixed gently with 5X sample loading 
buffer in a ratio of 1:4 (v/v) and incubated at 90ºC for 3-4 minutes to disrupt the 
non-covalent bonds of polypeptide (protein denaturation). The samples were loaded to 
the stacking gel and electrophoresis was carried out at 90-100 volts until the dye front 
reached the bottom of the gel.  
 
2.1.18 Analysis of GPx4 protein expression by western blot  
After separation by SDS-PAGE, the protein molecules on the gel were transferred 
onto a membrane and then probed using a specific antibody to quantitatively detect 
GPx4 protein. Transfer of protein molecules to a polyvinylidene difluoride (PVDF) 
membrane (Whatman) was carried out using semi-dry blotting in a transfer 
electroblotting machine. The polyacrylamide gel (approximately 7cm X 9cm) was 
placed upon a PVDF® membrane (7cm X 9cm) (Whatman) and two sets of three 
pieces of filter papers (Whatman) were placed on top of the gel and at bottom of the 
PVDF membrane. The entire stack was placed in the transfer machine and lightly 
wetted using a transfer buffer. The transfer buffer was prepared by mixing 1X 
SDS-PAGE running buffer and methanol (Fisher Scientific) in a ratio of 4:1 (v/v). A 
roller was used to roll over the stack gently to squeeze out any air bubbles between 
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the gel and the PVDF membrane. A small volume of transfer buffer was dripped on 
top of the stack to prevent the membrane becoming over-dry. Transfer was performed 
at 10 volts (constant voltage) for one hour.  
 
After transfer of the proteins, the PVDF membrane was placed into 10ml of 5% (w/v) 
non-fat milk powder solution in TPBS and incubated at 4ºC overnight or at room 
temperature for 1 hour. TPBS was prepared by adding 0.05% (v/v) Tween-20 (Sigma) 
into 1X PBS and mixing thoroughly. Incubation in milk powder solution blocks 
(saturates) the protein-absorbing ability of PVDF and therefore prevents any 
non-specific binding of the antibodies to the membrane.  
 
The PVDF membrane was then incubated for 1 hour with 10ml of rabbit polyclonal 
anti-GPx4 antibody (1st antibody) (LF-PA0055, Ab Frontier, Korea) diluted 1/1000 
(v/v) in 3% (w/v) milk-TPBS. The membrane was washed 3 times with 10ml of TPBS, 
each time for 10 minutes. The PVDF membrane was then incubated for 30 minutes 
with 10ml of horseradish peroxidase (HRP)-labeled anti-rabbit serum (2nd antibody) 
diluted 1/3000 (v/v) in 3% (w/v) milk-TPBS. The membrane was washed 3 times with 
10ml of TPBS, each time for 10 minutes and washed once with 10ml of 1XPBS for 
10 minutes.  
 
Detection of western blot was carried out using the Amersham Hyperfilm ECL™ 
reagent (GE Healthcare). For each membrane, 2ml of ECL solution mix was prepared 
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by adding Solution A and Solution B in a ratio of 40:1 (v/v) and mixed gently. The 
2ml ECL mix was added to the PVDF membrane, sealed with 2 pieces of plastic film 
and incubated in darkness for 5 minutes. ECL emits fluorescence after being 
catalyzed by HRP and the fluorescent signal was captured on film.  
       
2.1.19 Preparation of cell lysate using reporter lysis buffer (RLB) for 
luciferase assays 
Caco-2 cells stably transfected with NF B- or TATA-luciferase reporter constructs 
were tested for their ability to express luciferase at baseline and in response to known 
NF B inducers. The samples of cell lysate from these cells were prepared using the 
reporter lysis buffer (RLB) and the luciferase assay reagent (LAR) used to measure 
luciferase activity (described in Section 2.1.21) following the protocols provided by 
the manufacturer (Promega).      
 
Cells were washed 2-3 times using 1X PBS and 200µl of 1X RLB (provided as 5X 
RLB, diluted with water) added per well of a 6-well plate. Cells were lysed by 
freeze-thawing and vortexing. Cells were frozen in a -20ºC freezer for 15 minutes and 
then warmed at room temperature for 15 minutes. Cells were scraped off using a cell 
scraper and the cell suspension in 1X RLB was transferred into a sterile 1.5ml 
microcentrifuge tube. The cell suspension was then vortexed vigorously for 15 
seconds and the cell debris was pelleted by centrifugation at 12,000 for 2 minutes at 
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4ºC. The supernatant fluid (cell lysate) was carefully collected in 2 aliquots (~70µl of 
each) and stored at -80ºC before use.   
 
2.1.20 Quantification of protein concentration using bicinchoninic acid 
(BCA) protein assay 
The BCA protein assay is a colorimetric assay that determines protein concentration 
based on the formation of Cu2+ -protein complex. Certain amino acids present in the 
proteins, such as cysteine and tyrosine, are able to convert Cu2+ to Cu1+ and therefore 
change the colour of protein solutions from blue to purple. As a result, the protein 
concentration, determining the efficiency of Cu2+ to Cu1+ conversion, can be measured 
at absorbance wavelength of 562 nm. The BCA protein assay is acceptable with the 
PBS-Triton buffer (see Section 2.1.16) and the reporter lysis buffer (see Section 
2.1.19) and therefore was used to determine protein concentration for GPx4 western 
blot and for luciferase assay, respectively. 
 
The BCA assay reagent (Sigma) was prepared by mixing the bicinchoninic acid 
solution and the 4% (w/v) CuSO4 •5H2O solution (both provided in the kit) in a ratio 
of 50:1 (v/v). To build up the standard curve, standard solutions of bovine serum 
albumin (BSA) (provided in kit) were prepared at concentrations of 0, 0.2, 0.4, 0.6, 
0.8 and 1µg/µl. The samples harvested from 6-well plate were estimated to be at 
concentrations of 1-3µg/µl and therefore were diluted in ratios of 1/4, 1/5, and 1/10 
with water. The BSA dilutions and sample dilutions were loaded in a clear, 
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flat-bottomed 96-well plate. For each well, 25µl of protein dilution was mixed with 
200µl of BCA assay reagent and incubated at 37ºC for 30 minutes. The 96-well plate 
was then read on a Multiskan Ascent plate reader at wavelength of 562 nm and the 
protein concentrations were evaluated on the reference of the standard curve. 
 
2.1.21 Quantification of luciferase activities in NF B- and 
TATA-luciferase transfected Caco-2 cells using a luminometer 
To measure the luciferase activities in NF B- and TATA-luciferase reporter 
transfected Caco-2 cells, assays used luciferase assay reagent (LAR, Promega) for 
sample preparation. Quantification was performed using a Truner TD-20e 
luminometer. LAR were prepared by dissolving 1 vial of luciferase assay substrate 
(lyophilized, provided with kit) with 105ml of luciferase assay buffer (provided with 
kit) and stored in darkness at -80ºC before use. The luciferase assay substrate is Beetle 
Luciferin, which can be oxidized by firefly luciferase in a few seconds releasing 
fluorescence as described below (instructions provided by the manufacturer):  
  
                  Firefly luciferase 
Luciferin + ATP + O ---------------------  Oxyluciferin + AMP + PPi + CO  + Light 
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For each sample, 20µl of cell lysate and 100µl of LAR (stored at -80ºC, thawed in 
room temperature before use) were added to a luminometer tube and mixed 
thoroughly by repeatedly flicking the bottom of tube. A Truner TD-20e luminometer 
was set up with a 2-second measurement delay and a 10-second measurement read. 
Blank reading was repeated 3 times under the conditions of no luminometer tube 
being placed in the machine, or only LAR being present. Then the tube containing the 
sample mix was placed into the luminometer and reading of luciferase activity was 
performed with three repeats per sample. The average of the three reading numbers 
was taken and the luciferase activity was calculated per mg total cell lysate (luc/mg). 
 
2.1.22 Semi-quantitative analysis of ROS levels in Caco-2 cells grown in 
Se-depleted medium and in cells treated with GPx1 siRNA using 
carboxy-H2DCFDA 
5-(and-6)-carboxy-2´,7´-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) is 
a cell membrane-permeable fluorescent dye for detection of reactive oxygen species 
(ROS). After being cleaved by ROS, the product emits a fluorescence signal that can 
be captured by a fluorescence microscope or read by a luminometer. A 
semi-quantitative analysis can be performed by comparing ROS levels in one group of 
cells (test) against another group of cells (control) and expressing data in a percentage 
relative to the level of control. This analytical method was used to estimate the effects 
of Se depletion and GPx1 knockdown on ROS levels and the ROS levels were 
determined by staining cells with Image-iT™ LIVE Green Reactive Oxygen Species 
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(ROS) Detection Kit (Invitrogen) following the protocol provided by manufacturer 
and reading carboxy-H2DCFDA fluorescence signal on a BMG LABtech Fluostar 
Omega luminometer.  
 
Briefly, Caco-2 cells were seeded in a black, flat-bottomed 96-well plate at 6X104 
cells/well for Se depletion experiment and at 3X104 cells/well for GPx1 knockdown 
and grown in 100µl of normal growth medium (Section 2.1.9) for 24 hours. Then cells 
were either changed with Se-depleted or Se-supplemented medium and grown for 3 
days (Section 2.1.12), or treated with GPx1 siRNA or scrambled control siRNA (at a 
concentration of 30nM) (Section 2.1.11) and grown for 3 days. After 3 days, cells 
were washed gently once with 100µl/well of pre-warmed 1XHBSS/Ca/Mg solution 
(without phenol red, H8264, Sigma) and ROS measured.   
 
The Image-iT™ LIVE Green Reactive Oxygen Species (ROS) Detection Kit 
(Invitrogen) contains Component A (carboxy-H2DCFDA as powder, 275µg/vial), 
Component B (Hoechst 33342, 400µl of a 1mM solution), Component C (tert-butyl 
hydroperoxide solution) and Component D (500µl DMSO). Preparation of a 10mM 
stock solution of carboxy-H2DCFDA was performed by adding 50µl of DMSO into 
one vial of carboxy-H2DCFDA and mixing until complete dissolving. Preparation of 
a 25µM working solution was performed by adding 5µl of 10mM stock solution into 
2ml of pre-warmed 1XHBSS/Ca/Mg solution and mixing gently. In addition, Hoechst 
33342 as a control dye that stains nucleic acid was also added. Each 2ml of 25µM 
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carboxy-H2DCFDA working solution was mixed with 2µl of 1mM Hoechst 33342 
solution (at a final concentration of 1µM Hoechst 33342).  
 
50µl of carboxy-H2DCFDA-Hoechst 33342 mix was added to each well of a 96-well 
plate and incubated at 37ºC for 30minutes. The 96-well plate was wrapped with foil to 
prevent disturbance by light. After incubation, cells were washed three times with 
100µl/well of pre-warmed 1XHBSS/Ca/Mg solution and then 50µl of 
1XHBSS/Ca/Mg solution was added per well. The carboxy-H2DCFDA fluorescent 
signal was then read at 495/529nm (excitation/emission) wavelength and the Hoechst 
33342 fluorescent signal was read at 350/461nm wavelength in a BMG LABtech 
Fluostar Omega luminometer. For each well, reading was performed with 20 repeats 
for each signal and the signal value was calculated by taking the average of the 20 
readings. To compare the difference in ROS levels between the Se-depletion and 
Se-supplementation cells, the average carboxy-H2DCFDA signal value of Se depleted 
cells was expressed in a percentage of the average value of Se-supplemented cells, 
which was standardized as “1”. To compare the difference in ROS levels between the 
GPx1 siRNA and scrambled control siRNA treated cells, the average 
carboxy-H2DCFDA signal value of GPx1 siRNA treated cells was expressed in a 
percentage of the average value of control siRNA treated cells, which was 
standardized as “1”. The Hoechst 33342 data for nucleic acid staining were used as a 
control of cell number and staining efficiency.  
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3.   Development of NF B-luciferase reporter model in Caco-2 cells 
3.1  Introduction 
In order to assess the influence by Se and antioxidant selenoproteins on the NF B 
signalling in Caco-2 cells, a reliable and convenient method to monitor the activation 
status of NF B transcriptional activity was established. To date, the widely-used 
methodologies to study NF B activation include:  
 
1) Western blotting or immunohistochemical methods to indicate the nuclear 
translocation of NFkB, i.e. increased NFkB subunits in nuclear and decreased NF B 
subunits in cytoplasm (Prabhu et al., 2002, Crack et al., 2006, Tallant et al., 2004);  
 
2) Electrophoretic mobility shift assay (EMSA) to show the DNA-binding affinity of 
NF B to a target promoter, i.e. the transcriptional activity of NF B factor 
(Brigelius-Flohe et al., 1997, Li et al., 2001);  
 
3) Western blotting and/or PCR-based methods to assess the expressional status of 
one or more target genes under NF B control (Roebuck, 1999a), including 
DNA-microarray and PCR-array (Atkinson et al., 2009, Takase et al., 2008); 
 
 
4) Additional methods, most of which assess changes in activation of intermediate 
products involved in the activation of the NF B signalling pathway, e.g. Western blot 
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to show changes in I B protein expression (Li and Engelhardt, 2006), or enzymatic 
assays to assess changes of I B kinase (IKK) activity (Tallant et al., 2004).  
  
In addition to these methods, luciferase reporter approaches have also been used (Li et 
al., 2001, Carlsen et al., 2002, Vykhovanets et al., 2008). These take advantage of a 
luciferase gene driven by a promoter responsive to NF B transcription activity. As a 
result, the luciferase activity, which can be easily measured and quantified, reflects 
the status of NF B activation. One such reporter system has been constructed 
comprising of a firefly luciferase coding sequence fused to a promoter containing 
three NF B binding sites (3X  B) (Maier et al., 2003, Kirillov et al., 1996) and 
applied to a number of in vivo studies assessing the NF B response in different mouse 
tissues (Carlsen et al., 2002, Vykhovanets et al., 2008). For example, in transgenic 
mice carrying this reporter, activation of NF B signalling has been monitored using in 
vivo imaging of various tissues following vein injection of NF B inducers such as 
TNF  and LPS (Carlsen et al., 2002). In addition, in mouse prostate tissues increased 
NF B activation was detected following the administration of IL1
✁
 and this method 
was suggested to be useful in drug screening of positive and negative NF B 
regulators (Vykhovanets et al., 2008).  
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To investigate NF B signalling in response to Se status in Caco-2 cells, the 3X  B 
luciferase reporter system was used by this study. This reporter system is detailed in 
Figure 9 and is based on a providing promoter that contains three binding sites 
responsive to various types of NF B hetero- and homo- dimers, including two binding 
sites with affinity for the Class I NF B (NF B1 and NF B2) motif: 
5’-GGGRNNYYCC-3’ and one  B-like site motif: 5’-HGGARNYYCC-3’. As a 
result, NF B activation in response to various inducers can be detected through 
measuring luciferase activity. Also within the promoter and downstream of the 3X  B 
sites, is a TATA box which is used to maintain the baseline expression of luciferase in 
the unstimulated state. 
 
A construct containing the 3X B-luciferase sequence was obtained from Prof. Rune 
Blomhoff, University of Oslo (Carlsen et al., 2002). Before its use in this study, the 
construct required modifications which allowed it to be applied to in vitro 
experiments. These modifications included:  
 
i. Firstly, a control construct was required that comprised only a TATA box and 
luciferase coding sequence (CDS) to that Caco-2 cells stably transfected with the 
construct could be used to assess the background luciferase expression not attributable 
to NF B signalling. To make this construct, the TATA box and luciferase CDS were 
isolated by restriction digestion and inserted into an appropriate vector.  
 
93 
 
ii. Secondly, the required sequences were cloned into either pcDNA3.1 v5-his-TOPO 
or pBLUE-TOPO plasmids (respective maps are given in Figure 10) that can be 
expressed in mammalian cells.   
 
Figure 9: Sequence information of the 3X  B-luciferase and TATA-luciferase 
sequences used in cloning strategy 
(A): The construct of 3X B-luciferase comprises of 3X  B binding sites, TATA box 
and luciferase CDS, and the control construct of TATA-luciferase comprises of 
TATA box and luciferase CDS. (B): The 3X  B-luciferase insert contains restriction 
sites of Hind III and Apa I, and the TATA-luciferase insert contains restriction sites of 
BamH I and Apa I. In addition, the 3 NF B binding sites (bold box), the TATA core 
(light box) and the luciferase CDS initiation site (arrow) are shown.   
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Figure 10: Plasmid maps of pcDNA3.1 v5-his-TOPO and pBLUE-TOPO 
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3.2  Cloning of the 3X  B-luciferase construct and TATA-luciferase 
construct in pcDNA3.1 v5-his-TOPO 
The cloning strategy used by the present study was as follows:  
 
I). pcDNA3.1 v5-his-TOPO or pBLUE-TOPO used as the plasmid vector were 
digested by either a.) Hind III and Apa I to clone the 3X  B-luciferase construct or b.) 
BamH I and Apa I to clone the TATA-luciferase construct (see Figure 7.2);  
 
II). the 3X  B-luciferase and TATA-luciferase sequence used as inserts were obtained 
by Hind III and Apa I restriction digest and by BamH I and Apa I restriction digest, 
respectively (see Figure 9); 
 
III). the respective vector and 3X  B-luciferase insert or TATA-luciferase insert were 
ligated and both the ligation products were confirmed by restriction digestion and 
sequencing. 
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Cloning of the 3X  B-luciferase construct and TATA-luciferase construct in 
pcDNA3.1 v5-his-TOPO was performed by Fan C, University of Newcastle.  
 
The ligation product of 3X  B-luciferase in pcDNA3.1 v5-his-TOPO was checked by 
restriction digest using Pst I and/or Sac II. As shown in Figure 11 (A), since the 
expected construct contains one Pst I site and one Sac II site, double digestion would 
be expected to result in DNA fragments of 6519bp and 1396bp. As shown in Figure 
11 (B), electrophoresis of the digestion product indicated that the 3X B-luciferase 
sequence had been correctly inserted into the pcDNA3.1 v5-his-TOPO vector.  
 
The ligation product of TATA-luciferase in pcDNA3.1 v5-his-TOPO was checked by 
restriction digest using Sal I, Pst I, Cla I, and Pst I and Cla I. As shown in Figure 11 
(C), the expected TATA construct contains two Sal I sites, one Pst I site, and one Cla 
I site (located on the insert). Therefore, restriction digest would be expected to result 
in DNA fragments of 5608bp and 2222bp (Sal I), linearized plasmid (Pst I or Cla I), 
and DNA fragments of 5524bp and 2306bp (Pst I and Cla I), respectively. As shown 
in Figure 11 (D), electrophoresis of the digestion product from TATA construct 
indicated that the TATA-luciferase sequence had been inserted correctly. In 
comparison, restriction digest of the 3X B construct by Sal I was found to result in 
DNA fragments of 4756bp, 2222bp, 885bp and 52bp, with two extra Sal I sites 
located within the 3X  B binding region (also shown in Figure 11 (A) and (D)).  
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The ligation products of 3X  B-luciferase in pcDNA3.1 v5-his-TOPO and 
TATA-luciferase in pcDNA3.1 v5-his-TOPO were confirmed by sequencing (data 
now shown), in which the presence of 3X  B binding sites on the 3X  B construct 
and the presence of TATA box together with the absence of 3X  B binding sites on 
the TATA construct were confirmed.   
 
Figure 11: 3X  B-luciferase and TATA-luciferase sequences in pcDNA3.1 
v5-his-TOPO and restriction digest of ligation product 
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Map of 3X  B-luciferase construct in pcDNA3.1 v5-his-TOPO (A) shows the 
position of 3X  B binding sites together with the TATA box and luciferase CDS and 
the position of restriction sites. Restriction digestion with Pst I and Sac II (B) 
suggested that the ligation product contained the 3X  B sequences. In addition, 
restriction digestion by Sal I on the 3X  B construct provided further evidence for the 
presence of 3X  B binding sites (D). Map of TATA-luciferase construct in pcDNA3.1 
v5-his-TOPO (C) shows the position of TATA box and luciferase CDS and the 
absence of 3X  B binding sites and the position of restriction sites. Using restriction 
digest by Sal I, Pst I and Cla I, the ligation product was suggested to be the TATA 
construct (D).  
 
 
 
3.3  Cloning of NF B- (3X  B-) luciferase construct in pBLUE-TOPO 
To clone the 3X  B-luciferase construct into pBLUE-TOPO (cloning strategy shown 
in Figure 12), the vector was prepared from a pBLUE-TOPO plasmid (kindly 
provided by Prof Dianne Ford, Newcastle University) and the 3X  B-luciferase insert 
was prepared from the previously established 3X  B-luciferase construct in 
pcDNA3.1 v5-his-TOPO. Both of vector and insert were obtained by restriction 
digestion using Hind III and Apa I.  
 
Slightly different from the empty pBLUE-TOPO plasmid (map shown in Figure 10), 
the pBLUE-TOPO plasmid used in the experiment contained an insert of 1000bp 
within the PCR cloning site. This insert was flanked by Hind III recognition sites and 
could be completely removed in Hind III and Apa I restriction digestion. As shown in 
Figure 12 (A) (map of pBLUE-TOPO containing the 1000bp insert, 8793bp in length), 
restriction digestion by Hind III and Apa I generated DNA fragments of 1069bp, 
3230bp and 4494bp (shown in Figure 12 (C)), of which the 4494bp fragment was the 
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pBLUE-TOPO vector to be used in ligation (Figure 12 (C)). The buffer, enzymatic 
activity and other details in experiment were as listed in Table 4.  
 
In addition, the insert of 3X B-luciferase was obtained by Hind III and Apa I 
restriction digest on the 3X B-luciferase construct in pcDNA3.1 v5-his-TOPO. The 
restriction map of the 3X B-luciferase in v5-his-TOPO (7915bp in length) shown in 
Figure 12 (B), restriction digest by Hind III and Apa I generated DNA fragments of 
2500bp and 5415bp (results shown in Figure 12 (D)), of which the 2500bp fragment 
was the 3X B-luciferase insert (Figure 12 (D)).  
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Table 4: Procedure for restriction digestion in cloning of the 
NF B-luciferase-pBLUE-TOPO construct 
Restriction enzymes (Promega) used in cloning of NF B-luciferase-pBLUE-TOPO 
construct was listed as above with respective buffer, enzymatic activity and 
production size instructed.  
 
Cloning Procedure Restriction Enzyme Buffer Activity Product size 
Hind III 100% pBLUE-TOPO 
Vector Apa I 
B 
50-75% 
1069bp 3230bp 
4494bp 
Hind III 100% 3X B-luciferase 
Insert Apa I 
B 
50-75% 
2500bp 
5415bp 
Confirmation of the 
NF B-luciferase 
pBLUE-TOPO 
construct   
Sal I D 100% 52bp 4672bp  
2200bp 
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Figure 12: Cloning of the NF B-luciferase pBLUE-TOPO construct 
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(A): pBLUE-TOPO vector with Hind III and Apa I restriction sites highlighted. 
(B): pNF B-luc-v5-his-TOPO construct containing 2.5kb Hind III-Apa I insert with 
3X B sites (red) and luciferase gene. 
(C): pBLUE-TOPO vector restricted with Hind III and Apa I. DNA bands of ~4.5kbp, 
3.2kbp and 1.0kbp correspond to Hind III-Apa I and Hind III fragments (see Fig A). * 
represents fragment isolated for cloning.  
(D): pNF B-luc-v5-his-TOPO construct restricted with Hind III and Apa I. DNA 
bands of ~5.4kbp and 2.5kbp correspond to Hind III-Apa I fragments (see Fig B).* 
represents fragment isolated for cloning.  
(E): NF B-luc-pBLUE-TOPO construct containing 2.5kbp NF B-luciferase insert. 
Sal I restriction sites are highlighted.  
(F): NF B-luc-pBLUE-TOPO construct restricted with Sal I. DNA bands of ~4.7kbp 
and 2.2kbp correspond to Sal I fragments (see Fig E). The 52bp Sal I-Sal I fragment 
was lost from the electrophoresis gel.  
(G): DNA sequence chromatograh to confirm cloning of the NF B-luciferase 
fragment in pBLUE-TOPO. The NF B sites are identified by the three red boxes; the 
TATA site is boxed in blue and the start of the luciferase gene is indicated in green.  
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Following restriction digest and electrophoresis, the DNA fragments of 4494bp 
(pBLUE-TOPO vector) and of 2500bp (3X B-luciferase insert) were then extracted 
from the gel and purified to be used in ligation. Ligation of the NF B-luciferase insert 
into the pBLUE-TOPO Hind III and Apa I- restructured vector was performed using 
T4 DNA ligase at 4°C overnight (details as shown in Chapter 2 Section 2.1.5). The 
ligation products were transformed into TOP10 cells and recombinant bacteria 
selected using Ampicillin (100mg/ml). Bacterial clonies were selected and each 
cultured in LB medium (Ampicillin 100mg/ml) overnight. Plasmids from each clone 
were purified (Miniprep Kit, Invitrogen) and screened by restriction digest to select 
those containing the 3X B-luciferase-pBLUE-TOPO construct. 
 
As shown in Figure 12 (E), the expected NF B-luciferase-pBLUE-TOPO construct 
would generate three Sal I restriction sites, two positioned within the 3X  B binding 
sites and one positioned within the pBLUE-TOPO vector. As a result, digestion with 
Sal I was expected to generate three DNA fragments of 52bp, 2200bp and 4672bp 
respectively (Figure 12 (E) and Table 4), in contrast to the pBLUE-TOPO plasmid 
containing one Sal I site resulting in linearization. DNA electrophoresis of the Sal I 
digestion products showed several clones to be of the expected restriction pattern, i.e. 
~4672bp and ~2200bp bands (Figure 12 (F)). The cloning of the NF B-luciferase 
insert in the pBLUE-TOPO vector was confirmed by sequencing. This showed the 
presence of the 3X B binding sites, the TATA box and the initial part of the 
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luciferase CDS (Figure 12 (G)) and confirmed that construct had been engineered 
successfully.  
 
3.4  Cloning of TATA-luciferase construct (control) in pBLUE-TOPO 
To clone the TATA-luciferase construct into pBLUE-TOPO (cloning strategy shown 
in Figure 13), which functioned as the control construct lacking the NF B-binding 
sites, the pBLUE-TOPO plasmid was restructured using BamH I and Apa I. 
Restriction digestion by BamH I and Apa I were predicted to result in two DNA 
fragments of 4512bp and 4281bp, respectively (as shown in Figure 13 (A)). These 
would be difficult to separate by electrophoresis. Therefore, an additional restriction 
enzyme EcoR V was used in a triplet digestion. Complete restriction digestion by the 
three enzymes generated three DNA fragments of 1995bp, 2286bp and 4512bp 
(Figure 13 (C)), respectively, of which the 4512bp fragment was the required 
pBLUE-TOPO vector to be used in ligation. This fragment was gel extracted and 
purified (Figure 13 (C)). The buffer, enzymatic activity and other details in 
experiment were as listed in Table 5.  
 
To obtain the TATA-luciferase insert, the previously established TATA-luciferase 
construct in pcDNA3.1 v5-his-TOPO was restructured with BamH I and Apa I. The 
restriction map of TATA-Luc-v5-his-TOPO plasmid (7830bp in length) is shown in 
Figure 13 (B) and digestion by BamH I and Apa I generated DNA fragments of 
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2397bp and 5433bp, of which the 2397bp fragment was the TATA-luciferase insert to 
be used in ligation (Figure 13 (D)) and gel extracted and purified.  
Table 5: Procedure for restriction digestion in cloning of the 
TATA-luciferase-pBLUE-TOPO construct 
Restriction enzymes (Promega) used in cloning of TATA-luciferase pBLUE-TOPO 
construct was listed as above with respective buffer, enzymatic activity and 
production size instructed.  
 
The purified DNA fragments of 4512bp (pBLUE-TOPO vector) and of 2397bp 
(TATA-luciferase insert) were ligated together (procedure as described in Chapter 2 
Section 2.1.5). The ligation products were transformed in TOP10 cells and bacteria 
selected on LB agar plates containing Ampicillin (100mg/ml). Bacterial colnies were 
selected, plasmids purified (Miniprep Kit, Invitrogen) and conformation of 
Cloning Procedure Restriction Enzyme Buffer Activity Product size 
BamH I 75-100% 
EcoR V 100% 
pBLUE-TOPO 
Vector 
Apa I 
MC 
75-100% 
1995bp  
2286bp  
4512bp 
BamH I 75-100% TATA-luciferase 
Insert Apa I 
MC 
75-100% 
2397bp 
5433bp 
Confirmation of the 
TATA-luciferase 
pBLUE-TOPO 
construct 
Kpn I J 100% 6909bp 
(linearization) 
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TATA-luciferase construct in pBLUE-TOPO was screened by restriction digest using 
Kpn I (Figure 13 (E) and (F)) and determined by sequencing (Figure 13 (G)). 
 
Figure 13: Cloning of the TATA-luciferase pBLUE-TOPO construct 
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(A): pBLUE-TOPO vector with BamHI, EcoRV and ApaI restriction sites highlighted. 
(B): TATA-Luc-v5-his-TOPO construct containing 2.4kbp BamHI-ApaI insert with 
TATA site and luciferase gene. 
(C): pBLUE-TOPO vector restricted with BamHI, EcoRV and ApaI. DNA bands of 
~4.5kbp, 2.3kbp and 2.0kbp correspond to BamHI-ApaI, BamHI-EcoRV and 
EcoRV-ApaI (see Fig A). * represents fragment isolated for cloning.  
(D): TATA-Luc-v5-his-TOPO construct restricted with BamHI and ApaI. DNA bands 
of ~5.4kbp and 2.4kbp correspond to BamHI-ApaI fragments (see Fig B). * represents 
fragment isolated for cloning. 
(E): TATA-Luc-pBLUE-TOPO construct containing 2.4kb TATA-luciferase insert. A 
unique KpnI restriction site derived from the pBLUE-TOPO MCS is highlighted. 
(F): TATA-Luc-pBLUE-TOPO construct not restricted (uncut) or linearised (cut) 
using the unique KpnI site derived from the pBLUE-TOPO MCS.  
(G): DNA sequence chromatogram to confirm cloning of the TATA-luciferase 
fragment in pBLUE-TOPO. The KpnI and BamHI restriction sites are highlighted; the 
TATA site is boxed in blue and the start of the luciferase gene is indicated in green. 
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As shown in Figure 13 (E), the TATA-luciferase construct in pBLUE-TOPO was 
expected to conserve one Kpn I restriction site positioned within the residual sequence 
of the pBLUE-TOPO vector. As a result, digestion with Kpn I would be expected to 
linearize the plasmid of 6909bp, in contrast to the NF B-luciferase-pBLUE-TOPO 
which should remained uncut. This is because the Kpn I site originally locates 
between the Hind III and BamH I sites on the pBLUE-TOPO vector and in cloning of 
the NF B-luciferase-pBLUE-TOPO construct it was abolished during the Hind III 
and Apa I digestion. DNA electrophoresis of the Kpn I digestion products confirmed 
several clones to be of the expected restriction pattern, i.e. linearized 6909bp plasmid 
(Figure 13 (F)) and differentiated the TATA-luciferase construct from the 
NF B-luciferase construct in pBLUE-TOPO. 
 
The cloning of the TATA-luciferase insert in the pBLUE-TOPO vector was 
confirmed by sequencing (Figure 13 (G)). This revealed the presence of BamH I site 
(as the fusion site of vector and insert), TATA box, and the beginning part of the 
luciferase CDS. In addition, as expected the NF B-binding sites were absent on the 
control construct (Figure 13 (G)).  
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3.5  Stable transfection of the NF B- and TATA- luciferase constructs in 
Caco-2 cells and preliminary study of the NF B-luciferase Caco-2 cells 
To obtain cell lines expressing the NF B-luciferase reporter and its control, Caco-2 
cells were stably transfected with each of the two constructs contained in either 
pcDNA3.1 v5-his-TOPO or pBLUE-TOPO vectors. Briefly, Caco-2 cells were seeded 
24h before transfection in 6-well plate to reach ~90% confluency and washed 1X with 
PBS; For each transfection, 2-6 g of construct DNA and 5 l of transfection reagent 
Lipofectamine• • 2000 (Invitrogen) were diluted in 2.5ml Opti-mem (Gibco) and 
applied to the cells. Twenty-four hours later, cells were returned to normal growth 
medium for a further 24h, the transfected Caco-2 cells were detached from the 6-well 
plates by trypsin treatment, collected and transferred into 10mm Petri dishes for 
growth under the selection of Neomycin (750ug/ml). 
 
The presence of Neomycin resistance gene encoded in the NF B-luciferase 
pBLUE-TOPO construct and TATA-luciferase pBLUE-TOPO construct, as shown in 
Figure 10, allows cell survival when cells are grown in neomycin. Recombinant 
Caco-2 cells expressing the construct genes were able to survive, whereas 
non-recombinant Caco-2 cells would be killed by the neomycin. In order to select the 
Caco-2 cells, neomycin (G418), at a concentration of 750 g/ml, was added to the 
growth medium for 4 weeks until all untransfected cells had died. The Caco-2 cells 
transfected with either the NF B-luciferase construct or the TATA-luciferase 
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construct were harvested as a mixed population, and these are described either as the 
NF B-luciferase reporter model or the TATA-luciferase reporter model (control). 
 
The NF B- and TATA- luciferase constructs contained in pcDNA3.1 v5-his-TOPO 
were transfected in Caco-2 cells and the luciferase activities in these cells were 
assessed in the absence (to show baseline luciferase expression) and presence (to 
show the responsiveness to NF B activation) of NF B inducer TNF  (20ng/ml). 
Results are shown in Figure 14 (A) and (B). Details of the luciferase assay procedures 
are described in Chapter 2 Section 2.1.19-2.1.21. The luciferase activity was 
expressed as luciferase activity per mg total cell lysate (luc/mg). 
 
As shown in Figure 14 (A), the mean baseline luciferase activity of the Caco-2 cells 
transfected with NF B-luciferase v5-his-TOPO was 67.4 ± 6.2 luc/mg, whereas the 
mean baseline luciferase activity of the control TATA-luciferase v5-his-TOPO 
transfects was 242.1 ± 20.7 luc/mg. Compared with the models transfected with 
pBLUE-TOPO constructs (described later), the baseline luciferase activities of both 
NF B and TATA models transfected with v5-his-TOPO constructs were considerably 
higher. In addition, the TATA-luciferase v5-his-TOPO Caco-2 cells showed a higher 
(~4 fold) level of baseline luciferase expression than the NF B Caco-2 cells.  
 
As shown in Figure 14 (B), the responsiveness of the v5-his-TOPO reporter cells to 
NF B signalling was tested after TNF  (20ng/ml) stimulation. Owing to the large 
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difference in baseline luciferase activities, data for both NF B model and TATA 
model are presented as fold-change relative to their baseline levels, respectively. In 
the NF B-luc-v5-his-TOPO reporter cells, treatment of 20ng/ml TNF  for 4 hours 
resulted in approximately 8 fold increase of luciferase activity compared with the 
unstimulated level. However, in the TATA-luc-v5-his-TOPO reporter cells, the same 
treatment was also observed to result in approximately 4 fold increase of luciferase 
activity compared with its baseline level. Therefore, the responsiveness to NF B 
signalling inducer TNF  was found in both NF B- and TATA-luciferase reporter 
cells of the v5-his-TOPO transfect line, and the NF B Caco-2 cells exhibited a larger 
responsive effect (8 fold) than the TATA Caco-2 cells (4 fold). The unexpected 
response by the TATA-luc-v5-his-TOPO cell line is analyzed in discussion. 
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Figure 14: NF B- and TATA- luciferase Caco-2 model based on pcDNA3.1 
v5-his-TOPO constructs: Baseline luciferase activities and responsiveness to 
TNF  
Luciferase activity was measured in Caco-2 cells stably transfected with NF B- or 
TATA- luciferase constructs in pcDNA3.1 v5-his-TOPO before or after stimulation 
with TNF . The mean baseline luciferase activity of the TATA-luc reporter model 
was 242.1 ± 20.7 luc per mg total cell lysate whereas baseline luciferase activity of 
the NF B-luc reporter model was 67.4 ± 6.2 luc/mg (shown in (A)). In the presence of 
NF B inducer TNF  (20ng/ml), 4 hours treatment resulted in ~8 fold increase of 
luciferase activity in the NF B-luc Caco-2 cells compared to the baseline level, and a 
~4 fold increase of luciferase activity in the TATA-luc Caco-2 cells (shown in (B)).   
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The other pair of constructs, the NF B- and TATA-luciferase constructs in 
pBLUE-TOPO, were also transfected in Caco-2 cells that harvested in a mix 
population. To show the baseline luciferase expression and the responsiveness to 
NF B activation in these cells, the luciferase activities were measured in the absence 
and presence of known NF B inducers TNF  and flagellin. Following stimulation of 
cells by 20ng/ml TNF  (Sigma) (Kelly et al., 2004), the luciferase activities were 
measured 0, 1, 2, 4, 6 and 8 hours. Stimulation by Salmonella typhimurium flagellin 
(Invivogen) was at a concentration of 100ng/ml (Kelly et al., 2004) and luciferase 
activities were measured 0, 1, 2, 4, 6, 8 and 12 hours after addition of flagellin.  
 
As shown in Figure 15 (A), the mean baseline luciferase activity of the 
NF B-luciferase pBLUE-TOPO Caco-2 cells was 22.7 ± 2.3 luc/mg, whereas the 
mean baseline luciferase activity of the TATA-luciferase pBLUE-TOPO Caco-2 
model was 10.7 ± 0.5 luc/mg. The NF B-luciferase Caco-2 model showed a higher 
(~2 fold) level of baseline luciferase expression compared to the control TATA 
Caco-2 cells (Figure 15 (B)). However, the baseline luciferase activities of both 
models were low. 
 
The responsiveness of the reporter cells to NF B activation by TNF  and flagellin are 
shown in Figure 15 (C) and (D). NF B-luciferase pBLUE-TOPO Caco-2 cells treated 
with 20ng/ml TNF  exhibited increased luciferase activity starting 1 hour after TNF  
addition and peaking at 4h about approximately 12 fold above baseline levels (Figure 
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15 (C)). In contrast, the control TATA-luciferase pBLUE-TOPO Caco-2 cells 
exhibited no increase in luciferase activity after addition of TNF  and remained 
baseline levels. Similarly, as shown in Figure 15 (D), treatment of the 
NF B-luciferase pBLUE-TOPO Caco-2 cells with 100ng/ml flagellin resulted in 
increased luciferase activity but no change in activity was observed in the 
TATA-luciferase pBLUE-TOPO control cells. The luciferase activities of the NF B 
cells started to increase at 2h after the addition of flagellin, peaked between 4-8 hours 
~6.4 fold of the baseline level and then started to decrease.  
 
In summary, these results confirmed the ability of the NF B-luciferase 
pBLUE-TOPO Caco-2 cells to report the status of NF B activation in response to 
potential inducers. In addition, the responsiveness was specific to the NF B signalling. 
The establishment of the luciferase reporter model by the present study therefore 
provided a convenient tool to assess the activation of NF B signalling in Caco-2 cells 
and allowed investigation of the regulatory effects of Selenium and selenoproteins on 
the NF B signalling pathway. 
11
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Luciferase activity was measured in Caco-2 cells transfected with either 
NF B-luciferase or TATA-luciferase construct in pBLUE-TOPO. (A): the baseline 
luciferase activity of NF B Caco-2 cells was 22.73luc/mg on average and the baseline 
luciferase activity of TATA Caco-2 cells was 10.74luc/mg on average. (B): the 
luciferase expression was also found to be ~2 fold higher in NF B Caco-2 cells 
compared with TATA Caco-2 cells.  
After stimulation with TNF  (20ng/ml) or Salmonella typhimurium flagellin 
(100ng/ml), there was a dramatic increase of luciferase activity in the NF B Caco-2 
cells but not in the control TATA Caco-2 cells (C and D). The increase started 1h and 
peaked by up to ~12 fold 4h after TNF  addition (C). Similarly, the increase started 
2h after flagellin addition and reached a plateau of a 6.4 fold increase stage after 
between 4 and 8 hours (D). These results indicate that the NF B-luciferase Caco-2 
model is able to sensitively and specifically report the activation of NF B signalling. 
Groups were compared using a 2-tailed Student t-test (***: p<0.001). 
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3.6  Discussion 
The transcription factor NF B modulates the expression of a large number of proteins 
many of which are inflammatory cytokines or peptides involved in the inflammatory 
process (Vallabhapurapu and Karin, 2009). Studies in these pathways have provided 
insights into how inflammatory events develop and are controlled in human tissues 
(Neurath et al., 1998, Karin and Greten, 2005). The aim of the research described in 
this thesis is to investigate the regulatory effects of micronutrient Selenium and 
Se-dependent antioxidants on the NF B inflammtory signalling pathway in human 
colonic epithelial Caco-2 cells. The present Chapter describes the work that 
established a reliable and convenient method to assess the activation status of NF B 
signalling.  
 
Compared to the other methods to study the NF B signalling pathway (as listed in 
Section 3.1), the NF B-luciferase reporter system takes advantage of a luciferase gene 
driven by a promoter sequence containing NF B binding sites and therefore reports 
NF B signalling into luciferase expression when NF B sites are activated. In this 
study, Caco-2 epithelial cells were stably transfected with constructs modified from a 
previously proven NF B reporter construct (Carlsen et al., 2002, Vykhovanets et al., 
2008), in which a promoter containing 3X  B binding sites was fused to the luciferase 
coding sequence (Kirillov et al., 1996, Maier et al., 2003). However, for use in Caco-2 
cells and in vitro experiments by this study, re-cloning of the NF B-luciferase 
sequence into a new vector was required. The main reason of this was to generate a 
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control construct to specify the background and changes of luciferase expression 
which are not attributable to NF B signalling. 
 
Selective cloning of the NF B-luciferase or the TATA-luciferase (control) construct 
employed pcDNA3.1 v5-his-TOPO or pBLUE-TOPO as vector and Caco-2 cells 
stably transfected with each construct were harvested as a mixed population. In the 
pBLUE-TOPO transfection cell lines, the NF B-luciferase-pBLUE-TOPO and the 
TATA-luciferase-pBLUE-TOPO Caco-2 cells exhibited luciferase expression in the 
absence and presence of NF B inducers. As shown in Figure 15 (A), in unstimulated 
cells the NF B-luc pBLUE-TOPO Caco-2 model displayed mean luciferase activity 
of 22.7luc/mg whereas the TATA-luc pBLUE-TOPO Caco-2 model displayed mean 
luciferase activity of 10.7luc/mg. Possible reasons for the difference in baseline 
luciferase expressions between the two models include:  
 
1. the background NF B tone in Caco-2 cells drives luciferase expression in the 
NF B-luciferase reporter but not in the TATA-luciferase reporter which lacks any 
NF B binding sites. Since that NF B is an essential modulator for cell inflammatory 
response (Wong and Tergaonkar, 2009), complete silence of NF B signalling might 
be hazardous and a background tone of NF B signalling is almost inevitable, which 
has been previously observed in other cell types (Coiras et al., 2007, Carlotti et al., 
2000). Also, NF B signalling is responsive to various endogenous physiological 
mediators (Jang et al., 2004, Ramakers et al., 2007) or apoptotic mediators (Schneider 
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et al., 1997) which naturally maintain cell function and background NF B signalling 
might be activated by these endogenous inducers. In addition, for long time NF B 
signalling has been known to be activated by oxidative stress (Schreck et al., 1991, 
Gloire et al., 2006), which occurs at a certain level during the cell respiration.  
 
2. the difference in copy numbers of NF B and TATA constructs transfected in 
Caco-2 cells; 
 
3. the difference in the recombinant sites where the NF B and TATA constructs were 
integrated into the Caco-2 genome. 
 
If the possibilities 2 and 3 occur during transfection they might result in variability of 
the baseline luciferase expression in different cells. In the present study, the 
transfected Caco-2 cells were harvested as a mix population. Alternatively, the 
transfected cells could be harvested from individual clones and as a result, those cells 
expressing luciferase on a comparable level could be screened out and cultivated 
further. Using this strategy, the uneven expression of baseline luciferase activity could 
be avoided. However, in this study the baseline luciferase expressions in both NF B 
and TATA Caco-2 models are low and the difference between the two should not be 
problematic.   
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The ability of the NF B-luciferase pBLUE-TOPO Caco-2 model to respond to NF B 
activators was also tested using known NF B inducers TNF  and flagellin. TNF  is 
an inflammatory cytokine responsible for activation of NF B through the endogenous 
signalling pathway (Li and Lin, 2008), whereas flagellin is a bacterial component 
activating NF B through an exogenous signalling pathway (Tallant et al., 2004). 
Luciferase activities of the NF B Caco-2 cells were increased by ~12 fold compared 
with the baseline level when cells were stimulated with 20ng/ml TNF  for 4 hours, 
and increased by ~6.4 fold compared with the baseline level when cells were 
stimulated with 100ng/ml flagellin for 4-8 hours (Figure 15 (C) and (D)). Despite of 
the variations in the peaking time for NF B activation (4h for TNF  and 4-8h for 
flagellin) and in the extent of increase of luciferase activities (12 fold by TNF  and 
6.4 fold by flagellin), which are mostly likely resulted from the different 
NF B-inducing signalling pathways, the responsiveness of the NF B reporter model 
was found sensitive to inducers. In contrast, increased luciferase activity was not 
observed in the control TATA-luciferase Caco-2 model which contained no NF B 
binding sites, suggesting that the reporter system was specific. Therefore, the NF B 
reporter Caco-2 model established in the present study work well in response to 
stimulation and the regulatory effects of Se supply and antioxidant selenoproteins on 
the NF B signalling pathway were investigated and results described and discussed in 
the following Chapters. 
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In addition to the NF B reporter model constructed using the pBLUE-TOPO vector, a 
similar reporter system was established using constructs contained in the pcDNA3.1 
v5-his-TOPO vector. However, both the NF B- and TATA- luciferase reporter cells 
transfected with the v5-his-TOPO constructs exhibited considerably higher level of 
baseline luciferase activity (242.1 luc/mg for TATA cells and 67.4 luc/mg for NF B 
cells), and an unexpected responsiveness to NF B inducer TNF  was observed (4 fold 
increase of luciferase activity compared to the baseline level) in the control 
TATA-luciferase reporter cells, which was not engineered with the 3X  B binding 
sites.  
 
A possible explanation of these effects is the CMV promoter contained in the 
pcDNA3.1 v5-his-TOPO plasmid vector but not the pBLUE-TOPO vector. CMV 
promoter is a strong promoter originated from the human cytomegalovirus and is used 
to promote strong expression of the gene cloned in the construct (Schlabach et al., 
2010), i.e. the NF B- or TATA- luciferase gene in the present study. CMV promoter 
has been reported to contain NF B binding sites and therefore responsive to NF B 
signalling (Sambucetti et al., 1989). As a result, the transfected Caco-2 cells with the 
v5-his-TOPO constructs are able to express luciferase at a high level when driven by 
CMV promoter. In addition, following the NF B induction by TNF , the 
TATA-luciferase-v5-his-TOPO Caco-2 transfects were also stimulated to express 
luciferase under the control of CMV promoter (4 fold increase), whereas the 
NF B-luciferase-v5-his-TOPO transfects expressed luciferase under the control of 
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both CMV promoter and 3X  B binding region (8 fold increase). Owing to the 
disturbance by CMV promoter, the NF B reporter system based on pcDNA3.1 
v5-his-TOPO constructs was abandoned and not used in the experiments described in 
the following chapters.  
 
Lastly, it is worth emphasizing that in the studies described in this thesis, TNF  at a 
concentration of 20ng/ml and flagellin at a concentration of 100ng/ml, which were 
used to induce NF B signalling, are on an experimental level aiming to achieve 
maximal inflammatory response. A concentration of 20ng/ml TNF  is much higher 
than that found under physiologial and pathogenic conditions (Turner et al., 2010). 
Plasma TNF  concentration has been documented to be 75 +/- 15 pg/ml in the normal 
population (physiological condition) and 100-5000 pg/ml in sepsis patients 
(pathogenic condition) (Damas et al., 1989). Flagellin at a concentration ranging 
10-100ng/ml has been suggested sufficient to stimulate TLR5 (Hayashi et al., 2001) 
and its pathogenic level has not been documented. Using 20ng/ml TNF  or 100ng/ml 
flagellin, two models of NF B signalling pathways in response to immune cytokine or 
bacterial components were established in Caco-2 cells and further investigations of 
the regulatory mechanisms of these pathways are presented in the following chapters.        
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4.  Study of the relationship between selenium and NF B 
inflammatory signalling pathways 
4.1  Introduction 
Until recently, knowledge of Se was limited mainly to antioxidant protection in the 
cellular environment through its relatively well-characterized GPx and TrxR 
selenoprotein families (Brigelius-Flohe, 1999). Yet increasing evidence has linked Se 
to additional protective functions, such as the reduced incidence of inflammation and 
carcinogenesis (Brigelius-Flohe, 2008). This evidence includes:  
 
1) epidemiological studies that have linked low Se intake with a susceptibility to 
inflammatory bowel disease (IBD) and its associated complications (Karp and Koch, 
2006);  
 
2) clinical trials that have shown Se supplementation to be linked to a reduction in  
IBD symptoms and the decreased usage of therapeutic drugs (Karp and Koch, 2006);  
 
3) biochemical studies that have suggested that Se and/or selenoprotein GPxs are 
involved in arachidonic acid metabolism (the LOX and COX pathways) and the 
control of leukotriene (LT) and prostaglandin (PG) synthesis (Sordillo et al., 2008, 
Seiler et al., 2008, Chen et al., 2003);  
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4) data indicating that Se and/or selenoprotein GPxs participate in the NF B 
signalling pathway regulating its activation and the expression of NF B target genes 
(Brigelius-Flohe, Banning et al. 2004; Kim, Johnson et al. 2004; Vunta, Davis et al. 
2007). 
 
The potential for Se to regulate the NF B signalling pathway could be linked to Se 
modulating ROS production in the cell. ROS are known to activate NF B directly, or 
to indirectly serve as a secondary messenger in NF B activation through cytokines 
such as IL1
✁
, and bacterial components such as lipopolysaccharide (LPS) 
(Brigelius-Flohe, Banning et al. 2004; Vunta, Davis et al. 2007). Thus ROS may 
function as links that extend the function of Se from one of antioxidant protection to 
NF B regulation.  
 
For example, Se has been identified as an inhibitory factor in NF B activation by LPS 
(Kim et al., 2004) or IL1
✁
 (Brigelius-Flohe et al., 2004). This inhibitory effect was 
proposed to function through modification of ROS production, stimulated by 
cytokines, by the activity of GPx antioxidant selenoproteins (Brigelius-Flohe et al., 
2004, Li et al., 2001). In macrophages the inhibition of LPS-induced NF B activation 
via Se was suggested to be through regulation of the COX-1 arachidonic acid 
metabolism pathway and the resultant production of prostaglandin 5d-PGJ2 which, in 
turn, inhibited the activation of NF B signalling (Vunta et al., 2007).  
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Intriguingly, evidence for protective effects of Se against the development of 
inflammation has been found in specific tissues, including gastrointestinal (GI) tract, 
lung and prostate (Duffield-Lillico, Reid et al. 2002; Whanger 2004; Karp and Koch 
2006), all of which have constant exposure to oxidative stress and microbial challenge. 
However, the present knowledge of the anti-inflammatory effects of Se in these 
tissues remains limited. Essentially little is known about how Se and the 
selenoproteins impact on NF B signalling pathway in human GI cells. For this reason, 
in the present study the human colonic epithelial cell line, Caco-2, was used to 
investigate whether the activation of NF B by the inflammatory cytokine TNF  or the 
bacterial component flagellin was modulated by Se. 
 
Being an endogenous cytokine participating in the innate immunity, TNF  is known 
to induce NF B signalling through its receptor TNF receptor 1 (TNFR1) and 
associated ligands TRAF2 and RIP (Li and Lin, 2008). ROS production linked to 
TNF  is thought to be mitochondrial (Hsu et al., 1996, Morgan et al., 2008) or from 
activity of NAPDH oxidases (Li et al., 2009, Yazdanpanah et al., 2009) and 
associated with the activation of NF B signalling. In comparison, flagellin, a 
component of bacteria, including pathogens, is known to induce NF B activation 
through Toll-like receptor 5 (TLR5) signalling and associated ligands IRAK and 
TRAF6 (Tallant et al., 2004). ROS production by flagellin is probably through the 
apoptotic effects of MAPK pathway (p38 and JNK), since both NF B and MAPK 
signalling has been suggested to be activated following flagellin stimulation (Harrison 
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et al., 2008, Zeng et al., 2006). In addition, a further TLR member TLR4 when bound 
by bacterial Lipopolysaccharide (LPS) has been suggested to be linked to NAPDH 
oxidase activity (Nox4) and ROS production resulting in NF B activation (Park et al., 
2006). Similar events could be presumed to occur in the flagellin-TLR5 pathway. 
Taken together, these two NF B signalling pathways represent alternative NF B 
activation models and were investigated in the present study.  
 
To monitor NF B activation, a previously established 3X NF B-luciferase reporter 
construct (Carlsen et al., 2002, Vykhovanets et al., 2008) was modified for 
experiments in Caco-2 cells and the establishment of NF B-luciferase reporter Caco-2 
model was as described in Chapter 3. In addition, interleukin 8 (IL8), as a known 
NF B target gene was assessed by semi-quantitative PCR to quantify its expression at 
the mRNA level, following stimulation of the Caco-2 cell models with either TNF  or 
flagellin. 
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4.2  Results 
4.2.1  Se depletion and decrease of GPx1 expression  
To study the effect of Se supply on NF B activation, Se depletion experiments were 
performed using a previously established protocol (Pagmantidis et al., 2005) in which 
Caco-2 cells were grown for 3 days in Se-depleted or Se-supplemented culture 
medium (see Chapter 2 Section 2.1.12). Se depletion is known to lead to a lowering of 
mRNA expression, synthesis and activity of a number of selenoproteins (Bermano et 
al., 1995, Pagmantidis et al., 2005, Sunde et al., 2009) and GPx1 and SelW expression 
are particularly sensitive to Se supply (Pagmantidis et al., 2005, Kipp et al., 2009). In 
order to verify that Se depletion had occurred in the experiments, Caco-2 cells were 
grown for 3 days in Se-depleted or Se-supplemented culture medium, RNA extracted 
and then semi-quantitative PCR was used to assess the expression of GPx1. 
 
As shown in Figure 16, the expression of GPx1 was significantly lower in Se-depleted 
cells compared to those grown in Se-supplemented medium (p<0.001).  
Quantification of the data (Figure 16) showed that the mean relative expression of 
GPx1 was lowered by 60% compared to the Se-supplemented controls. The reduction 
of GPx1 expression, which is in agreement with the previous findings (Pagmantidis et 
al., 2005), indicated that the cells were indeed in a Se-depleted state using this 
established method. 
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Figure 16: Se depletion and GPx1 mRNA expression in Caco-2 cells 
Caco-2 cells were grown for 3 days in Se-depleted or Se-supplemented culture 
medium, RNA extracted and GPx1 expression assessed by semi-quantitative RT-PCR 
(A). GPx1 expression was quantified by densitometry and normalized to the 
housekeeping gene GAPDH (B). GPx1 expression was lowered by ~60% in cells 
grown in Se-depleted medium compared with supplemented cells (B). Groups were 
compared using a 2-tailed Mann-Whitney U-test (***p<0.001) 
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4.2.2  The impact of Se depletion on TNF -induced NF B-activation in 
the Caco-2 luciferase reporter model 
The impact of Se depletion to NF B signalling pathway was studied using the Caco-2 
cell models transfected with the luciferase reporter constructs as described previously 
(Chapter 3). Firstly the effects of Se supply on NF B signalling were assessed by 
growing the transfected cells +/- Se and quantififying luciferase activity. Luciferase 
activity was calculated per mg total lysate protein and expressed as relative luciferase 
activity (RLA, luciferase activity relative to the standard protein concentration).  
 
As shown in Figure 15A, depleting the amount of Se in the cell growth medium did 
not affect the baseline luciferase activities in either the cells transfected with NF B- 
or TATA-luciferase reporter. Therefore, deprivation of Se in the culture medium did 
not result in major changes to the background luciferase reporter activity.  
 
The effect TNF  challenge on the NF B pathway was studied in the Se-depleted and 
Se-supplemented Caco-2 cells by treating the cells with 20ng/ml TNF  for 2 or 4 
hours respectively. To compare the Se+ and Se- treatments, the data was expressed as 
ratios relative to the level of luciferase activity in Se+ treatment group, which was 
standardized as 100% (see Figure 17B). 
 
When the cells were challenged with TNF , an increase in NF B-driven luciferase 
activity was observed and this was greater in the Se-depleted cells, with an 
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approximate 30% increase in TNF -NF B activation resulting from Se depletion. 
Such an increase was not observed in Caco-2 cells transfected with the 
TATA-luciferase construct, suggesting that the effect was NF B specific. In addition, 
the increase was observed at both 2 hours and 4 hours after addition of TNF . The 
data suggest that depletion of Se in the culture medium amplified NF B activation in 
response to TNF stimulation. 
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Caco-2 cells transfected with either NF B- or TATA- luciferase constructs were 
grown for 3 days in Se-depleted (Se-) or Se-supplemented (Se+) culture medium, 
followed by treatment with 20ng/ml TNF . 
Protein lysate was harvested using 1X Reporter lysis buffer, and luciferase activity 
was determined and expressed per mg total lysate protein and as relative luciferase 
activity (RLA). Results relating to unstimulated Caco-2 cells, without TNF  addition, 
are shown in (A). Results relating to TNF  stimulated Caco-2 cells are shown in (B). 
Groups were compared using a 2-tailed Mann-Whitney U-test (** p<0.01; * p<0.05). 
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4.2.3  The impact of Se depletion on IL-8 mRNA expression  
To further extend the findings obtained using the NF B-luciferase reporter model and 
investigate the impact of Se depletion on NF B-signalling pathways, the expression 
of a known NF B target gene, encoding the cytokine IL8, was assessed by 
semi-quantitative RT-PCR. To show the response of IL8 to TNF -NF B activation, 
Caco-2 cells +Se were treated with 20ng/ml TNF  for 1, 2, 4 and 6 hours respectively, 
and IL8 mRNA expression determined. As shown in Figure 18, IL8 levels in 
unstimulated Caco-2 cells were barely detectable but following stimulation of the 
cells with TNF , IL8 expression was elevated with the highest level observed after 1 
hour. 
 
To explore the effects of Se supply on IL8 expression, Caco-2 cells were grown for 3 
days in Se-depleted or Se-supplemented culture medium followed by addition of 
20ng/ml TNF  for 1 hour. RNA was extracted and semi-quantitative PCR was used to 
assess the expression of IL8, GPx1 (to validate Se depletion) and GAPDH. The 
expression levels of IL8 and GPx1 were normalized to the house keeping gene 
GAPDH. After TNF  treatment, Figure 19 (A), the PCR bands for IL8 expression in 
the Se-depleted Caco-2 cells were considerably more intense compared with those in 
Se-supplemented cells. These data expressed as a ratio relative to the level of the Se+ 
control (shown in Figure 19 (B)), indicated Il-8 expression to be significantly 
increased (p<0.001), about 50% compared to control. GPx1 expression was found to 
be significantly decreased (p<0.001), approximately 60% compared to control, which 
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was in agreement with previous findings. Therefore Se depletion was associated with 
an increased IL8 response in the TNF -NF B activation pathway 
 
 
 
Figure 18: Induction of IL8 mRNA expression in Caco-2 cells following 1, 2, 4 
and 6 hours of TNF  treatment 
Caco-2 cells were cultured with or without 20ng/ml TNF  for 1, 2, 4 and 6 hours, 
RNA extracted and IL8 expression assessed by semi-quantitative RT-PCR. At all time 
points, IL8 expression in the absence of TNF  was barely detectable but when cells 
were stimulated with TNF , IL8 expression was detected.  
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Figure 19: Effect of Se depletion on TNF -induction of IL-8 expression in Caco-2 
cells 
Caco-2 cells were grown for 3 days in Se-depleted (Se-) or Se-supplemented (Se+) 
culture medium and incubated with 20ng/ml TNF  for one hour.  IL8 expression was 
determined by semi-quantitative RT-PCR and normalized to the house keeping gene 
GAPDH. PCR bands of IL8, GPx1 and GAPDH are shown in (A). Bands were 
quantified by densitometry and data plotted as ratios relative to the level of Se+ 
control (B). (***p<0.001) indicates significance using 2-tailed Mann-Whitney U-test 
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4.2.4  The impact of Se depletion on flagellin-induced NF B-activation in 
a luciferase reporter model 
The impact of Se depletion on the NF B signalling pathway, which has been shown 
previously to up-regulate NF B activation and target gene IL8 expression in response 
to activator TNF , was further investigated but using an alternative NF B activator, 
bacterial flagellin. Unlike TNF , which is synthesized by host cells, flagellin is an 
exogenous ligand, and synthesised by bacteria. This experiment was to test if, in 
response to flagellin, Se supply affects NF B signalling through a different or similar 
mechanism to that of TNF . In this study, the luciferase reporter model was used to 
monitor NF B activation following Se depletion. 
 
As shown in Figure 15 (Chapter 3), NF B activation as indicated by luciferase 
activity in the transfected Caco-2 cells showed that NF B activation by flagellin 
occurred 2-8 hours after addition of the ligand, with activation peaking at 4-8 hours. 
Therefore, to investigate possible effects of Se on flagellin-induced NF B activation, 
the measurement of luciferase activity was performed at 2 and 6 hours after treatment. 
Cells were grown for 3 days in Se- or Se+ culture medium and afterwards treated with 
100ng/ml flagellin for either 2 or 6 hours. The cell lysates were extracted and data 
expressed as RLA per mg total cell lysate and further expressed as a ratio relative to 
the level of Se+ control. 
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As shown in Figure 20, the induction of luciferase activity by 100ng/ml flagellin was 
specific to NF B, as the cells transfected with the TATA- luciferase construct showed 
only low-level activity. However, following the flagellin challenge there was no 
significant difference in luciferase activity between cells cultured in Se-depleted or 
Se-supplemented medium, indicating that Se supply did not affect NF B activation by 
flagellin. In addition, the data were similar in both 2 and 6 hour treatment groups, 
suggesting that Se depletion had no effect at any stage of NF B activation in response 
to flagellin. These data therefore suggested that while Se supply effected the  
TNF-NF B induction it did not influence flagellin-NF B induction, suggesting the 
involvement of different pathways with different Se sensitivity.  
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4.3  Discussion 
Aiming to contribute to knowledge of the mechanisms by which selenium influence 
health, studies in this chapter investigated the regulatory effects of Se supply on the 
NF B inflammatory signalling pathways in colonic epithelial Caco-2 cells. For these 
studies cells were cultured plus and minus Se to study differential Se supply, and the 
endogenous cytokine TNF  and the exogenous bacterial flagellin were used as 
inducers of NF B activation. To assess the activation status of NF B signalling, a 
previously established 3X luciferase reporter construct (Carlsen et al., 2002), which 
was modified to be used in in vitro rather than in vivo experiments (described in 
Chapter 3, also see Figure 15) was employed.  The response in endogenous 
expression of a known NF B target gene, IL8, and a mediator of the inflammatory 
response was also investigated. 
 
Se depletion was found to increase NF B activation by TNF . In studies using the 
NF B luciferase reporter, a 1.3 fold increase in luciferase activity was found in cells 
grown in Se-depleted culture medium, compared with the luciferase activity detected 
in cells grown in Se-supplemented culture medium (see Figure 17 (B)). This increase 
was restricted to NF B activation by TNF  as the baseline luciferase activity was 
maintained in Se- or Se+ groups (Figure 17 (A)). Consistently, in studies using 
semi-quantitative PCR to assess IL8 expression, Caco-2 cells cultured in Se-depleted 
medium exhibited a 1.5 fold increase in IL8 induction in response to TNF , when 
compared to the IL8 level in the control Se-supplemented cells (see Figure 19). These 
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results suggested that Se supply regulates the TNF -NF B signalling pathway, and 
insufficient Se results in increased NF B activation. Further, the increased NF B 
status in Se depletion was found at both 2 and 4 hours after TNF  stimulation (Figure 
17 (B)), suggesting that Se depletion affected NF B activation by resulting in both 
faster and greater response to TNF .  
 
In comparison, in the studies of NF B activation by flagellin using the NF B 
luciferase reporter, no difference in induced luciferase activity was found in cells 
cultured in Se-depleted or Se-supplemented medium (see Figure 20), suggesting that 
Se supply was unable to affect the NF B signalling pathway activated by flagellin. 
The investigation of flagellin-NF B activation was also performed at the earlier and 
peaking stages (2 and 6 hours, respectively, see Figure 15) and neither time points 
were found with significantly change. Therefore, Se supply was found to differentially 
affect NF B activation induced by different stimuli. 
 
These results provide evidence of a regulatory effect of Se on NFkB activation in 
human gastrointestinal epithelial cells. In the human gut, constant exposure to bacteria 
and oxidative stress occurs (Hisamatsu et al., 2008, Duerkop et al., 2009), and Se has 
been suggested to help protect against the development of inflammation (Karp and 
Koch, 2006, Whanger, 2004). However, there is only limited knowledge of the 
underlying mechanism. The results in this chapter suggest that Se supply regulates 
NFkB signalling and target gene induction in gut epithelial cells in response to TNF , 
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i.e. Se helps dampen the inflammatory response. Therefore, in addition to the 
established findings that Se affects the generation of inflammatory metabolites 
including the leukotrienes and prostanoids from arachidonic acid (Dey et al., 2009, 
Huang et al., 1999), these findings associating Se with regulation of NFkB signalling 
provide further insights into how Se is involved in mediating the cellular signalling 
responsiveness to endogenous or exogenous inflammatory stimuli. 
 
The NFkB signalling pathway controls over 200 downstream target genes, many of 
which may directly participate in the development of inflammation, such as 
inflammatory cytokines, immuno-receptors and antigen presentation proteins (Pahl, 
1999) (also see the NFkB target genes being collected on website: nfkb.org, updated 
up to 2008). As a result, the increased NFkB signalling response found in Se depletion 
may be expected to result in multiple inflammatory consequences through excessive 
expression of target genes. For instance, IL8 as a model NFkB target in this study is a 
chemoattractant to recruit neutrophils and to activate downstream immune cascades 
(Kucharzik and Williams, 2002, Roebuck, 1999a). IL8 has been suggested to be 
expressed in colonic epithelial cells and is associated with the development of 
inflammatory bowel disease (IBD) (Kucharzik and Williams, 2002, Ohkusa et al., 
2009, Subramanian et al., 2008). Therefore, when Se is insufficient, the activities of 
TNF , synthesized by epithelial cells and macrophages, could generate excessive IL8 
production through the NFkB signalling pathway, which may further recruit 
lymphocytes and macrophages to the colonic epithelium and lead to excessive 
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inflammation. In this study, only the expression of IL8 was examined, but it would be 
interesting to examine the expression of other NFkB activated genes, for example, 
interleukin 6 (inflammatory cytokine), interleukin 12 (inflammatory cytokine), 
vascular cell adhesion molecule-1 (VCAM-1) and COX-2 (prostaglandin synthase), to 
assess the wider effects of Se depletion on inflammatory pathways.  
 
The increase in NFkB activation, as detected using the reporter construct, and the 
increase in IL8 expression, as detected by semi-quantitative RT-PCR were consistent, 
but the extent of the changes was different. This variability may have arisen from the 
different techniques used in the analyses but it could also have been due to cis- or 
trans- elements in the promoter of the IL8 gene modifying the response to NFkB 
(Hoffmann et al., 2002b, Roebuck, 1999b). Therefore, although a 30% increase in 
NFkB activation in response to Se depletion appeared moderate, the resulting positive 
and/or negative effects on NFkB target genes cannot be predicted. 
 
Compared with the TNF -NF B pathway, Se was shown to have no effect on the 
flagellin-associated NF B activation pathway. Given the fact that these two NF B 
activation signalling pathways utilized different receptors and signalling pathways 
(TNF • •TNFR1• •NF B and flagellin• •TLR5• •NF B)• • (Li and Lin, 2008, Simon 
and Samuel, 2007), it was perhaps not unexpected to find that Se depletion affected 
them differently. In addition, different catalytic processes are also involved in their 
respective activation mechanisms (details in Chapter 1, Section 1.2b and 1.2c, also see 
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previously in section 4.1). Therefore, based on the difference in these aspects, it is 
reasonable to conclude that Se depletion regulates the inflammatory signalling in 
some types of NF B activation pathways but not in all. Further investigations to test 
the ability of Se to modulate the NF B pathway activated by other inducers, e.g. H2O2 
(as oxidative stress), IL1
✁
 (as another inflammatory cytokine) and LPS (as another 
bacterial component), would be potentially informative and helpful. 
 
In summary, studies in this chapter investigated the regulatory effects of Se on NF B 
signalling pathways and showed that Se depletion leads to greater NF B activation by 
TNF! but not flagellin. However, these studies provide clues as to how Se exerts this 
effects; for example, if its effects are due to reduced activities of one or more of the 
selenoproteins. Therefore the next step in these studies was to investigate through 
which selenoprotein(s) Se regulates NF B activation. It has been suggested that some 
of the major effects of Se are through its antioxidant proteins that protect the cells 
against oxidative stress and Redox signalling. Thus the effects of knockdown of GPx1 
and GPx4 were studied in association with the NF B signalling pathway and these 
studies will be described in the following chapters.
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5.   Effects of GPx1, SelW, SelH on NF B inflammatory signalling 
5.1  Introduction 
In the previous Chapter the effects of Se depletion on the NF B signalling pathway 
were studied in Caco-2 cells and found to result in increased NF B activation in 
response to TNF  (Figures 17 and 19). Following on from this observation, the 
particular mechanisms underlying this connection were explored by investigating the 
role of individual selenoproteins in the modulation of NF B inflammatory signalling 
by Selenium.  
 
Of the selenoproteins identified so far, GPx1 has a relatively well-characterised 
antioxidant function (Brigelius-Flohe, 2006), and a high sensitivity to Se supply 
(Pagmantidis et al., 2005, Sunde et al., 2009). GPx1 is expressed in all tissues 
including the gastrointestinal epithelium (Moghadaszadeh and Beggs, 2006, 
Brigelius-Flohe, 1999), is present in the cytoplasm, and catalyzes the removal of the 
soluble hydroperoxides, such as H2O2 (Forstrom et al., 1979), but when coupled with 
phospholipase, also removes some membrane-associated oxidative fatty acids 
(Grossmann and Wendel, 1983). Because of these features of GPx1, and also because 
of the fact that the production of oxidative species has been frequently found 
associated with the activation of NF B signalling in response to various types of 
inducers, including IL1
✁
 (Li and Engelhardt, 2006), TNF  (Jamaluddin et al., 2007) 
and Lipopolysaccharide (LPS) (Bhattacharyya et al., 2008), GPx1 has been suggested 
to be one of the selenoproteins potentially capable of regulating NF B signalling 
pathway through its antioxidant ability (Li et al., 2001, Kretz-Remy et al., 1996, 
Crack et al., 2006).  
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In the breast cancer cell line MCF7, NF B activation by endogenous cytokine IL-1
✁
 
was found to be partially inhibited by overexpressed GPx1, as assessed by EMSA (to 
show NF B DNA-binding) and measurement of luciferase activity of an NF B 
reporter gene (Li and Engelhardt, 2006). In addition, this inhibitory effect was shown 
in parallel with decreased H2O2 production after IL-1
✁
 stimulation, so linking the 
regulatory effects of GPx1 on the IL-1
✁
-NF B response to its antioxidant ability. 
Moreover, the inhibition of NF B activation by GPx1 overexpression was also found 
in the other pathways activated by UV irradiation, TNF! (0.5ng/ml) and H2O2 (1mM), 
with the recorded reductions being 25~30%, 25~30% and >50%, respectively (Li et 
al., 2001). Overall these results suggest that GPx1, as an antioxidant selenoprotein, is 
able to regulate the NF B signalling pathway in the breast cancer cells. However, the 
transduction signal and the regulatory mechanisms controlling NF B signalling 
pathways have been suggested to be hugely variable according to the cell-type and 
inducer (Gloire et al., 2006, Vallabhapurapu and Karin, 2009). 
 
The effects of GPx1 on NF B signalling in human gut cells remain to be determined. 
Therefore, the first aim of the work described in this chapter was to assess the 
function of GPx1 in relation to NF B activation by TNF! in Caco-2 cells, so as to 
contribute to our understanding of the regulatory role of GPx1 in the functioning of 
the colonic epithelium. In addition, a second aim was to investigate the roles of two 
other selenoproteins, SelW and SelH, in the activation of NF B signalling. SelW and 
SelH are two selenoproteins also known to be highly sensitive to Se supply 
(Pagmantidis et al., 2005, Kipp et al., 2009), and therefore they might also be 
responsible for the NF B-regulatory effects observed in Se depletion. Moreover, 
SelW and SelH have also been suggested to have possible antioxidant functions 
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(Dikiy et al., 2007, Jeong et al., 2002b), but are not as well-defined as the GPx family, 
and therefore exploration of their individual impacts on NF B signalling could 
contribute to our understanding of their function. 
 
In order to assess the roles of these selenoproteins, the expression of GPx1, SelW and 
SelH was knocked down using siRNA in Caco-2 cells and then their respective effects 
on the TNF -NF B response were studied. Using this strategy, the experiments 
described in this chapter aimed to address the question of which selenoprotein(s) are 
involved in regulating NF B inflammatory signalling pathways in Caco-2 cells. 
 
Importantly, the biological effects observed following the knockdown of 
selenoproteins should provide different information compared with previous studies 
using the overexpression technique (Li and Engelhardt, 2006, Fan et al., 2003). The 
latter takes advantage of the selective delivery of DNA constructs containing a 
specific gene into cells to obtain a cell line with higher expression of the targeted gene 
and highlight its biological impacts. In contrast, siRNA knockdown inhibits gene 
expression by delivering small exogenous antisense oligoneucleotides into cells, 
which bind to the target mRNA sequence and cause a mRNA degradation process 
called RNA interference (Reynolds et al., 2004). Therefore the knockdown 
experiments serve as a model of loss-of-function study and can provide useful 
information in parallel with the previous studies by Se depletion. 
 
In summary, the work described in this chapter aimed to investigate if any of the three 
particular selenoproteins, GPx1, SelW and SelH, were involved in the regulation of 
the TNF -NF B signalling pathway by Se depletion. The experiments used siRNA 
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knockdown to assess the individual functions of GPx1, SelW and SelH in relation to 
the TNF -NF B response. NF B activation was assessed by NF B luciferase reporter 
activity and/or the expression of NF B target gene IL8, as assessed by 
semi-quantitative RT-PCR. In addition, investigations to assess the effects of Se 
depletion and GPx1 knockdown on ROS levels, and their influence on the system of 
redox control, were also conducted. 
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5.2  Results 
5.2.1 Design of GPx1-specific siRNA and knock-down of GPx1 expression 
In order to assess the function of GPx1, a siRNA specific to the GPX1 gene was 
designed and used to knock down GPx1 expression in Caco-2 cells. The design of 
GPx1 siRNA was performed according to published methods (Reynolds et al., 2004, 
Ui-Tei et al., 2004). The GPx1-specific siRNA, 21nt in length, shared sequence 
homology of less than 15nt with the other human mRNA transcripts and therefore is 
expected to be specific to GPX1 gene.  
 
The GPx1-specific siRNA is complementary to sequences within exon 1, which are 
common to GPx1 transcript variants. GPX1 gene has been suggested to encode at 
least two well-documented isoforms (Thierry-Mieg and Thierry-Mieg, 2006), variant 
1 (NM_000581.2) (containing exon 1 and 2) and variant 2 (NM_201397.1) 
(containing mainly exon 1). However, the two GPx1 transcript variants appear not to 
function with major difference, since both of them encode the catalytic SeCys using 
the UGA codon within exon 1 (Mullenbach et al., 1988). Therefore GPx1 siRNA was 
designed to target exon 1. The sequence information of GPx1 siRNA and of GPx1 
mRNA is shown as below: 
 
 
Sequence Information of GPx1 siRNA 
 
Target mRNA: aaggtactacttatcgagaat 
SiRNA:      gguacuacuuaucgagaau -uu        (sense strand) 
           uu-ccaugaugaauagcucuua             (antisense strand)
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Sequence Information of GPx1 gene (exon 1 and exon 2) 
[atgtgtgctgctcggctagcggcggcggcggcggcggcccagtcggtgtatgcctt
ctcggcgcgcccgctggccggcggggagcctgtgagcctgggctccctgcggggcaa
ggtactacttatcgagaatgtggcgtccctctgaggcaccacggtccgggactacac
ccagatgaacgagctgcagcggcgcctcggaccccggggcctggtggtgctcggctt
cccgtgcaaccagtttgggcatcag][gagaacgccaagaacgaagagattctgaat
tccctcaagtacgtccggcctggtggtgggttcgagcccaacttcatgctcttcgag
aagtgcgaggtgaacggtgcgggggcgcaccctctcttcgccttcctgcgggaggcc
ctgccagctcccagcgacgacgccaccgcgcttatgaccgaccccaagctcatcacc
tggtctccggtgtgtcgcaacgatgttgcctggaactttgagaagttcctggtgggc
cctgacggtgtgcccctacgcaggtacagccgccgcttccagaccattgacatcgag
cctgacatcgaagccctgctgtctcaagggcccagctgtgcctag]
 
• •GPx1 exon 1 and exon 2 are separated and GPx1 siRNA mRNA target is underlined. 
 
To test the ability of siRNA to knock down GPx1 expression, 5 X 105 Caco-2 cells 
were seeded into each well of a 6-well plate 24h before transfection. At 40-50% 
confluency, cells were treated with 5µl transfection reagent Lipofectamine 2000™ 
(Invitrogen) together with either 40, 80 and 120 pmol of GPx1 siRNA or an equal 
amount of a “scrambled” control siRNA. After 2 days, total RNA was harvested and 
semi-quantitative RT-PCR used to assess the expression of GPx1 and GAPDH 
transcripts (Figure 21 (A)). The scrambled control siRNA did not match any human 
mRNA transcripts and cells treated with this siRNA served as the control for normal 
GPx1 expression. GAPDH is a housekeeping gene and its transcript level was used as 
internal control. GPx1 expression in the GPx1-specific siRNA or the scrambled 
control siRNA treatment groups was calculated as a ratio of GPx1/GAPDH transcript 
levels (Figure 21 (B)). To show the knock-down, the adjusted GPx1 expression 
(GPx1/GAPDH ratio), of the GPx1 siRNA treatment group were further compared 
relative to the level of the scrambled control siRNA group, in which the level of the 
scrambled control group was standardized as ‘1’ (Figure 21 (C)). 
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Figure 21: siRNA knock-down of GPx1 expression 
(A): GPx1 expression as assessed by RT-PCR, was decreased following treatment 
with GPx1 specific siRNA, but no obvious change was found in the expression of 
GAPDH. (B): for quantification, the mRNA level GPx1 expression was adjusted to 
the GAPDH expression, and calculated as a ratio of GPx1/GAPDH. (C): the data were 
expressed in a ratio relative to the level of control siRNA group (standardized as ‘1’). 
Groups were compared using a Student 2-tail t test (*** p• •0.001; * 0.01<p• •0.05). n=4 
 
 
 
 
 
 
 
 
151 
 
As shown in Figure 21 (A), the GPx1 expression exhibited a clear decrease in the 
GPx1 siRNA treatment group, but not in the “scrambled” control siRNA treatment 
group, whereas the GAPDH levels were unchanged. This was confirmed by 
quantification of the bands and expression of the data as a ratio of GPx1 and GAPDH 
transcript levels (Figure 21 (B)). In this preliminary study, GPx1 knockdown assessed 
by comparing the GPx1 siRNA and the control siRNA treatment groups (Figure 21 
(C)) was shown to be 55% at mRNA level and this effect was similar with 40, 80 and 
120pmol siRNA treatments. This 55% knock down by siRNA was similar to the 
lowering of GPx1 level (60%) in the Se depletion experiments (Chapter 4, Section 
4.2.1). 
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5.2.2  The impact of GPx1 siRNA knockdown on TNF -induced 
NF B-activation in NF B luciferase reporter model 
In order to study the effect of GPx1 siRNA knockdown on the NF B signalling 
pathway activated by TNF , Caco-2 cells transfected with NF B or TATA (control) 
luciferase constructs were treated with 80pmol GPx1siRNA or scrambled control 
siRNA for 3 days to knock down GPx1 expression on protein level, incubated with 
20ng/ml TNF  for 2-4 hours to activate NF B and the total cell lysate harvested using 
1X Reporter lysis buffer. To assess the extent of activation of NF B signalling, 
quantification of luciferase activity was calculated per mg total cell lysate (data shown 
as relative luciferase activity (RLA)). 
 
Incubation with TNF  for 2-4 hours resulted in NF B activation in Caco-2 cells 
(Figure 15 (C)). To assess if GPx1 knock-down resulted in a faster or greater NF B 
response, luciferase activity was assessed at baseline and 2 and 4 hours after addition 
of TNF . As shown in Figure 22 (A), the baseline luciferase activities in NF B and 
TATA Caco-2 cell models exhibited no difference in groups treated with 
lipofectamine, GPx1siRNA + lipofectamine, or scrambled control siRNA + 
lipofectamine. Therefore a decrease in GPx1 expression by siRNA treatment appeared 
to cause no change in the background luciferase reporter activity. To compare the 
difference between GPx1siRNA and scrambled control siRNA treatment groups after 
stimulation with TNF , the RLA values were further calculated relative to the level of 
scrambled control siRNA group, which was standardized as ‘1’. The effects of GPx1 
knockdown on luciferase activity 2 and 4 hours after TNF  activation are shown in 
Figure 22 (B) and (C), respectively. 
15
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(A): Baseline luciferase activities (expressed as relative luciferase activity per mg 
protein, RLA) measured in both the NF B- and TATA-luciferase Caco-2 cells 
following treatment with lipofectamine, lipofectamine and GPx1 siRNA, and 
lipofectamine and scrambled control siRNA for 3 days. (B) and (C): the luciferase 
activities measured in the NF B- and TATA-luciferase Caco-2 cells following the 
same treatments (as above), and stimulation with 20ng/ml TNF  for 2 (shown in (B)) 
and 4 hours (shown in (C)). To show the effects of GPx1 knockdown, the luciferase 
activities (RLA values) in all groups were further calculated relative to the level of the 
scrambled control siRNA group (standardized as ‘1’). Groups were compared using a 
2-tailed Mann-Whitney U-test (**p<0.01). n=9 in (B), 6 in (C). 
 
 
 
Following stimulation with TNF , NF B activation, as reported by luciferase activity, 
was decreased in cells treated with 80pmol GPx1siRNA, as compared with the control 
cells treated with either lipofectamine, or lipofectamine and a scrambled control 
siRNA (Figure 22 (B) and (C)). The decrease was by ~13% at 2 hours and by ~25% at 
4 hours after TNF treatment, respectively, and these effects were statistically 
significant (Figure 22 (B) and (C)). Therefore, GPx1 siRNA treatment appeared not to 
affect the baseline activity of the luciferase reporter, but resulted in decreased 
luciferase reporter activity in response to TNF  stimulation. No effect was observed 
in cells stably transfected with the TATA- (control) luciferase construct, suggesting 
that this observed effect was specific to the NF B signalling pathway (Figure 22 (B) 
and (C)). In summary, in the present study using an NF B luciferase reporter, GPx1 
siRNA knockdown was found to down-regulate the TNF -NF B response by 13-25%, 
compared to the control treatment with scrambled control siRNA.  
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5.2.3  The impact of GPx1 siRNA knock-down on the expression of 
NF B target gene IL8 
The impact of GPx1 siRNA knockdown was further assessed by measuring the 
expression of the NF B target gene, IL8, following TNF  stimulation. As shown in 
Chapter 4 (Figure 18), IL-8 was found to be expressed at low levels in Caco-2 cells 
but was up-regulated quickly after 1h TNF  stimulation (20ng/ml) of the cells. 
Therefore, in this study, Caco-2 cells were treated with 80pmol GPx1 siRNA or 
scrambled control siRNA for 3 days, incubated with 20ng/ml TNF  for 1 hour to 
induce IL8 expression, the total RNA harvested and semi-quantitative RT-PCR used 
to assess the expression of IL8, GPx1 and GAPDH. Semi-quantitative RT-PCR 
analysis of GPx1 expression was to validate that the siRNA treatment had decreased 
GPx1 mRNA expression. RT-PCR amplification of GAPDH as a house keeping gene 
was used as the internal control. The expressions of IL8 and GPx1 were calculated as 
a ratio of IL8/GAPDH or GPx1/GAPDH transcript levels, respectively. To compare 
the different effects of GPx1 siRNA and scrambled control siRNA treatments on the 
IL8 response, the IL8 expressions (IL8/GAPDH ratio) were calculated relative to the 
IL8 expression of the scrambled control siRNA group, which was standardized as ‘1’. 
 
As shown in Figure 23 (A), GPx1 expression was clearly reduced in the GPx1 siRNA 
treatment groups, compared with the lipofectamine control or the scrambled control 
siRNA treatment groups, suggesting that GPx1 knockdown had occurred. In addition, 
as shown in Figure 23 (A), the IL8 PCR bands appeared slightly less intense in the 
GPx1 siRNA treatment group compared with those in the control treatment groups. 
The GAPDH PCR bands were unchanged in the groups of Lipofectamine treatment, 
GPx1 siRNA treatment and scrambled control siRNA treatment, confirming that the 
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expression of GAPDH, as an internal control gene, was not affected by the GPx1 
siRNA.  
 
Figure 23: Impact of GPx1 siRNA knock-down on TNF -induced IL-8 
expression 
(A): Semi-quantitative RT-PCR analysis of IL8, GPx1 and GAPDH transcript levels 
in Caco-2 cells treated with lipofectamine, lipofectamine and GPx1 siRNA, and 
lipofectamine and scrambled control siRNA and stimulated with 20ng/ml TNF  for 1 
hour.   
(B): quantitative analysis comparing the IL8 levels in the GPx1 siRNA and scrambled 
control siRNA treatment groups. IL8 expressions in the three treatment groups (as 
above) were calculated as a ratio of IL8/GAPDH transcript levels, and then further 
expressed in ratios relative to the level of the scrambled siRNA treatment group, 
which was standardized as “1”. Groups were compared using a 2-tailed 
Mann-Whitney U-test (** p• •0.01; * p• •0.05). n=8 
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As shown in Figure 23 (B), quantification of the data showed that IL8 expression in 
the GPx1 siRNA treatment group was approximately 80% relative to the IL8 level of 
the scrambled control siRNA treated cells, and this decrease in expression was 
statistically significant (p<0.05). Therefore, a 17% decrease of IL8 expression in 
response to TNF  was observed following GPx1 knockdown, and this is in 
concordance with the decreased NF B-luciferase activity described in last section.  
 
In summary, the results of both luciferase and IL8 measurements indicated that GPx1 
knockdown negatively affected the NF B response to TNF  in Caco-2 cells. This 
result was different to what would have been predicted from results of Se depletion 
experiments. To attempt to understand the potential mechanism(s) responsible for this 
difference, several additional experiments were performed:  
 
1) A siRNA approach was used to test whether the knockdown of either of two other 
selenoproteins sensitive to Se nutritional status modulated NF B signalling as 
assessed by the luciferase reporter; 
 
2) Since ROS have been suggested to be both an essential mediator of NF B 
activation and the target of Se depletion and GPx1 knockdown, ROS production in the 
Se depletion and GPx1 knockdown experiments were compared; 
 
3) The expression profiles of major selenoproteins were compared between the two 
treatments, so as to assess if the differences in effects due to knockdown or Se 
depletion were related to the expression of other selenoproteins. 
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5.2.4  The impact of siRNA knockdown of SelW and SelH on 
TNF -induced NF B-activation 
Two other selenoproteins sensitive to Se supply are SelW and SelH (Sunde et al., 
2009). These particular selenoproteins may be involved in antioxidant protection and 
yet not fully characterized (Dikiy et al., 2007). Therefore, SelW and SelH could have 
a role in the up-regulated NF B inflammatory signalling observed in Se depletion. To 
test this, the expressions of SelW and SelH were independently knocked down in 
Caco-2 cells using siRNA, and their resulting effects on the TNF -NF B response 
were studied using the luciferase reporter model. 
 
Briefly, Caco-2 cells (5X105/well) transfected with NF B- or TATA- (control) 
luciferase constructs were treated with lipofectamine and 80pmol SelW or SelH 
siRNA to knock down either SelW or SelH expression, or a “scrambled” control 
siRNA. Treatment with siRNA was for 3 days to reach an expected maximal 
knockdown of protein, the cells were incubated with 20ng/ml TNF  for 4 hours and 
total cell lysates were prepared from harvested cells using 1X Reporter lysis buffer. 
To assess the effects of SelW or SelH knockdown on NF B activation, luciferase 
activity was calculated per mg total cell lysate and expressed as RLA value. To 
compare the difference in luciferase activity between the SelW/SelH siRNA and 
control siRNA treatment groups, the RLA values in all groups were further expressed 
in ratios relative to the level of the scrambled control siRNA treatment group, which 
was standardized as “1”. In addition, total RNA from the cells treated with SelW or 
SelH siRNA, or control siRNA, was extracted 2 days after treatment and knockdown 
of mRNA expression assessed by RT-PCR. The SelW and SelH knockdown and their 
effects at 4 hours of TNF -induced NF B activation are shown in Figure 24. 
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(A) and (B): Semi-quantitative RT-PCR analysis of SelW and SelH expression in 
Caco-2 cells treated with 80pmol SelW siRNA, SelH siRNA, or a scrambled control 
siRNA; (C) and (D): densitometry quantification of the PCR bands present in (A) and 
(B), to show the extents of SelW and SelH knockdown on mRNA level. (n=3) 
(E): luciferase activities in cells treated with SelW siRNA, SelH siRNA, and control 
siRNA, and after stimulation with 20ng/ml TNF  for 4 hours (left panel), or at 
baseline (right panel). To show the effects of SelW or SelH knockdown, the luciferase 
activities (RLA values) in all groups were calculated relative to the level of the group 
treated with the control siRNA and stimulated with TNF  (standardized as ‘1’). 
Groups were compared using a 2-tailed Mann-Whitney U-test. (n=6) 
 
As shown in Figure 24 (A) and (B), Caco-2 cells treated with either SelW or SelH 
siRNA, respectively, compared with the scrambled control siRNA treatment group, 
displayed decreased SelW and SelH expression. As shown in Figure 24 (C) and (D), 
data quantification revealed that the knockdowns of SelW and SelH were 60% and 
40%, respectively.  
 
As shown in Figure 24 (E), using luciferase activity to assess NF B activation 
following 20ng/ml TNF  stimulation, no significant differences in RLA values were 
found between either the SelW siRNA or SelH siRNA treatment groups, and the 
scrambled control siRNA treatment group. Therefore, knockdown of SelW and SelH 
appeared to confer no change in the TNF -NF B response compared with the 
scrambled control, as assessed by the NF B-luciferase reporter system. These results 
suggested that although the decreased expression of SelW and SelH would have 
occurred in Se depletion, the decreases of these proteins would not be expected to 
influence the NF B activation in response to TNF  in Caco-2 cells. 
 
 
 
 
161 
 
5.2.5  Comparison of ROS production in Se depletion and GPx1 siRNA 
knock-down 
Results described previously indicated that NF B activation by TNF  was increased 
following Se depletion (Figures 12 and 14), and yet decreased by GPx1 siRNA 
knock-down (Figures 16 and 17). Thus, while Se depletion and GPx1 siRNA 
knock-down both reduced the expression of GPx1 by approximately 60%, their 
effects on the regulation of the NF B signalling pathway were contrary. In order to try 
to explain this apparent contradiction, the differences in background cellular 
environment between the Se depletion and GPx1 knockdown experiments were 
investigated. The aim was to try to understand which mechanisms were essential for 
regulation of NF B signalling and responsible for the different effects observed in 
response to the two treatments. 
 
As mentioned previously, ROS have been suggested to be one of the key mediators 
during the activation process of the NF B signalling pathways (Vallabhapurapu and 
Karin, 2009). Specific to TNF -NF B signalling transduction, the production of 
oxidative species following TNF  stimulation has also been suggested to be crucial 
for the activation of the TNF receptor complex (TNF -TNFR1-TRADD-RIP-TRAF2), 
phosphorylation of NF B inhibiting protein I B and release of NF B into nucleus 
(Jamaluddin et al., 2007, Gloire et al., 2006, Li and Lin, 2008). ROS production, as a 
result of TNF  stimulation, has been suggested to arise from TNF-induced caspase-8 
apoptosis in mitochondria (Gloire et al., 2006) and/or from the NADPH oxidases 
responding to the activated TNFR1 receptor (Kim et al., 2007, Yazdanpanah et al., 
2009, Li et al., 2009). To investigate this factor, ROS levels in Caco-2 cells grown in 
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Se-depleted and Se-supplemented medium, and ROS levels in cells treated with GPx1 
siRNA and scrambled control siRNA, were measured and compared. 
 
To test the potential changes in ROS levels induced by Se depletion, Caco-2 cells 
seeded in a 96-well plate were grown for 3 days in Se-depleted (Se-) or 
Se-supplemented (Se+) culture medium (90% confluent at day 3). To investigate the 
changes in ROS production caused by GPx1 siRNA knockdown, Caco-2 cells seeded 
in a 96-well plate were treated with lipofectamine and GPx1 siRNA or scrambled 
control siRNA for 3 days (in 90% confluency at day 3). Cells were washed 3 times 
with 1XHBSS and incubated with 25 M 5-(and-6)-carboxy-2´7´- 
dichlorodihydrofluorescein diacetate (Carboxy-H2DCFDA) for 15 minutes (as 
described in Chapter 2, Section 2.1.22). Carboxy-H2DCFDA is a fluorescent dye 
permeable to the cell membrane and is able to label the oxidative species in a 
subcellular environment (Shimizu et al., 2004). The labelled Caco-2 cells were 
washed 3 times with 1XHBSS and the ROS levels measured at 495/529nm wave 
length. Comparisons in ROS levels following Se depletion or GPx1 knockdown are 
shown in Figure 25. 
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Figure 25: Impact of Se depletion and GPx1 knock-down on ROS levels 
(A): Comparison of ROS levels in Caco-2 cells grown in the Se-depleted (Se-) and 
Se-supplemented (Se+) culture medium. ROS levels were determined by measuring 
the fluorescent activity of the oxidized Carboxy-H2DCFDA and expressed relative to 
the level of the Se+ group (standardized as “1”).  
(B): Comparison of ROS levels in Caco-2 cells treated with GPx1 siRNA and 
scrambled control siRNA. The ROS level of the GPx1 siRNA treatment group was 
expressed relative to the level of the control siRNA group (standardized as “1”). 
Groups were compared using a 2-tailed Mann-Whitney U-test (*** p• •0.001; n.s: not 
significant). n=12 for (A) or 24 for (B) 
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To compare the effects of Se depletion with Se supplementation, the average 
fluorescent activity of the oxidized Carboxy-H2DCFDA measured in the Se- 
medium-grown cells were expressed in a ratio relative to the average activity 
measured in the Se+ medium-grown cells, which was standardized as ‘1’ (Figure 25 
(A)). Results showed that Caco-2 cells cultured in Se- medium exhibited higher (~1.6 
fold, p<0.001) ROS levels than the cells cultured in Se+ medium, suggesting that Se 
depletion resulted in an increase of ROS levels in Caco-2 cells. 
 
In addition, the results shown in Figure 25 (B) compared the ROS levels in the GPx1 
siRNA and control siRNA-treated Caco-2 cells (standardized as ‘1’) and found that 
these cells exhibited comparable ROS levels between the two treatment groups, the 
difference between which was not statistically significant (p=0.07). Therefore, GPx1 
knockdown appeared not to cause any obvious effects on ROS levels in Caco-2 cells.  
 
In summary, the results of studies suggested that Se depletion elevated ROS levels in 
Caco-2 cells whereas GPx1 knockdown had no effect. This therefore provides a 
potential explanation of why the TNF -induced NF B activation was differentially 
affected by Se depletion and by GPx1 knockdown. To further search for any 
differences in background cellular environment between Se depletion and GPx1 
knockdown, the effects of these treatments on the selenoprotein gene expression were 
studied.    
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5.2.6  Comparison of the expression of antioxidant selenoproteins in Se 
depletion and GPx1 siRNA knock-down 
As described previously, Se depletion and GPx1 siRNA knockdown in Caco-2 cells 
were shown to have different regulatory effects both on the TNF -NF B signalling 
pathway, and on the production of cellular oxidative stress. Yet in both experiments 
the regulatory effects on NF B signalling and ROS was in concordance (increased 
NF B activation and increased ROS production in Se depletion; decreased NF B 
activation and unchanged ROS production in GPx1 knockdown). These results 
suggested that the differential regulation of NF B activation induced by TNF , relied 
on the differential control of ROS production in Caco-2 cells either by Se depletion or 
by GPx1 knockdown. Therefore, a retrospective study to investigate the upstream 
antioxidant system was carried out to interpret the present data, and the expression of 
antioxidant selenoproteins was compared between Se depletion and GPx1 knockdown 
experiments. 
 
Selenoproteins incorporate Se and depleted Se supply is known to decrease the 
synthesis and activity of a number of selenoproteins including GPx1, GPx4, SelW, 
SelH and TrxR1, and increase the expression of GPx2 (Pagmantidis et al., 2005, 
Bellinger et al., 2009). In some cases this is paralleled by a decrease in mRNA 
expression (Pagmantidis et al., 2005, Kipp et al., 2009). Among the selenoproteins 
affected by Se depletion, GPx1, GPx4, TrxR1, TrxR2 and GPx2 are 
well-characterized antioxidants with different substrate specificity. For example, 
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GPx1 and GPx2 matabolise water soluble oxidative species such as H2O2, whereas 
GPx4 is also able to catalyze the lipid hydroperoxides present on the cell membrane 
(Brigelius-Flohe, 1999). SelW and SelH, on the other hand, have also been suggested 
to have possible antioxidant functions (Whanger, 2009, Dikiy et al., 2007). Therefore, 
depleted Se supply would be expected to cause dramatic changes in the balance of the 
antioxidant system, by affecting multiple antioxidant selenoproteins and as a result, 
releasing variable types of oxidative substrates. In comparison, GPx1 knockdown 
would be expected to affect only the expression of GPx1, and release the water 
soluble oxidative species. However, the expression of the other antioxidant 
selenoproteins, despite presumably not being directly affected by the siRNA treatment, 
had not been assessed following GPx1 knockdown. 
 
To assess the expression of the selenoproteins, Caco-2 cells were cultured for 3 days 
in Se-depleted (Se-) or Se-supplemented (Se+) medium, or treated with lipofectamine 
and GPx1 siRNA or scrambled control siRNA for 3 days to induce GPx1 knockdown. 
In all groups, total RNA was harvested and semi-quantitative RT-PCR was used to 
assess the mRNA expression of GPx1, GPx4, GPx2, SelW, SelH and the house 
keeping gene GAPDH as an internal control. In order to show the effects of Se 
depletion or GPx1 knockdown, the expression of each selenoprotein gene was further 
compared between Se- and Se+ culture conditions (expressed in a ratio relative to the 
level of Se+ group), or between GPx1 siRNA and scrambled control siRNA 
treatments (expressed in a ratio relative to the level of scrambled control siRNA 
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group). The expression profiles of GPx1, GPx4, SelW, SelH and GPx2 in Se 
depletion and GPx1 knockdown are presented in Figure 26. 
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Figure 26: Expression profile of antioxidant selenoprotein mRNA in Se depletion 
and GPx1 knockdown 
(A): The expression of the selenoprotein mRNAs encoding GPx1, GPx4, SelW, SelH 
and GPx2 in Caco-2 cells grown in Se- and Se+ medium. Expression was adjusted to 
the GAPDH transcript level and in all comparisons the Se- group data expressed in a 
ratio relative to the Se+ group data (standardized as ‘1’). (B): The expression of the 
above selenoproteins in the cells treated with GPx1 siRNA and control siRNA. Data 
in the GPx1 siRNA treatment group expressed relative to the data in the control 
siRNA treatment group. Groups were compared using a Student 2 tail t-test. 
(**p<0.01; * p<0.05). n=3 
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mRNA expression of the antioxidant selenoproteins was found to be differently 
affected by Se depletion and by GPx1 knockdown. In Se depletion (Figure 26 (A)), 
the Se- group exhibited significant decrease of expression of GPx1 (~60%), SelW 
(~40%) and SelH (~50%) mRNAs, compared with the Se+ control group. The 
expression of GPx4 and GPx2 mRNAs were not significantly changed between Se- 
and Se+ groups. In comparison, in GPx1 knock-down (Figure 26 (B)), which was 
shown to reduce the GPx1 mRNA level by ~50%, the expression of SelW and SelH 
mRNAs were not affected compared with the control siRNA treatment group. The 
expressions of GPx4 and GPx2 were also unchanged. Therefore, Se depletion was 
found to result in the decreased expression of several antioxidant selenoprotein genes, 
whereas GPx1 knockdown was found only to decrease the expression of GPx1. These 
results indicated that the overall antioxidant system was regulated differently by Se 
depletion and GPx1 knockdown, and therefore suggested a possible explanation of 
how the different regulation of ROS level and NF B activation occurred following the 
two experimental treatments. 
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5.3  Discussion 
In the previous chapter the effect of Se supply on the NF B inflammatory signalling 
pathway was studied. An increased activation of an NF B-driven reporter together 
with increased expressional response of NF B target gene IL8 to TNF  were found in 
Caco-2 cells, when Se was depleted in the culture medium. To understand how Se 
depletion exerts this effect and elevates NF B signalling, the individual functions of 
the selenoproteins GPx1, SelW and SelH in relation to NF B regulation were 
examined, the different impacts on cellular ROS level between Se depletion and GPx1 
knockdown were compared, and the influence on the antioxidant system between Se 
depletion and GPx1 knockdown was examined by assessing the expression of the 
antioxidant selenoproteins under the two conditions.  
 
GPx1, SelW and SelH, whose expression is dramatically decreased in Se depletion 
(Pagmantidis et al., 2005, Kipp et al., 2009), were studied using the siRNA 
knockdown technique, and the impact of knockdown on the activation of NF B 
signalling pathway was assessed. As shown in Figure 21 and Figure 24 (A-D), 
treatment of Caco-2 cells with 80pmol (~30nM) siRNA resulted in ~55%, ~50% and 
~40% knockdown of gene expression of GPx1, SelW and SelH, respectively, as 
judged by mRNA levels. These knockdown levels were comparable to the levels of 
reduction in gene expression observed following Se depletion, which were ~60%, 
~40% and ~50% for GPx1, SelW and SelH, respectively (shown in Figure 26, also 
discussed later). Since a siRNA knockdown experiment is generally specific to the 
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gene of target (Reynolds et al., 2004), experiments using siRNA knockdown were 
carried out to help to dissect the complicated picture of Se depletion, and provide 
useful information about whether, and if so, how, the decrease of expression of each 
selenoprotein may affect the TNF -induced NF B signalling in Caco-2 cells. 
 
Using an NF B-luciferase reporter to monitor the transcriptional activation of NF B 
signalling, and using semi-quantitative PCR to assess the expression of the NF B 
target gene IL8, GPx1 siRNA knockdown by 55% was found to result in significantly 
decreased luciferase activity (by 25% at 4 hours after addition of TNF ), and 
decreased IL8 expression (by 17% at 1 hour after addition of TNF ), compared with 
the groups treated with a scrambled control siRNA (shown in Figure 22(B) and Figure 
23(B)). In addition, this regulatory effect was found specific to the NF B signalling in 
response to TNF , since the baseline luciferase activities were similar between the 
GPx1 siRNA and scrambled control siRNA treatment groups. Therefore, GPx1 
knockdown was found to inhibit the TNF-NF B signalling pathway and its effect was 
contrary to the effects of Se depletion, where a 30% increase of NF B-luciferase 
activity and a 50% increase of IL8 expression were observed. 
 
Using the NF B-luciferase reporter, siRNA knockdown of SelW (50%) and siRNA 
knockdown of SelH (40%) did not change the NF B signalling response to TNF  
(shown in Figure 24 (C)). These data indicated that these two selenoproteins were not 
responsible for the effects on NF B signalling caused by Se depletion. 
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Knockdown of each of three individual selenoproteins known to respond to Se 
depletion did not reproduce the elevated NF B signalling found in Se depletion. 
Therefore the regulatory effects of Se depletion cannot be explained by the reduced 
expression of either GPx1, SelW or SelH, suggesting that either an alternative 
selenorprotein is affected by depleted Se supply and is responsible for the increased 
NF B signalling, or that the combined reduced expression of multiple selenoproteins, 
together, caused the increased TNF -NF B response. The other selenoproteins known 
to be affected by Se supply include TrxR1 (Crosley et al., 2007) and GPx4, the 
expressions of which have been reported to be reduced mildly, by~30%, in cells 
grown in the Se-depleted medium (Pagmantidis et al., 2005). TrxR1 and GPx4 are 
also essential antioxidant enzymes and therefore potential modulators for NF B 
signalling. Thioredoxin and thioredoxin reductases (TrxRs), particularly TrxR1 
(cytosolic TrxR) and TrxR2 (mitochondrial TrxR), have been previously described as 
negative and positive regulators of NF B activation, respectively, in Hela cells and 
vascular endothelial cells (see Chapter 1 Section 1.1d) (Schenk et al., 1994, Glineur et 
al., 2000, Sakurai et al., 2004). GPx4 overexpression has been previously associated 
with decreased NF B nuclear translocation in response to UV-irradiation in 
fibroblasts (Wenk et al., 2004). Therefore these additional two or three selenoproteins 
are possible candidates responsible for the elevated TNF -NF B activation seen in Se 
depletion and need to be further examined. It is also possible that the increased NF B 
signalling found in Se depletion was caused by the overall repression of multiple 
selenoproteins, which was supported by later experiments when the regulatory effect 
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on ROS was studied, in Caco-2 cells either Se depleted or subject to GPx1 siRNA 
knockdown. 
 
The close correlation of ROS levels with activation of the NF B signalling pathway 
has been suggested in the previous publications, in which ROS have been documented 
either to directly activate NF B signalling (Gloire et al., 2006, Fan et al., 2003, Taylor 
et al., 2004), or in some other circumstances, function as a secondary messenger to 
mediate the activation of NF B when the signalling cascade was initiated by either 
cytokines such as TNF  or IL1
✁
 (Jamaluddin et al., 2007, Bol et al., 2003, Li et al., 
2009), or bacterial components such as LPS (Bhattacharyya et al., 2008, Sanlioglu et 
al., 2001). Of particular relevance to the present study, ROS have also been suggested 
to be critical for the NF B activation induced by TNF , and the major findings in this 
regard are summarized briefly as follows: 
 
1. In breast cancer cells, an increase of endosomal H2O2 production has been observed 
after TNF  stimulation (Li and Lin, 2008). When this H2O2 production was inhibited 
by either GPx1 overexpression (Li et al., 2001) or NADPH oxidase 2 (Nox2) siRNA 
(Li et al., 2009), TNF -induced NF B signalling was decreased. In addition, this 
H2O2 production has also been associated the recruitment of TRAF2 to the TNFR1 
receptor (Li et al., 2009). Therefore, ROS production by TNF  has been suggested to 
be essential for the TNF -NF B response in certain cell types.   
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2. The ROS production by TNF  may be from at least two sources, the mitochondria 
and/or the NADPH oxidases. TNF  is capable of inducing the caspase-8 apoptosis 
pathway and the latter could result in the release of ROS from mitochondria (Morgan 
et al., 2008, Hsu et al., 1996, Tang et al., 2009). In addition, endosomal H2O2 
production by TNF  has been suggested to be from the Nox2 complex (Li et al., 2009, 
Yazdanpanah et al., 2009). 
 
3. As described in Chapter 1 Section 1.2b-1.2d, ROS production can mediate the 
NF B signalling through several possible mechanisms. ROS are capable of enhancing 
the activities of the MAP3Ks, including NF B inducing kinase (NIK) (Li and 
Engelhardt, 2006, Kim et al., 2008) and MAP3K1 (Lee and Koh, 2003, Lee et al., 
2008), which participate in the phosphorylation cascade (MAP3Ks IKK I B 
 NFkB) for NF B activation. ROS are also capable of inhibiting the MAPK 
phosphatases that counteract with the MAP3Ks, and therefore help to maintain the 
active state of NF B signalling (Kamata et al., 2005, Farooq and Zhou, 2004).  
Although in the present study the particular MAP3K kinase and regulatory 
mechanisms, by which ROS might mediate the TNF -NF B response in Caco-2 cells, 
remained not characterized, it is clear that ROS play an essential role in the activation 
of TNF -induced NF B signalling (Jamaluddin et al., 2007, Li and Lin, 2008). 
 
4. The production of ROS has also been suggested to mediate the cross-talk between 
apoptosis signalling and the NF B inflammatory signalling, both of which can be 
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activated by TNF  (Chen and Goeddel, 2002). ROS production, in large amounts, has 
been suggested to lead to apoptosis and/or necrosis, and in moderate to small amounts, 
has been suggested to activate the JNK and NF B signalling pathways (Gloire et al., 
2006). Particularly, NF B signalling, after being activated, can repress apoptosis by 
expressing anti-apoptotic cytokines (Nakano et al., 2006, Kamata et al., 2005). 
Therefore, in the present study, the ROS production by TNF  in Caco-2 cells was 
expected to be in a relative small amount and subject to the regulation by Se and 
antioxidant selenoproteins.   
 
Because of the critical impact that ROS could have in modulating the activation of 
NF B signalling pathway, it was essential for the present study to compare the 
regulatory effects of Se depletion and GPx1 knockdown on the ROS levels in Caco-2 
cells. As assessed by ROS-indicating dye Carboxy-H2DCFDA( (Shimizu et al., 2004), 
Figure 25 (A)), a statistically significant increase of ROS level, by ~1.6 fold, was 
found in Caco-2 cells grown in Se- medium, compared with the ROS level in control 
cells grown in Se+ medium. In contrast, in the GPx1 knockdown experiment (Figure 
25 (B)), no difference in ROS level was found in cells treated with GPx1 siRNA or 
scrambled control siRNA. Therefore, these results suggested that the ROS level was 
differently affected by Se depletion and by GPx1 knockdown. 
 
Taking together the NF B reporter data, the IL8 expression measurements, and the 
ROS data, it is clear that effects of Se depletion and GPx1 knockdown are distinct. 
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Whereas Se depletion resulted in both the up-regulated NF B signalling in response 
to TNF  (Figure 17 and 19) and the increased ROS level in Caco-2 cells (Figure 25 
(A)), siRNA knockdown of GPx1 (Figure 21) resulted in down-regulated NF B 
signalling (Figure 22 and 23) and no change of the ROS level (Figure 25(B)). 
Therefore, the regulatory effects of Se depletion and GPx1 knockdown on the 
TNF-NF B activation are largely concordant to their regulatory effects on ROS. Since 
ROS has been suggested widely to be an essential mediator in the activation of NF B 
signalling, it would be logical to speculate that the NF B-regulatory effects of Se 
depletion and GPx1 knockdown were via their respective impacts on ROS, with the 
increased activation of NF B signalling by Se depletion being associated with 
increased ROS levels, and the decreased activation of NF B signalling by GPx1 
knockdown occurring in the absence of any changes in ROS levels. 
 
Se depletion is known to cause expressional changes in a number of selenoproteins 
(Bellinger et al., 2009), whereas GPx1 knockdown by siRNA was expected to 
specifically decrease the expression of GPx1. Using semi-quantitative RT-PCR to 
assess the mRNA expression of antioxidant selenoproteins including GPx1, GPx4, 
SelW, SelH and GPx2, Se depletion was shown to dramatically decrease the 
expressions of GPx1 (by 60%), SelW (by 40%) and SelH (by 50%), but to have no 
obvious effect on the expressions of GPx4 and GPx2 (Figure 26 (A)). Sensitivity of 
GPx1, SelW and SelH to Se depletion is similar to previous studies in Caco-2 cells 
(Pagmantidis et al., 2005) and in mouse colon (Kipp et al., 2009). Whereas early work 
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showed changes in GPx4 (decrease by ~24%) and GPx2 (increase by ~63%) mRNA 
expression (assessed by RNA hybridisation) following Se depletion in Caco-2 cells 
(Pagmantidis et al., 2005), the present work showed no changes. This was likely to be 
an effect of different techniques used for assessing mRNA expression. However, it is 
clear that Se depletion alters the balance of multiple antioxidant selenoproteins.  
 
Using the same method, GPx1 siRNA knockdown was shown to decrease the 
expression of GPx1 but did not affect the gene expression of the other antioxidant 
selenoproteins investigated (Figure 26 (B)). Therefore, the sustained expression of 
these selenoproteins, including GPx2 and GPx4, which are both known antioxidants 
more efficient than GPx1 (Brigelius-Flohe, 2006, Brigelius-Flohe, 1999), was found 
to be a major difference between the Se depletion and GPx1 knockdown experiments. 
This difference could be responsible for the different impact on the control of 
redox-signalling and NF B signalling.  
 
In GPx1 knockdown, although no direct evidence has been found by the present study 
to support this, compensation by the other Se dependent and/or independent 
antioxidants could occur, resulting in consistent ROS levels and decreased NF B 
activation following TNF  stimulation. Indeed, as shown in Figure 26 (B), there was 
a trend towards the average GPx2 expression being higher in the GPx1 siRNA 
treatment group compared with the control group but the difference was not 
significantly different, probably due to the large standard errors caused by the limited 
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number of the experiment repeats. Therefore, it would be useful to carry out repeat 
measurements of GPx2 mRNA expression in the GPx1 siRNA treated cells.  
 
In the present study, the investigations using semi-quantitative RT-PCR 
fundamentally revealed how antioxidant selenoproteins respond to changes in Se 
supply (Se depletion) or selenoprotein expression (GPx1 knockdown), resulting in 
different biological consequences (NF B inflammatory signalling). However, 
additional or even more precise information could have been obtained, if time had 
been allowed, using real-time PCR to strengthen the current investigation assessing 
the mRNA level, using Western bloting to assess the protein levels or enzymatic 
assays to assess protein activity (for example, measurement of GPx1, GPx4 and 
TrxR1 activities in reduction of their specific ROS targets would have complemented 
this work) (Crane et al., 2009, Campbell et al., 2007). In addition, TrxR1 and TrxR2 
are other essential antioxidant selenoproteins (briefly reviewed in Section 1.1d) but 
have not been included in the present data (Figure 26) and their expression profiles in 
the Se depletion and GPx1 knockdown experiments remain to be determined in future. 
The proposed compensation in antioxidant expression could possibly occur at the 
protein expression or protein activity level.    
 
Moreover, a further possible strategy would be to knock down more than one 
antioxidant selenoprotein together using combined siRNA treatments. For example, 
double transfection of Caco-2 cells with both GPx1 and GPx2 siRNAs would 
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decrease the expression of both GPx1 and GPx2, mimicking the double knock-out 
(GPx1 -/- and GPx2 -/-) mouse model which exhibited susceptibility to bacterial 
infection in colon (Esworthy et al., 2003). Investigations of the effects of double 
knock-down (GPx1 and GPx2, or GPx1 and GPx4) on NF B response in Caco-2 cells 
would provide additional insights in how the antioxidant selenoproteins compensate 
for each other’s function and contribute to the control of inflammatory signalling 
pathways.  
 
In summary, the experiments described in this chapter investigated the influence of 
siRNA knockdown of GPx1, SelW and SelH on the TNF -induced activation of 
NF B signalling pathway. The results showed that none of these knockdown 
experiments was able to reproduce the increased NF B response observed following 
Se depletion, but resulted in either decreased NF B response (by GPx1 knockdown, 
opposite to the influence by Se depletion) or unchanged NF B response (by SelW or 
SelH knockdown). Although in these studies the knockdown levels of these 
selenoproteins were comparable to their respective reductive levels by Se depletion, 
their distinct regulatory effects suggested that, individually, the decreased expression 
of GPx1, SelW or SelH was not able to cause the increased response of NF B 
signalling. These results suggested that most likely, Se depletion elevates the 
TNF -NF B activation through repressing the expression of multiple antioxidant 
selenoproteins, rather than through the decreased expression of any single one. 
Alternatively, it remains possible that the effect of Se depletion resulted from the 
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decreased expression of a selenoprotein other than GPx1, SelW and SelH. In the next 
Chapter the effects of GPx4 knockdown were studied in relation to the NF B 
signalling induced by TNF  and flagellin. 
 
The present finding that GPx1 knockdown resulted in decreased TNF-NF B response 
and IL8 gene expression is, interestingly, contrary to the suggestions from earlier 
publications, which described stably-transfected cells overexpressing GPx1 and found 
that in these cells the H2O2 production was lowered and the activation of NF
 B 
signalling was repressed (Li et al., 2001, Kretz-Remy et al., 1996, Fan et al., 2003, 
Ishibashi et al., 1999, Li and Engelhardt, 2006). This conflict in the data might be 
explained by the different techniques in use. GPx1 knockdown models loss of 
function, whereas GPx1 overexpression models gain of function. Although gain of 
GPx1 function could enhance its beneficial effects on antioxidant protection and 
inhibition of the inflammatory signalling, partial loss of GPx1 function may not result 
in the converse effects, perhaps due to the compensatory activities of the other 
antioxidant proteins.  
 
In previous studies using the GPx1 knock-out (GPx1 -/-) mouse model, no obvious 
developmental abnormalities were observed and the mice remained healthy in 
hyperoxia, a condition causing excess hydroperoxide challenge (Ho et al., 1997). 
However, when GPx1 -/- knockout was coupled with GPx2 -/- knockout, the double 
knockout mouse model exhibited increased sensitivity to microflora challenges, 
181 
 
developed excessive colonic inflammation (Esworthy et al., 2003) and showed 
increased accumulation of cell DNA errors (transition, transversion or small deletion 
for DNA damage), which is an important event in cancinogenesis (Lee et al., 2006). 
In addition, GPx1 -/- mice in other studies were also shown to have no difference in 
TNF-induced primary apoptosis signalling, but had increased susceptibility to 
secondary necrosis/T-cell induced liver cell injury (Bajt et al., 2002), exhibited 
increased NF B signalling (assessed by EMSA for chromatin binding affinity of p65 
NF B subunit) after ischemia-reperfusion injury in neuron (Crack et al., 2006), and 
exhibited increased apoptosis and NF B response to H2O2 challenge in their 
fibroblasts (de Haan et al., 2004). Taken together, these observations suggest that a 
loss of GPx1 function is relatively benign, unless a second strike stressing the 
redox-system occurs, such as that which occurs in Se depletion, ischemia-reperfusion 
injury and H2O2 challenge. 
 
Secondly, in GPx1 overexpression studies, culture medium supplemented with Se was 
used to enhance the additional expression of GPx1 (Li et al., 2001). It cannot be 
excluded that the expressions and/or activities of other selenoproteins might also have 
been affected by the Se supplementation, but these were not carefully determined. 
Therefore, the studies of GPx1 overexpression with Se supplementation might 
potentially have brought additional beneficial effects on other antioxidant 
selenoproteins and this should also be taken into consideration.  
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Thirdly, the cell models used in the present and previous studies were different and 
involved a colonic epithelial Caco-2 cell line in the present work, but breast cancer 
MCF-7 or T47D cell lines (Li et al., 2001, Li and Engelhardt, 2006, Kretz-Remy et al., 
1996), and mouse renal cells (Ishibashi et al., 1999) in ealier experiments. The 
different cell types might be distinct in their properties relating to redox-control and 
NF B signalling transduction. For example, MCF7 cells have been suggested to 
express endogenous GPx1 at a very low level (Li et al., 2001, Kretz-Remy et al., 1996) 
and not to express GPx2, which is expressed mainly in the gastrointestinal epithelium. 
In comparison, Caco-2 cells express both GPx1 and GPx2 at high levels 
(Brigelius-Flohe, 1999). Therefore, the MCF7 and Caco-2 cells might also respond 
differently to changes in GPx1 expression. 
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6.   Effects of GPx4 on NF B inflammatory signalling 
6.1  Introduction 
Changes in Se supply to either the host cell environment or a cell culture system are 
known to affect the transcript expression, protein synthesis and enzymatic activity of 
sensitive selenoproteins such as GPx1 and SelW, but have also been suggested to 
influence some other selenoproteins such as GPx4 and TrxR1, which rank in the 
middle of the selenoprotein incorporation hierarchy (Pagmantidis et al., 2005, Kipp et 
al., 2009). For example, GPx4 expression, as assessed by mRNA levels using a 
macroarray, was found to be reduced by 24% and TrxR2 expression by 27% in 
Caco-2 cells cultured in Se-depleted medium (Pagmantidis et al., 2005). A recent 
study using a microarray and quantitative PCR approach, to screen genes expressed in 
the colon of mice fed with Se deficient or adequate diets, have reported a decrease of 
~35% in TrxR1 expression in mice fed a marginally low Se diet, but no obvious 
changes in GPx4 and TrxR2 expression (Kipp et al., 2009). In Chapter 5 Section 5.2.6, 
Se depletion was found not to change GPx4 mRNA expression in Caco-2 cells as 
assessed by semi-quantitative RT-PCR (Figure 26). Taking these results together, it is 
reasonable to suggest that during insufficient Se supply, although the most dramatic 
changes of gene expression, protein synthesis and activity occur in the sensitive 
selenoproteins, such as GPx1, the other selenoproteins, such as GPx4 and TrxR1, may 
also be mildly affected by Se depletion and their influence on NF B signalling should 
be taken into consideration.  
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Furthermore, selenoproteins such as GPx4 have been suggested to be of particular 
biological importance, especially in the repression of cellular oxidative stress and 
regulation of the redox-signalling pathways (Imai and Nakagawa, 2003, 
Brigelius-Flohe, 2006). Like GPx1, GPx4 is also widely distributed in tissues 
including the gastrointestinal epithelium (Chu et al., 1993). However, whereas GPx1 
catalyzes mainly the water-soluble oxidants, e.g. H2O2, GPx4 catalyzes a much wider 
selection of oxidative targets such as phospholipid hydroperoxides (Chu et al., 1993) 
and lipid hydroperoxides (Thomas et al., 1990), most of which are associated with 
lipid peroxidization in cell and mitochondrial membranes. Moreover, GPx4 is able to 
employ substrates for ROS reduction other than glutathione (GSH) (Aumann et al., 
1997). GPx4 comprises three isoforms including mitochondrial GPx4, cytosolic GPx4 
and nuclear GPx4 (Arai et al., 1996, Pfeifer et al., 2001), of which mitochondrial 
GPx4 has been suggested to be particularly important in preventing pro-apoptotic 
oxidative stress in mitochondria (Liang et al., 2007, Imai et al., 2003b). Taking these 
aspects together, GPx4 has been suggested to be an essential antioxidant in the cell 
environment.  
 
GPx4’s regulatory effects on redox-signalling are based on its ability to repress a wide 
range of reactive oxidative species that the other GPxs do not reduce. For example, 
GPx4 may regulate eicosanoid biosynthesis through inhibition of the oxidative 
signalling involved in the positive feedback of the lipoxygenase (LOX) and 
cyclooxygenase (COX) pathways (details included in Chapter 1 Section 1.3a). In 
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comparison, any regulatory effects of GPx4 on the NF B signalling pathway, which 
has also been widely suggested to use redox-signalling to mediate its activation (see 
Chapter 1 Section 1.2b-1.2d), has not yet been systematically investigated. A major 
difficulty is the variable transductional signalling used in NF B activation according 
to different cell-types and inducer-types. However, a limited number of previous 
studies have suggested a close association between GPx4’s repression of 
redox-signalling and the inhibition of NF B activation in certain cell types. For 
example, in human vascular endothelial cells (ECV304 cells), overexpression of 
GPx4 was found to result in decreased NF B activation by IL-1, which was also 
observed following Se supplementation and in fact caused complete cancellation of 
NF B activation (Brigelius-Flohe et al., 1997). In epidermal fibroblast cells, NF B 
activation by UV irradiation and phospholipid hydroperoxides, known inducers as 
oxidative stress, was found to be repressed by GPx4 overexpression (Wenk et al., 
2004). In addition, in rabbit muscle cells, inhibition of active NF B signalling in 
response to lipid hydroperoxides, an oxidative substrate preferentially catalyzed by 
GPx4, was also achieved by GPx4 overexpression (Brigelius-Flohe et al., 2000). 
Together, these findings provide evidence that in certain cells, the antioxidant ability 
of GPx4 is associated with its regulatory effects on NF B signalling pathways. 
However, GPx4’s effect on NF B signalling in many other cells or tissues, including 
the gastrointestinal epithelial cells, remains to be determined.  
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In Chapter 4 and 5, Se depletion was shown to increase NF B signalling in response 
to TNF , but not flagellin, in Caco-2 cells. In addition, it was found that the 
TNF -NF B response was decreased by GPx1 knockdown but unaffected by SelW or 
SelH knockdown. The distinct effects on NF B signalling by Se depletion and by 
knockdown of GPx1, SelW or SelH raised the possibility of an alternative mechanism 
being involved in the increased TNF -NF B response observed in Se depletion. Since 
reduced synthesis and expression of GPx4 has also been suggested to occur in Se 
depletion, and GPx4 as an essential antioxidant has been suggested to be associated 
with regulation of NF B signalling by earlier findings, experiments using the 
NF B-luciferase reporter model were carried out to investigate GPx4’s regulatory 
effect on NF B signalling pathway in Caco-2 cells. The approach taken was to lower 
GPx4 expression using siRNA and then stimulate cells with either TNF  or flagellin. 
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6.2  Results 
6.2.1  Design of GPx4 siRNA and siRNA knock-down of GPx4 
In order to study the function of GPx4 in Caco-2 cells, siRNAs specific to the GPX4 
gene were designed and used to knockdown GPx4 expression. The GPX4 gene has 
been reported to encode three different transcript variants, namely cytosolic GPx4 
(cGPx4), mitochondrial GPx4 (mGPx4) and nuclear GPx4 (nGPx4) (Arai et al., 1996, 
Pfeifer et al., 2001). Experiments were performed initially to determine which GPx4 
transcript variants are expressed in Caco-2 cells. These experiments used RT-PCR 
and, as shown in Figure 27, amplification of both cGPx4 and mGPx4 isoforms was 
achieved, but there was no evidence for expression of nGPx4, which has been 
suggested to be expressed specifically in sperm cells (Pfeifer et al., 2001). These data 
indicate that the mitochondrial and cytosolic GPx4 are expressed in Caco-2 cells. 
 
Figure 27: Detection of GPx4 transcript variants in Caco-2 cells 
The expression of GPx4 transcript variants in Caco-2 cells was detected using RT-PCR. Lane 
1: molecule weight markers; Lane 2: amplification of both cGPx4 and mGPx4; Lane 3: 
amplification of mGPx4 only.   
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Design of the GPx4 siRNA was carried out following the published methods 
(Reynolds et al., 2004, Ui-Tei et al., 2004). Low sequence homology (• •15nt out of 
21nt length of siRNA) with the other human mRNA transcripts was achieved so as to 
limit the non-specific binding of siRNA to the off-target mRNAs. As a result, two 
siRNA sequences, GPx4siRNA01 and GPx4siRNA02, were designed. The sequence 
information of the two GPx4 siRNA together with the sequence information of the 
GPx4 mRNA transcripts is shown in Figure 28: 
 
189 
 
 
 
Figure 28: Scheme showing GPx4 isoforms and design of GPx4 siRNA 
GPx4 gene encodes 7 exons (exon 1a and exon 2 to 7). mGPx4 is transcribed from 
exon 1a to exon 7 and cGPx4 is transcribed from exon 2 to 7. GPx4 gene also encodes 
an alternative exon 1 as exon 1b, which is used to transcribe nGPx4 but this is not 
shown above. Exon 1a was suggested to translate a mitochondrial translocation leader 
sequence whereas exon 2 to 7 was suggested to translate the main part of GPx4 with 
catalytic function (Arai et al., 1996). Exons are separated by brackets and the mRNA 
targets of GPx4siRNA01 (design 1) and GPx4siRNA02 (design 2) are respectively 
underlined.  
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The target sequences of GPx1siRNA01 and GPx4siRNA02 were present in both 
cGPx4 and mGPx4 transcripts and therefore these siRNA were unable to differentiate 
between the cGPx4 and mGPx4 transcripts expressed in Caco-2 cells. This was 
mainly due to the difficulty of selecting a siRNA target within exon1a, a short 
sequence of 84nt, which is the only differential sequence uniquely found in mGPx4. 
As a result, GPx1siRNA01 and GPx4siRNA02 were designed to sequences in exon 3 
and exon 4, respectively, and the two GPx4 siRNAs would be expected to knockdown 
cGPx4 and mGPx4 transcript variants. 
 
In order to test the ability of siRNA to knockdown GPx4 expression, Caco-2 cells of 
~50% confluency were seeded in a 6-well plate one day before addition of 5 l 
transfection reagent Lipofectamine 2000™ and 80pmol of either GPx4siRNA01 or 
GPx4siRNA02. To assess the knockdown at the mRNA level, treatment by each 
GPx4 siRNA was maintained for 2 days, total RNA harvested and semi-quantitative 
RT-PCR carried out to measure the expression of GPx4 and GAPDH. GAPDH is a 
house keeping gene and was used as the internal control. To assess the knockdown at 
the protein level, treatment by each GPx4 siRNA was maintained for 3 days, total cell 
lysate was harvested and GPx4 expression was determined by western blot using 
polyclonal anti-GPx4 as described in Section 2.1.17 (Chapter 2 Materials and 
Methods). The results of siRNA treatment on GPx4 expression at the mRNA and 
protein levels are shown in Figure 29 and Figure 30, respectively. 
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Figure 29: siRNA knockdown of GPx4 expression at the mRNA level 
Caco-2 cells were treated with either GPx4siRNA01 or GPx4siRNA02 (80pmol) for 2 
days. (A) and (B): the results assessed using semi-quantitative RT-PCR to show the 
expression of GPx4 and GAPDH (internal control) at the mRNA level in the groups 
of GPx4siRNA01 and GPx4siRNA02, respectively. (C) and (D): quantification of the 
data indicating the knockdown of GPx4 expression by 80pmol GPx4siRNA01 and 
GPx4siRNA02, respectively. GPx4 expression was calculated as a ratio of 
GPx4/GAPDH transcript levels and further compared between the siRNA treatment 
group and the control groups (untreated or treated with lipofectamine). Groups were 
compared using a 2-tailed Mann-Whitney U-test (***: p<0.001; **: p<0.01). n=6 
  
.   
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As shown in Figure 29 (A) and (B), treatments with 80pmol of GPx4siRNA01 and 
GPx4siRNA02 for 2 days, respectively, resulted in a slight decrease and a clear 
decrease in GPx4 mRNA expression, compared to the control groups without any 
treatment or treated only with lipofectamine. In addition, GAPDH expression was not 
affected by GPx4 siRNA treatments. Quantification by densitometry of the RT-PCR 
bands allowed calculation of the GPx4 expression as a ratio of GPx4/GAPDH 
transcript levels, and the GPx4 expressions were further compared between the 
siRNA treatment group and the control groups. Knockdown of ~40% was achieved 
with 80pmol GPx4siRNA01, whereas knockdown of ~50% was achieved with 
GPx4siRNA02, compared with the control group of untreated Caco-2 cells 
(standardized as ‘1’) (Figure 29 (C) and (D)). Therefore, both GPx4 siRNA appeared 
to be capable of GPx4 knockdown in Caco-2 cells. However, GPx4siRNA02 
appeared to have the greater knockdown effect and therefore its effects were 
investigated further. 
 
In order to test GPx4 knockdown at the protein level, treatments with 40, 80 and 
120pmol GPx4siRNA02 were maintained for 3 days. As shown in Figure 30 (A), 
groups treated with this GPx4 siRNA exhibited reduced GPx4 protein expression to 
various extents when compared to the control groups, i.e. untreated cells or cells 
treated only with lipofectamine. Considerable knockdown of GPx4 protein were 
observed in groups treated with 80 and 120pmol siRNA, with GPx4 protein being 
barely detectable in the 120pmol treatment group. After quantification (shown in 
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Figure 30 (B)) using the untreated group standardized as ‘1’, GPx4 knockdown by 40, 
80 and 120pmol siRNA was found to be by ~20%, ~60% and >85% at the protein 
level, respectively. Therefore, treatment with 80pmol siRNA was found to achieve a 
similar knockdown in GPx4 expression (50~60%) at both mRNA and protein levels, 
and treatment with 120pmol siRNA was found to result in a much larger effect on 
GPx4 protein expression with knockdown of over 85%.  
 
 
Figure 30: siRNA knockdown of GPx4 expression at the protein level 
Caco-2 cells treated with 40, 80, 120pmol of GPx4siRNA02 were assessed by western 
blotting using an anti-GPx4 antibody. Results showed various extents of reduced 
GPx4 expression at the protein level, compared with the control group (standardized 
as ‘1’) of untreated cells; 40, 80 and 120pmol GPx4 siRNA were found to result in 
approximately 20%, 60% and more than 85% knockdown of GPx4 protein, 
respectively. n=3 
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In summary, to establish a method to study GPx4’s function in Caco-2 cells, the 
design and experimental use of two siRNA specific to the GPx4 transcript showed 
that it is possible to knockdown GPx4 expression in Caco-2 cells. Using 80pmol 
siRNA treatment, ~40% knockdown of GPx4 mRNA expression was achieved using 
GPx4siRNA01 and a larger knockdown effect (50%) was achieved with 
GPx4siRNA02. Further investigation using GPx4siRNA02 showed that knockdown 
of GPx4 expression at the protein level was ~60% using 80pmol siRNA and >85% 
using 120pmol siRNA. Therefore, in further experiments assessing GPx4’s regulatory 
effect on NF B signalling, knockdown of GPx4 expression was carried out using 
120pmol GPx4siRNA02.   
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6.2.2  The impact of GPx4 knockdown on TNF -induced 
NF B-activation in the NF B luciferase reporter model 
The impact of GPx4 on the NF B signalling pathway in response to TNF  induction 
was studied using siRNA knockdown in Caco-2 cells expressing the NF B luciferase 
reporter. Caco-2 cells transfected with NF B or TATA (control) luciferase constructs 
were treated with 120pmol GPx4siRNA or a “scrambled” control siRNA for 3 days to 
reach maximal knockdown at the protein level, then incubated with 20ng/ml TNF  for 
2 or 4 hours to activate NF B signalling. TNF  treatment has been shown previously 
to result in activation of the NF B signalling-driven reporter after 2-4 hours 
stimulation (Figure 15). Total cell lysate was harvested using 1X Reporter lysis buffer 
and luciferase activity was measured, at baseline, and at 2 and 4 hours after addition 
of TNF . Activity was calculated per mg total cell lysate protein (relative luciferase 
activity, RLA) and then expressed as a ratio relative to the level of the “scrambled” 
control siRNA treatment group, which was standardized as “1”.  
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(A): Baseline RLA values measured in both NF B- and TATA- luciferase transfected 
Caco-2 cells and for each cell type, in the three treatment groups: only with 
lipofectamine, with GPx4 siRNA, and with scrambled control siRNA. (B) and (C): 
after 2 hours and 4 hours TNF  treatment, luciferase activity increased dramatically in 
the cells transfected with NF B-luciferase construct, compared with the TATA 
construct-transfected cells. Moreover, the levels of luciferase activity were compared 
within the treatment groups and expressed as a ratio relative to the control group 
(scrambled control siRNA treatment). Groups were compared using a 2-tailed 
Mann-Whitney U-test (non-significant: p>0.05). n=6 
 
 
 
In Caco-2 cells transfected with either NF B- or TATA- luciferase constructs, 
baseline RLA values exhibited a difference between the cell types but exhibited no 
difference among the three treatments (lipofectamine, lipofectamine and GPx4 siRNA, 
or lipofectamine and “scrambled” control siRNA) (Figure 31 (A)). Therefore, the 
background luciferase reporter activity appeared not to be affected by the GPx4 
knockdown. Furthermore, although large differences in RLA values between the 
NF B- and TATA- luciferase cell models were found both 2 hour and 4 hour after 
TNF addition, indicating that an induction of NF B signalling had indeed occurred in 
this experiment, there was no significant difference between the three treatment 
groups (Figure 31 (B) and (C)). Therefore, these results suggested that in Caco-2 cells 
GPx4 knockdown to ~85% by 120pmol siRNA treatment resulted in no obvious 
changes of NF B-driven luciferase reporter after stimulation with TNF .  
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6.2.3  The impact of GPx4 knockdown on Flagellin-induced 
NF B-activation in the NF B luciferase reporter model 
Studies of the correlation between GPx4 knockdown and flagellin-induced 
NF B-luciferase activity were carried out as follows: Caco-2 cells transfected with 
NF B or TATA (control) luciferase constructs were treated with 120pmol 
GPx4siRNA or “scrambled” control siRNA for 3 days, then incubated with 100ng/ml 
Salmonella typhimurium flagellin to activate NF B signalling. As shown previously, 
treatment of Caco-2 cells with 100ng/ml flagellin resulted in increased luciferase 
activity 2-8 hours after addition of flagellin in the luciferase reporter model (Figure 15 
(D)). Therefore, in order to assess if GPx4 knockdown caused any effects on the 
flagellin-induced NF B signalling response, total cell lysate harvested and luciferase 
activities were measured at baseline, and at 2 and 6 hours after treatment. Activity 
was calculated per mg total cell lysate (relative luciferase activity, RLA) and 
expressed in a ratio relative to the level of the control siRNA treatment group.  
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(A): the luciferase activities at baseline in the NF B- and TATA- luciferase construct 
transfected Caco-2 cells and for each cell type, in three different treatment groups 
(lipofectamine only, lipofectamine and 120pmol GPx4 siRNA, and lipofectamine and 
120pmol control siRNA). (B): the luciferase activity levels expressed in a ratio 
relative to the level of control siRNA group after 2 hours flagellin treatment. (C): the 
luciferase activity levels expressed in a ratio relative to the level of control siRNA 
group after 6 hours flagellin treatment. Groups were compared using a 2-tailed 
Mann-Whitney U-test (*: p<0.05). n= 6 
 
Similar to the TNF -NF B experiment, the baseline luciferase activities exhibited 
comparable values between the GPx4 siRNA and the scrambled control siRNA 
treatment groups, again indicating that the background luciferase reporter activity was 
not affected by GPx4 knockdown (Figure 32 (A)). When Caco-2 cells were stimulated 
with Salmonella typhimurium flagellin (100ng/ml) for 2-6 hours, there was a clear 
increase in luciferase activity in the NF B-luciferase but not the TATA-luciferase 
transfected cells, suggesting that NF B signalling was activated (Figure 32 (B) and 
(C)). Comparison between the GPx4 siRNA and the scrambled control siRNA 
treatment groups showed that 2 hours after flagellin stimulation, GPx4 knockdown led 
to a small (20%) but statistically significant (p<0.05) decrease in luciferase activity 
(shown in Figure 32 (B)). However, 6 hours after flagellin stimulation, knockdown of 
GPx4 had no significant effect (shown in Figure 32 (C)). 
 
To further investigate the impact of GPx4 knockdown on the NF B signalling, 
expression of the NF B target gene IL8 was measured after flagellin stimulation. 
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6.2.4  The impact of GPx4 knockdown on expression of the NF B target 
gene IL8 following flagellin induction 
Semi-quantitative RT-PCR was used to assess the response of NF B target gene IL8 
to flagellin induction. Caco-2 cells were stimulated with Salmonella typhimurium 
flagellin (100ng/ml) for 0, 2, 4, 6 and 16 hours. IL8 expression in unstimulated 
Caco-2 cells was found to be very low, whereas following the stimulation by flagellin, 
the expression of IL8 increased dramatically with the highest level observed after 2 
hours (Figure 33).  
 
In order to assess the regulatory effect by GPx4 knockdown on the response of IL8 
expression to flagellin, Caco-2 cells were treated with 120pmol GPx4 siRNA or the 
“scrambled” control siRNA for 3 days, incubated with 100ng/ml flagellin for 2 hours 
to stimulate IL8 expression, and total RNA harvested. Semi-quantitative RT-PCR was 
used to assess the mRNA expression of IL8, GPx4 and GAPDH. The expression 
levels of IL8 and GPx4 (to show the effect of knockdown) were normalized to the 
level of house keeping gene GAPDH.  
 
A clear decrease in GPx4 expression was observed in the GPx4 siRNA treatment 
group compared with the control siRNA group, confirming that siRNA knockdown 
had occurred (Figure 34 (A)). In addition, a decrease in IL8 expression was also found 
in the GPx4 siRNA treatment group compared with the IL8 level in the scrambled 
control siRNA treatment group. Quantification of the data indicated a decrease in IL8 
expression by GPx4 knockdown, which was ~40% and of statistical significance 
(p<0.01) (Figure 34 (B)). Therefore, in addition to the finding that GPx4 knockdown 
resulted in decreased luciferase activity assessed by the NF B-luciferase reporter, 
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siRNA knockdown of GPx4 expression also resulted in decreased IL8 expression in 
response to flagellin. Together, these results suggested that GPx4 knockdown was 
associated with down-regulation of NF B signalling in response to flagellin challenge 
in Caco-2 cells. 
 
 
 
Figure 33: Induction of IL8 mRNA expression by flagellin for 0, 2, 4, 6 and 16 
hours treatment 
Caco-2 cells treated with 100ng/ml flagellin for 0, 2, 4, 6 and 16 hours and IL8 
expression assessed by RT-PCR. In treated cells (0 hour), IL8 expression was very 
low, whereas in cells treated with flagellin for 2 hours, IL8 expression was stimulated 
and at the highest level, compared with the other groups (4, 6 and 16 hours flagellin 
stimulation).  
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Figure 34: Imact of GPx4 siRNA knockdown: flagellin-induced IL8 expression in 
Caco-2 cells 
(A): Expression of IL8, GPx4 and GAPDH mRNAs in Caco-2 cells treated with 
120pmol GPx4 siRNA or scrambled control siRNA and incubated with 100ng/ml 
flagellin for 2 hours (assessed by semi-quantitative RT-PCR). (B): Quantification of 
the data comparing GPx4 and IL8 expression in the cells stimulated with flagellin and 
treated with GPx4 siRNA and scrambled control siRNA. Data were expressed in a 
ratio relative to the level of control siRNA treatment group. Groups were compared 
using a 2-tailed Mann-Whitney U-test (**: p<0.01). n=9 
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6.3  Discussion 
In the present study siRNA knockdown was used to investigate the role of GPx4 in 
the NF B signalling pathway in Caco-2 cells following activation by TNF  and 
flagellin. The aim was to test whether GPx4, as an essential antioxidant selenoprotein, 
exerts any regulatory effects on NF B activation, which has been suggested 
frequently to be associated with the redox-signalling. Using both the luciferase 
reporter model and measurement of endogenous IL8 mRNA level, the TNF -induced 
NF B signalling was not affected by GPx4 knockdown (Figure 32), whereas 
flagellin-induced NF B signalling was found to be decreased by GPx4 knockdown; 
luciferase activity was decreased by ~20% (Figure 33) and mRNA expression of the 
NF B target gene IL8 was decreased by ~40% (Figure 34). Critically, these 
experiments indicate that GPx4 knockdown has different effects on NF B signalling 
depending on the inducers. This suggests that knockdown of GPx4 affects part of the 
signalling pathways that are distinct between TNF  and flagellin-activated receptors.  
 
The inability of GPx4 knockdown to alter the luciferase expression by activated 
NF B signalling in response to TNF  provided additional information to the previous 
findings that knockdown of GPx1, SelW and SelH resulted in either decreased (Figure 
22) or unchanged (Figure 24) NF B-luciferase reporter activities by the same inducer. 
These selenoproteins tested were found (Figure 26) or have been suggested to be 
decreased in expression by Se depletion (also see Section 6.1 introduction). GPx4 
expression has been observed to be mildly decreased, by ~24%, in Caco-2 cells grown 
in Se-depleted medium (Pagmantidis et al., 2005), whereas GPx4 expression was 
decreased by >85% in the present study using 120pmol GPx4 siRNA, which was a 
much larger decrease than the effect caused by Se depletion. However, no significant 
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difference in luciferase activity driven by TNF -NF B signalling was identified in the 
GPx4 knockdown treatment group compared to the control groups treated with 
lipofectamine or treated with “scrambled” control siRNA. Therefore, in addition to 
the previous findings that knockdowns of either GPx1, SelW or SelH expression were 
unable to reproduce the up-regulated TNF -NF B signalling observed in Se depletion, 
findings by this study further suggested that knockdown of GPx4 expression, by 
>85%, was also unable to cause obvious effects on the TNF -NF B response.  
 
Therefore, comparing the results of increased NF B activation by Se depletion and 
the results from knockdown experiments (GPx1, SelW and SelH knockdown 
described in last chapter and GPx4 knockdown described in the present chapter), it is 
reasonable to suggest that the regulation of the NF B signalling pathway following 
TNF  induction by Se depletion, occurs through alternations in the redox-balance by 
systematic changes in the expression of multiple selenoproteins.  
 
The down-regulated NF B signalling in response to flagellin by GPx4 knockdown 
was identified using the luciferase reporter system and confirmed by semi-quantitative 
RT-PCR measurements of IL8 mRNA expression. This contrasts with the earlier 
finding (Chapter 4) that this particular NF B response was not affected by Se 
depletion. The mechanisms in regard to the decreased flagellin-NF B signalling 
remained to be explored. However, this pathway activates NF B signalling through 
the TLR receptors and therefore is different from the TNF  pathway. 
 
Owing to its effects on ROS clearance, GPx4 has been suggested to exert a repressive 
role in the activation of the NF B signalling (Banning and Brigelius-Flohe, 2005, 
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Wenk et al., 2004), but so far only limited evidence has been directly provided in this 
regard. Much of this evidence is based on observation of activation status of NF B 
signalling using overexpression experiments, rather than the knockdown approach 
used in the present work. Particularly, the targets of redox-signalling responsible for 
activation of NF B signalling need to be defined to explain the underlying 
mechanism(s). Intriguingly, in the previous Chapter, knockdown of GPx1 expression 
was also correlated with decreased NF B-luciferase reporter activities and IL8 
expression in response to TNF  in Caco-2 cells. These findings suggest that different 
selenoproteins have different effects on NF B signalling. In addition, it is possible 
that the regulatory role of the antioxidant selenoproteins in NF B signalling might be 
distinct when their levels are either overexpressed or knocked-down. Finally, this 
raises the question of how the antioxidant selenoproteins, together with the other 
antioxidants, are integrated into the control of NF B signalling, and how this explains 
the response to Se depletion.  
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7.   Final discussion 
The micronutrient Se, together with selenoproteins, has been widely studied in respect 
to its health implications in areas including antioxidant protection, immune function 
and inflammation, cancer risk, thyroid hormone metabolism (DIO family), calcium 
homeostasis (SelN) (Arbogast and Ferreiro, 2010), protein folding and ER-stress 
response (SelS, Sep15 and others) (Labunskyy et al., 2009, Shchedrina et al., 2010). 
In relation to this thesis, specifically, Se can provide significant protection of the 
gastrointestinal tract against inflammation and carcinogenesis (Karp and Koch, 2006, 
Duffield-Lillico et al., 2002). For example, Se intake has been associated inversely 
with the risk of colon cancer (Russo et al., 1997) and Se supplementation has been 
used as a non-therapeutic method to control the symptom of Inflammatory bowel 
disease (Halliwell et al., 2000).  
 
The anti-inflammatory effects of Se in the colon have been related to the function of 
the antioxidant selenoproteins. GPx1 -/- and GPx2 -/- double knock-out mice are 
sensitive to microbial challenges and vulnerable to development of colitis and colonic 
cancer (Esworthy et al., 2003). In addition, the antioxidant selenoproteins, GPx1, 
GPx2 and GPx4, can repress the biosynthesis of eicosanoids in various cells 
(summarized in Table 2). Se and selenoproteins GPx1 and GPx4 also have regulatory 
effects on the NF B inflammatory signalling pathways in the breast cancer cells and 
macrophages (reviewed in Section 1.3). However, it is unknown whether, and how, 
Se together with antioxidant selenoproteins has any regulatory effects on the NF B 
signalling pathway functioning in the human gastrointestinal tract, which system 
constantly requires the healthy maintenance of immune homeostasis.   
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The NF B signalling pathways are critical control factors for the inflammatory 
response. The potential linkage between Se/selenoproteins and the NF B signalling 
pathways is that NF B signalling pathways are frequently mediated by ROS 
(reviewed in Section 1.2b and 1.2c), and Se and antioxidant selenoproteins repress 
ROS. This potential link provides the rationale that supports the present studies. 
However, the NF B signalling pathways are complicated and many NF B inducers 
may also activate alternative pathways. For example, TNF  and flagellin both activate 
the MAPK and apoptosis pathways, in addition to the NF B pathway (Li and Lin, 
2008, Yu et al., 2003).  
 
The present study addressed the hypothesis that Se and selenoproteins modulate the 
NF B signalling pathways in human colonic epithelial cells in response to 
inflammatory challenges. To test the hypothesis, an NF B-luciferase reporter system 
was developed in Caco-2 cells and the effects of Se depletion and selenoprotein 
knockdown (GPx1, SelW, SelH and GPx4) were studied using both the reporter 
system and measurement of endogenous expression of the NF B target gene IL8, 
following stimulation of cells with the known NF B inducers TNF  and flagellin. 
Using this strategy, the activation of the NF B transcription activity was specifically 
reported as luciferase expression and its impact on the expression of selected target 
genes examined and used as confirmation. 
 
The other important selenoproteins not examined in the present study include TrxR1, 
TrxR2, GPx2, SelS and SelP, owing to the limition in time. TrxR1 and TrxR2 are 
essential antioxidants which reduce thioredoxin (Lu et al., 2009) and subsequently 
generate ROS and therefore interact with the GSH-GPx redox system. Thioredoxin 
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and Thioredoxin reductases (TrxRs) predominantly modulate DNA-binding affinity of 
NF B subunits, an event after I B-NF B disassociation. Thioredoxin has previously 
been shown to crosslink the thiol compounds (-SH) between the cysteine residues of 
p50 (for example, Cys62 of p50) (Hayashi et al., 1993) or c-Rel (Glineur et al., 2000) 
and promote oxidation and inhibition of the NF B DNA-binding ability (Hayashi et 
al., 1993). Therefore, TrxRs may unlock this inhibition by reducing thioredoxin and 
fully activate the NF B transcription factors (Sakurai et al., 2004). Particularly, 
TrxR1, the cytosolic form of TrxR, is expressed ubiquitously in all tissues and its 
expression has been shown to be sensitive to changes in Se supply (~4 fold increase in 
Se supplementation (40nM) and ~60% reduction in Se depletion for 7 days in 
endothelial EAhy926 cells (Crane et al., 2009), or ~35% reduction in mouse colon fed 
Se-deficient diet (Kipp et al., 2009)). Therefore, it will be important to study the 
influence of TrxR1 knock-down on TNF -NF B signalling in the future.  
 
GPx2 is an antioxidant selenprotein specificially expressed in the human 
gastrointestinal tract. The expression of GPx2 is highly stable (highest in Se 
incorporation hierarchy) and hardly lowered by Se depletion (Brigelius-Flohe and 
Kipp, 2009). Similarly, TrxR2 has also been suggested to be relatively stable and its 
expression is difficult to influence unless under prolonged Se depletion (7 days) 
(Crane et al., 2009). Therefore GPx2 and TrxR2 were not considered a priority for 
investigation in the present study of NF B signalling during Se depletion. In addition, 
the functions of SelP and SelS (see Section 1.1d) are only poorly characterized 
(Curran et al., 2005, Moghadaszadeh and Beggs, 2006) and their roles in NF B 
activation were not established.     
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To develop the NF B-luciferase reporter model in Caco-2 cells, the NF B-luciferase 
(test) and the TATA-luciferase (control) constructs were made by modification of the 
previously established 3X B-luciferase reporter (Carlsen et al., 2002). The 
modification was necessary because the TATA control construct, which has no NF B 
binding sites, was not provided with the original reporter system. These constructs 
were integrated with either the pBLUE-TOPO or the pcDNA3.1 v5-his-TOPO 
plasmid vector and stably transfected in Caco-2 cells. However, the preliminary 
studies of the v5-his-TOPO constructs found that the TATA control cells expressed 
baseline luciferase activity at a relatively high level (~242 luciferase units per mg 
protein lysate) and exhibited an unexpected responsiveness to TNF , by showing a 
4-fold increase of luciferase activity (Figure 14). A possible explanation was the 
presence of the CMV promoter in the pcDNA3.1 v5-his-TOPO plasmid. The CMV 
promoter has been suggested to be responsive to NF B transcription factors 
(Sambucetti et al., 1989), and it contains four binding sites of Class I NF B, 3X 
GGGACTTTCC and 1X GGGGATTTCC, corresponding to motif GGGRNNYYCC 
(R: purine, Y: pyrimidine, N: any base). Therefore, potential NF B binding sites of 
the CMV promoter were predicted to be causing the responsiveness of the TATA 
control cells.  
 
In comparison, the other pair of reporter cell lines, transfected with the NF B- and 
TATA-luciferase constructs in pBLUE-TOPO vector, that has no CMV promoter, 
exhibited low baseline luciferase activities and good responsiveness to TNF  and 
flagellin. The baseline luciferase activity was ~23luc units/mg in the NF B cells and 
~11luc units/mg in the TATA cells (Figure 15). Following treatment with TNF  for 4 
hours or flagellin for 6 hours, respectively, the NF B cells exhibited increases of 
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luciferase activity of 12 fold and 6.4 fold, respectively, whereas under both conditions 
the TATA cells exhibited no increase (Figure 15). Therefore, the NF B- and 
TATA-luciferase pBLUE-TOPO transfected Caco-2 cells are able to report, 
specifically, the activity of NF B transcription factors and were used to test the 
regulatory effects of Se and selenoproteins on the NF B signalling pathways.     
 
The impact of Se depletion on NF B signalling was studied using a previous 
established method that depletes Se in the cell growth medium, i.e. growing cells 
without FCS but in presence of insulin and transferrin, and in the control group, 
supplementing cells with sodium selenite (Pagmantidis et al., 2005). This method 
decreased the expression of mRNAs encoding selenoproteins such as GPx1, SelW and 
SelH (Figure 26 (A)). Following Se depletion/Se supplementation, the NF B- and 
TATA-luciferase Caco-2 cells were stimulated with TNF  (20ng/ml) and flagellin 
(100ng/ml) and luciferase activity was measured in these cells before and after 
stimulation. Without stimulation, the baseline luciferase activities of the NF B or 
TATA cells were comparable under the conditions of Se-depletion and 
Se-supplementation (Figure 17 (A)). Therefore, Se depletion itself did not affect the 
basic luciferase expression and the non-specific background NF B signalling in 
Caco-2 cells.  
 
When the NF B-luciferase cells were stimulated with TNF , there was a difference in 
luciferase activity between cells grown in Se depleted and Se supplemented medium. 
The Se- NF B-luciferase cells exhibited higher, an average of 30% more, luciferase 
activities than the Se+ NF B-luciferase cells 2 or 4 hours after TNF  stimulation 
(Figure 17 (B)). This difference was statistically significant (p<0.05 in the 4h TNF  
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treatment group and p<0.01 in the 2h TNF  treatment group). It was only observed in 
the NF B-luciferase cells and not in the TATA control cells, which maintained low 
luciferase activities throughout (Figure 17 (B)). Similarly, in the untransfected Caco-2 
cells after 1h TNF  stimulation, IL8 expression changed accordingly to whether the 
cells were cultured either minus Se or plus Se, with the Se-depleted group expressing 
on average 50% more IL8 mRNA than the Se+ group (p<0.001) (Figure 19 (B)). Thus, 
these observations support the hypothesis that Se supply has regulatory effects on the 
NF B signalling pathway in response to TNF  in Caco-2 cells, such that when Se 
supply is depleted elevated NF B activation occurs. 
 
When the reporter cells were, in parallel, stimulated with Salmonella typhimurium 
flagellin (100ng/ml), no difference was found between the luciferase activities 
measured in the Se- and Se+ growing cells (Figure 20). After 2h or 6h induction by 
flagellin, the NF B reporter cells exhibited increased luciferase activity indicating 
activated NF B signalling, but this response was similar in the cells either Se depleted 
or supplemented. Therefore, these findings suggest that, unlike the TNF -activated 
NF B signalling response, flagellin-activated NF B signalling is not influenced by Se 
supply. However, further experiments to monitor NF B activation by measurements 
of expression of a NF B target gene, such as IL8 mRNA, or the NF B DNA-binding 
affinity, would strengthen this conclusion.  
 
It is not surprising that Se depletion had different regulatory effects on the 
TNF -NF B and the flagellin-NF B signalling pathways, because these two 
pathways are processed independently through different signalling transduction 
cascades. TNF  activates NF B transcription factors using the adaptor proteins 
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TRADD, RIP and TRAF2, and it has been suggested that this activation is essentially 
associated with redox-signalling attributed to the flavokinase-Nox2 complex 
(Yazdanpanah et al., 2009) (Chapter 1 Section 1.2b). In comparison, flagellin 
activates NF B signalling using the adaptor proteins MyD88, IRAK4-IRAK1 and 
TRAF6, and pathway activation has been linked to redox-signalling produced from 
the IRAK4-Nox1 complex (Chapter 1 Section 1.2c). Furthermore, the 
phosphorylation of IKK subunits functions through TAK1, NIK, MAP3K1 or 
MAP3K3 in cells including lymphocytes, fibroblasts, breast cancer cells and 
fibroblast-like synovial cells for the TNF -NF B activation (reviewed in Section 
1.2b), and through TAK1 for the flagellin-NF B activation in human colonic 
epithelial T84 and Caco-2 cells (Kawahara et al., 2004). These distinct features in 
NF B-activation by TNF  and flagellin could potentially be responsible for the 
different effects seen in the Se depletion studies. Based on these observations, it is 
reasonable to suggest that Se supply might influence certain, but not all, types of 
NF B response in Caco-2 cells (see the latter parts of this discussion).  
 
The mechanism by which Se depletion resulted in an elevated NF B response to 
TNF  was further analyzed by using siRNA to knockdown expression of individual 
selenoproteins, including GPx1, SelW and SelH, and then assessing the impact on the 
NF B response to TNF  (Chapter 5). The reason for selectively studying these 
selenoproteins was because they all have well-characterized (GPx1) or suggested 
(SelW and SelH) antioxidant activity and, in addition, their expression is most 
affected by Se depletion (Sunde et al., 2009, Kipp et al., 2009). In Se depletion, the 
expressions of GPx1, SelW and SelH mRNA were lowered by 60%, 40% and 50%, 
respectively (Figure 26). Using siRNA, their mRNA expression was knocked down to 
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comparable levels, by 55%, 50%, 40%, respectively, which allows reasonable 
comparison of these data in the siRNA and Se depletion experiments. GPx1 
knockdown decreased the TNF -NF B response by ~13-25% (p<0.01), an effect 
contrary to that of Se depletion, when assessed by luciferase reporter activity (Figure 
22 (B)). This decrease was specific to TNF  stimulation, since the baseline luciferase 
activities were similar in the GPx1 siRNA and control siRNA groups. Moreover, 
following 1 hour of TNF  stimulation, the IL8 mRNA level also showed a significant 
decrease (17%, p<0.05) in the cells with GPx1 knockdown when compared to the 
cells without knockdown (Figure 23 (B)). Overall, these observations suggest that the 
knockdown of the antioxidant selenoprotein GPx1 alters the TNF -NF B response in 
Caco-2 cells, and yet this effect is contrary to the effect of Se depletion and is an 
inhibition of the activation of NF B signalling.  
 
In addition, the effects of SelW and SelH knockdown appeared not to change the 
TNF -NF B response in Caco-2 cells, as assessed by NF B-luciferase activity 
(Figure 24). Thus the TNF -induced NF B transcription activity seems not to be 
influenced either by SelW or SelH. Similarly, when GPx4 was knocked down by 
>85%, the Caco-2 reporter cells also exhibited no difference in luciferase activity 
after TNF  stimulation (Figure 31). The distinct effects of Se depletion and 
selenoprotein knockdown (GPx1, SelW, SelH and GPx4) raise the challenging 
question of how Se supply exerts its regulatory effects on the TNF -NF B response 
when its effects cannot be simply explained by the altered expression of one of the 
individual antioxidant selenoproteins. It is possible that Se depletion results in 
elevated NF B signalling by decreasing the expression of multiple selenoproteins, 
including GPx1, SelW, SelH (Figure 26), TrxR2 and GPx4 (Pagmantidis et al., 2005). 
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In comparison, siRNA knockdown only resulted in decreased expression of a single 
antioxidant selenoprotein which might not be enough to modulate the redox system 
sufficiently to affect the TNF -NF B response. This explanation was supported by 
the experiments measuring the ROS levels in the Se- cells and in the GPx1 
siRNA-treated cells. Compared with the Se+ cells, Se- cells exhibited 60% higher 
levels (p<0.001) of ROS (Figure 25 (A)), whereas compared with the scramble 
control siRNA-treated cells, the GPx1 siRNA-treated cells exhibited no obvious 
difference in ROS level (Figure 25 (B)). Since NF B activation has been suggested to 
be partly mediated through ROS (Gloire et al., 2006, Haddad, 2002), it is possible that 
Se depletion and GPx1 knockdown exert their respective effects on the TNF -NF B 
response, through their effects on ROS levels. 
 
It is possible, indeed likely, that Se depletion decreases the expression of multiple 
antioxidant selenoproteins, leading to an impaired redox system, increased ROS levels, 
enhanced redox-signalling and elevated NF B signalling in response to TNF  
stimulation. On the other hand, GPx1 knockdown decreases only GPx1 expression 
and the expression of other antioxidant selenoproteins is little affected (or possibly a 
compensatory increase), so following this treatment there is only slight stress to the 
redox system and ROS levels are unaffected. Thus in turn, this leads to unaffected or 
decreased redox-signalling (following compensation by the other antioxidant 
selenoprotein), and thus decreased NF B signalling following TNF  activation. 
 
In the present study the comparison between Se depletion and GPx1 knockdown at 
the cellular ROS level only provides indirect information for understanding their 
different effects in relation to the TNF -NF B response. Further investigations, such 
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as the double knockdown of two antioxidant selenoproteins, would be required to 
specifically test the hypotheses. On the other hand, it is still possible that some other 
untested selenoprotein, expression of which is also affected in the Se- cells, might be 
responsible for the elevated TNF -NF B response observed in the Se depletion 
experiments. Therefore, the exact roles of antioxidant selenoproteins in the Se 
depletion-caused elevation of TNF -NF B response still remain to be elucidated.  
 
Selenoproteins modulate the biosynthesis of eicosanoids, such as the leukotrienes 
through the 5-LOX metabolism pathway and prostaglandins through the COX1 and 
COX2 pathways (details reviewed in Section 1.3a), and some of these eicosanoids are 
capable of participating in the NF B signalling system. For example, leukotriene B4 
(LTB4), known to be inhibited by GPx1 and GPx4, is an NF B activator in 
monocytes (Huang et al., 2004). In contrast, a subtype of prostaglandin, the 
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was elevated by Se 
supplementation and inhibited NF B activation (Vunta et al., 2007). Although the 
interaction between the LOX/COX pathways and the NF B pathways was beyond the 
remit of the present study, these eicosaniods, as potential positive and negative NF B 
regulators, may also play a role in the regulation of the NF B signalling pathways by 
Se depletion and selenoprotein knockdown.   
 
Most of the studies of GPx1 (Li et al., 2001, de Haan et al., 2004, Li and Engelhardt, 
2006) and GPx4 (Wenk et al., 2004, Brigelius-Flohe et al., 1997) in relation to the 
NF B signalling pathways have suggested that these antioxidant selenoproteins exert 
negative regulatory effects. The present study found that in Caco-2 cells GPx1 and 
GPx4 knockdown were associated with a decreased TNF -NF B response (Figure 22 
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(B) and 23 (B)) and flagellin-NF B response (see Chapter 6 and Figure 32 (B) and 34 
(B)), respectively, therefore appearing to contradict the earlier findings. It is notable 
that in the present study, both the findings in relation to GPx1 knockdown and GPx4 
knockdown are consistent when the NF B signalling pathways were studied using the 
NF B-luciferase reporter model and the measurement of IL8 mRNA expression. 
Therefore, it is unlikely that these results were false-positive. The previous 
publications suggested that the NF B signalling pathways are negatively regulated by 
antioxidants because the antioxidants can repress the cellular production of ROS 
which mediates the NF B activation (Li et al., 2001, Li and Engelhardt, 2006). This 
proposed involvement of ROS is consistent with the findings of the present Se 
depletion studies, which resulted in both elevated ROS level and TNF -NF B 
response. However, ROS levels were unchanged in Caco-2 cells following GPx1 
knockdown (Figure 25 (B)), and this is partially consistent with the decrease in 
TNF -NF B response. Therefore, the present data indicates that mechanisms such as 
the compensatory control of ROS by antioxidants occur in the cells and also 
participate in regulating NF B inflammatory response. In addition, since human 
colonic epithelial Caco-2 cells are a new cell model for research into effects of Se on 
NF B signalling pathways, and NF B signalling pathways are highly cell-type and 
inducer-type dependent (reviewed in Section 1.2 and 1.3), it is feasible that the 
regulatory mechanisms identified in the TNF - and flagellin-induced NF B responses 
in Caco-2 cells are distinct from those observed in breast cancer and liver cells.  
 
Overall, combining the findings of both the Se depletion and selenoprotein 
knockdown experiments, the present study indicates that in a human gut epithelial cell 
line, Se supply exerts regulatory effects on the TNF -activated NF B signalling 
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pathway but has no obvious effects on the flagellin-activated NF B signalling 
pathway. Se depletion was associated with elevated TNF -induced NF B signalling 
in parallel with elevated cellular ROS level. At the level of individual selenoproteins, 
GPx1 knockdown exerted regulatory effects on the TNF -activated NF B signalling 
pathway in parallel with unchanged cellular ROS level, whereas GPx4 knockdown 
exerted regulatory effects on the flagellin-activated NF B signalling pathway. These 
findings suggest that the TNF -NF B and the flagellin-NF B signalling pathways are 
regulated differentially by Se and selenoproteins. The findings of the GPx4 
knockdown experiments suggested a novel regulatory role for GPx4 in the 
flagellin-NF B pathway, a pathway which has not been previously identified to be 
affected by Se depletion. Taking together the findings of the GPx1 and GPx4 
knockdown experiments, it appears that different antioxidant selenoproteins might 
exert regulatory effects on different NF B signalling pathways. Clearly, further 
investigation in future, provided more selenoproteins, such as TrxR1, TrxR2 and 
GPx2, could be included in studies of this area, would better expand the current 
knowledge that which selenoprotein(s) are the key player(s) in the regulation of which 
NF B inflammatory signalling pathways.    
 
TNF  is an inflammatory cytokine produced by mammalian cells. A large group of 
other cytokines, for example, IL1
✁
, TNF
✁
 and IL12, can also activate the NF B 
signalling in an endogenous pathway (Gilmore, 2008). As mentioned earlier, these 
cytokines bind to various membrane receptors such as TNFR1 and are used to transfer 
inflammatory signals from cell to cell (Li and Lin, 2008). Generally, these cytokines, 
together with their receptors, are ubiquitously expressed in all eukaryotic cells. In 
comparison, flagellin together with the other bacterial components, such as LPS and 
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Triacyl/Diacyl lipopeptide, are produced by bacterial cells and they are capable of 
activating NF B signalling through an exogenous pathway (Gilmore, 2008, Arancibia 
et al., 2007). These bacterial components bind to various TLR receptors and serve as 
direct inflammatory stimuli from bacteria to host cells (Arancibia et al., 2007). In 
addition, human gut epithelial cells can differentiate between pathogenic and 
commensal bacterial antigens so that only the former cause an inflammatory response 
(Gewirtz et al., 2001, Cario et al., 2002). For example, TLR5 is expressed on the 
basolateral surface of polarized intestinal cells and only the flagellin of the pathogenic 
bacteria, but not those of the commensal bacteria, can be transported to the basolateral 
cell membrane to activate the TLR5 pathway (Gewirtz et al., 2001). Another Toll-like 
receptor, TLR4, is expressed selectively in some gut epithelial cell-types, such as T84 
cells (Cario et al., 2002), but not the others, such as Caco-2 cells (data not shown). 
Therefore, it is likely that the exogenous bacterial stimuli, together with their 
receptors, can be differentiated and selectively controlled by the gut epithelial cells.  
 
On the basis of the type of NF B inducer, i.e. cytokines and bacterial antigens, the 
results of the present studies suggests a model in which the endogenous and 
exogenous NF B signalling pathways are differentially regulated by Se and 
selenoproteins to control against excessive inflammation in the gut epithelium. This is 
summarized below and illustrated in Figure 35. 
 
At the beginning of a bacterial challenge, except following extreme changes such as 
GPx4 knockdown, Se supply does not appear to influence the NF B inflammatory 
signalling in response to exogenous bacterial stimuli in the gut epithelial cells. This 
step probably allows the epithelial cells and/or immune cells to differentiate between 
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the pathogenic and commensal bacterial types and allows the immune cells to kill the 
invasive bacteria. Thus, the system allows the host to regulate the inflammatory 
response. However, Se supply seems to play a role in controlling the NF B response 
to endogenous, i.e. host, stimuli. Moreover, this control appears to be accomplished 
by the different antioxidant proteins compensating for each other. These controls help 
to repress any excessive inflammation in the epithelial cells and protect cells from 
damage. This model can help to explain the link between insufficient Se intake and 
the increased risk of colonic cancer (Whanger, 2004), on the basis that there is 
increased inflammation resulting in cell damage and cancer. In addition, Se 
supplementation can ease the symptoms of inflammatory bowel disease (Halliwell et 
al., 2000, Tirosh et al., 2007) due to the ability of Se to inhibit inflammation in 
response to the endogenous cytokines. The GPx1 -/- and GPx2 -/- double knockout 
mice acquire repeated colitis (Esworthy et al., 2003, Lee et al., 2006) due to the 
additional stresses on the antioxidant system that normally would repress 
inflammation.   
 
Finally, it is important to consider questions and hypotheses that would have been 
investigated if time had allowed. Here, Se depletion and GPx1 knockdown in relation 
to the selenoprotein expression had been studied using semi-quantitative RT-PCR 
addressing the mRNA level of selenoproteins GPx1, GPx4, SelW, SelH and GPx2 
(Figure 26). Additional investigations addressing the mRNA level of these 
selenoproteins using real-time PCRs, or addressing their protein level using Western 
blots or protein activity level using GPx1, GPx4 and TrxR1 activity assays, would 
have been useful to further define how these selenoproteins are differently affected by 
Se depletion and GPx1 knockdown. Also of interest would be whether, if so, and how 
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the proposed compensation in combined antioxidant protein expression contributed to 
ROS clearance. Moreover, the present investigations (Figure 26) did not measure the 
expression of TrxR1 and TrxR2 and additional information in regard to their mRNA 
and/or protein expression in response to Se depletion and GPx1 knockdown would be 
valuable. 
 
A further strategy to elucidate whether and how antioxidant selenoproteins co-operate 
to control NF B inflammatory signalling would be to perform double knock-down 
experiments using two siRNAs in a combination to decrease the expression of both 
selenoproteins, such as GPx1 + GPx2, or GPx1 + GPx4. The comparison of double 
knock-down models with the results from Se depletion and/or GPx1/GPx4 
knockdown on NF B response would complement the current knowledge based on 
knockdown experiments of single selenoproteins. In addition, the Se depletion 
experiments of the present study relied on the comparison of two cell culture 
conditions, i.e. Se depletion (0nM) and Se-supplementation (7ng/ml, equivalent to an 
optimal Se concentration of 40nM), and a dynamic study using a range of Se 
concentration (0-40nM) might better describe how Se status affects the regulation of 
NF B response from severe Se deficiency to optimal Se sufficiency.      
 
In the research area of NF B inflammatory signalling, to provide more support for the 
hypothesized NF B-regulation model (Figure 35), additional NF B signalling 
pathways, such as the endogenous IL1
✁
-ILR (interleukin receptor) pathway and 
exogenous LPS-TLR4 pathway, need to be studied in relation to Se depletion and/or 
selenoprotein knockdown to test if these pathways are also differentially regulated by 
Se. Meanwhile, the present study investigated NF B activation using a 
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NF B-luciferase reporter model and IL8 mRNA measurement, but additional 
methodologies, such as IL8 protein expression (in parallel with the IL8 mRNA 
expression data by the present study), the expression of more NF B target genes (a 
range of genes could be measured using commercial PCR-array approach), NF B 
DNA-binding affinity (using EMSA) and I B degradation (Western blot to measure 
I B level), could be used to further strengthen the current conclusions.  
 
The present study used the Carboxy-H2DCFDA method to measure the total ROS 
production in cells (Shimizu et al., 2004), but this method could not differentiate 
between water-soluble ROS, such as H2O2, and oxidative fatty acids, such as R-OOH, 
during the TNF -induced NF B activation and/or following Se depletion and GPx1 
knockdown. This needs to be addressed. In addition, it has been recently found that 
the NAPDH oxidase 2 (Nox2) complex and its derivative H2O2 play a key role in the 
TNFR1-NF B pathway (Li et al., 2009, Yazdanpanah et al., 2009). Therefore, 
alternative methodologies, such as assessment of Nox2 expression and activities, are 
needed to provide more precise information in order to further understand the effects 
of Se depletion and GPx1 knockdown on ROS levels and NF B signalling activation.  
 
Despite the possible link between Se intake, gut inflammation and colorectal cancer 
risk, the biochemical and cellular mechanisms that link Se intake, gut epithelial cell 
function and carcinogenesis are poorly understood. Most previous studies 
investigating the influence of Se supplementation or selenoprotein overexpression on 
inflammatory signalling mechanisms such eicosanoid synthesis or NF B signalling 
were not carried out on GI epithelial cells. The present research work is the first to 
study  the effects of Se depletion on NF B activation in response to TNF  or 
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flagellin in a colonic epithelial cell line (Caco-2 cells) and then to systematically 
analyze the different roles of depleted Se supply and down-regulated expression of 
selenoproteins GPx1, GPx4, SelW and SelH in NF B regulation. Se depletion was 
found to result in elevated NF B response to TNF , but not flagellin. This indicates 
that Se deficiency, may influence a particular NF B response rather than acting as a 
global modulator of these pathways. Further analyses using siRNA knockdown 
mimicked the down-regulation of GPx1, GPx4, SelW and SelH in Se depletion and 
revealed that altered expression of none of the tested selenoproteins exerted an effect 
on the TNF -NF B response that mimicked Se depletion. In addition, Se depletion 
increased cellular ROS levels, whereas GPx1 knockdown did not apparently change 
the ROS levels. These results indicate that Se, possibly through incorporation into 
multiple selenoproteins, acts as a unique control factor in NF B regulation and has 
greater effects on the redox-system and redox-sensitive signalling pathways than any 
individual antioxidant selenoproteins. Moreover, GPx1 knockdown was also found to 
decrease the TNF -NF B response, suggesting the existence of functional 
compensation of antioxidants and co-regulation of NF B activation by antioxidants in 
the redox-system.    
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